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Introduction 
Overview of the Thesis 
7 
8 
The purpose of this thesis was twofold; firstly, to assess the pathophysiology of restenosis 
following percutaneous transluminal coronary angioplasty (Part I); secondly, to explore the 
potential of a novel technique, intravascular beta-radiation therapy, to prevent the recurrence of 
coronary stenosis after percutaneous treatment (part IT). 
The first part of this thesis represents an attempt to add further insights into the complex 
mechanism of restenosis. As will emerge in this first section, our hypothesis has been that vessel 
remodeling, watched as a continuous process, will ultimately determine lumen loss after balloon 
angioplasty bnt not after stents. The pathophysiology of restenosis was addressed in the second 
chapter, which describes the relationship between inflammation, i.e. activated neutrophils, and 
angiographic lumen renarrowing after coronary stenting and balloon angioplasty. 
In the third chapter, the local vascular response to balloon injury was assessed by means of 
sub-segmental analyses of the entire target coronary segment using three~dimensional 
intravascular (lVUS) reconstmction. This chapter also introduces a new methodology to 
investigate the magnitude and mechanism of the restenotic process by assessing this 
phenomenon at the site of maximal lumen loss, which actually represents the location of 
maximal arterial wall response to injury. 
In chapter 4, neointimal proliferation and potential stent recoil (remodeling) were assessed in 
coronary segments treated with two second~generation tubular stents using three~dimensional 
lVUS volumetric quantification of the entire injured segment. As three~dimensjonal IVUS 
imaging is the most refined technology currently available, it has also been applied in the second 
part of the thesis (chapters 8-10, 12), which assesses the vascular wall response to intravascular 
radiation therapy; an emerging therapeutic modality to prevent restenosis. 
In the chapter 5, we described recent clinical applications of intracoronary radiation therapy. 
New methodological and procedure-related concepts mainly derived from the vascular effect of 
this new therapy are described in chapters 6 and 7. 
In chapters 8 to 10, morphological changes of vessel stmctures after intra coronary radiation 
therapy using either catheter~based systems or radioactive stent were assessed. Special attention 
has been given to vascular remodeling, which appeared to be highly influenced by radiation: 
Also, the "edge-effect" phenomenon, i.e. lumen loss observed in the edge of the irradiated 
segment, has also been explored in chapters 7 (by means of quantitative coronary angiography), 
9 and 10 (by means of three-dimensional IV US analysis). 
Finally, the potentially deleterious effects of this new therapy have been critically analyzed in 
the last 3 chapters (11-13). These chapters report an alarmingly high incidence of sudden 
coronary occlusion late after intravascular radiation therapy (chapter 11), and intriguing IVUS 
findings occurring late (6-month follow-up) after treatment, late stent mal apposition (chapter 
12) and persisting unhealed dissection (Chapter 13). 
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Introduction 
Facing the new millennium, the costly problem of restenosis after percutaneous transluminal 
coronary angioplasty (PTCA) remains unresolved. Indications for angioplasty as well as the 
number of percutaneous interventions performed each year1 have been expanded considerably 
since the early days. In 1994, a total of 224.722 coronary angioplasty (PTCA) procedures were 
reported in Europe, an increase of 52% compared with 19922, and the latest European statistics 
estimates that the annual need for PTCA is 739 per million inhabitants3 In view of these 
consideration, clinicians may realize why researchers are spending so much time and money in 
attempts to finding a solution tor this "iatrogenic disease" originated from the geniality ofet a14. 
The aim of this chapter is to summarize the current data regarding pathophysiology and 
prevention and/or treatment of restenosis, 
Pathophysiology of Restenosis 
The biological aspects of restenosis are much too complex for a clinical article; thrombosis, 
inflammation, smooth muscle cell (SMC) migration/proliferation and extra~cellular matrix 
formation/degradation represent the fundamental sequence of healing and ultimately lumen 
reduction after catheter~based vascular intervention 5-11, The interplay between these factors is 
coordinated by multiple intra- and extra-cellular elements (growth factors, cytokines, hormonal 
factors, nitric oxide, protein kinases, etc)IO, 12. Local mechanical stimuli, chronic shear and/or 
tensile stress 13 14, 15, may further influence the restenotic process. 
Based 011 experimental studies, platelet aggregation and thrombus formation have been 
suggested as the foremost process leading to restenosis7, 8,16,17, At the site of injury, platelet 
aggregation, so~called white thrombus, may represent the major source for attractants and 
mitogens for smooth muscle cells. The platelet derived growth factor (PDGF), which may also 
be secreted by endothelial cells and macrophages, has been considered as the major promoter of 
SMCs Illigration I8-21 . In addition, thrombin Illay stimulate SMC proliferation22 and precipitate 
endothelial dysfunction23 The hypothesis that thrombus represents the core of the restenotic 
process has been supported by studies using angioscopy providing clinical evidence of early 
thrombus formation after PTCA24, 25 
Inflammation has also been implicated with restenosis, since leukocytes have been found early 
and abundantly at the site of vascular injury26~28, The inflammatory cell component of the 
restenotic process appears to play a greater part following stent (foreign body) implantation 
than balloon angioplasty29~32, vVhether the association between enhanced inflammatory 
response and vessel enlargement, as observed in a recent experimental study33, represents a 
potential beneficial effect of inflammation34 on vessel remodeling remains to be elucidated. 
The smooth muscle cell has long been implicated in the restenotic process35 , 36 due to its 
ability to migrate, proliferate and synthesize extra-cellular matrix upon stimulation20, 29, 37~41, 
After shifting from the contractile to the synthetic phenotype, SMCs may proliferate from 24h to 
2-3 months after vascular injury, returning to the contractile phenotype after this period. 
Through fracture of the internal elastic membrane, these cells migrate into the intima, where 
they may continue to proliferate and synthesize extra-cellular matrix, which will ultimately 
constitute the bulk ofthe restenotic lesion. 
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Recent experimental data have suggested that adventitial myafibroblasts (an (x-actin staining 
cell) also proliferate and migrate into the neointima42. Therefore, the adventitia has been 
proposed to play an important role in supplying the intima layer with proliferative cellular 
elements for new lesion formation. The adventitia Illay further be implicated in vascular 
remodeling33, 42-44, since myofibroblasts are capable of collagen synthesis and tissue 
contraction as seen in wound healing45 . 
Last but not least, extra-cellular matrix (ECM), composed of various collagen sub-types and 
proteoglycans46 actually constitutes the major component of the restenotic lesion; neointimal 
hyperplasia has been shown ta be predominately a low cellular tissue47. Constituents ofECM, 
such as hyaluronan, flbronectin, osteopontim and vitornectin also facilitate SMCs migration48-
50. In addition, reorganization of the ECM, replacing hydrated molecules by collagen, may 
result in retraction of vessel wall 5l . 
A New Paradigm of Rest ell os is: Vascular Remodeling 
The ultimate clinical consequence of the above described puzzling processes is late lumen 
renarrowing. The relative contribution of each of the phenomena, vascular remodeling and 
neointimal hyperplasia, to the occurrence of restenasis may vary considerably from one patient 
to another and even from one site to another in a same vessel 52. 
Elastic recoil has been characterized a decade ago by means of quantitative angiography53 to 
occur immediately after balloon angioplasty54, 55 as a consequence of the natural elastic 
property of blood vessels to respond to stretch. Thus, this phenomenon is of doubtfbl utility for 
the process oflate lumen renarrowing. 
Neointimal proliferation was originally described as the most important mechanism of restenosis 
based on extensive experimental and autopsy works as described above56-58 . Based on this 
assumption, several clinical studies were conducted in attempts to prevent restenosis using 
pharmacological antiproliferative agents, but results have been largely disappointing59-72 We 
now know that only half of late lumen loss following PTCA procedures is due to intimal 
hyperplasia59 and a new paradigm of rest enos is has emerged: vascular remodeIing l4, 63, 73-76. 
The chronicle change of coronary artery dimensions was first described in 1972 by Mann et 
aJ77, who observed that African Masai tribesmen maintained lumen dimensions despite 
substantial atherosclerosis. Later, Glagov et al78 demonstrated that vessel enlargement 
compensates for atherosclerotic plaque increase, maintaining lumen dimensions. In this elegant 
autopsy work 78, up to 40% increase in plaque volume was neutralized by vessel enlargement; 
after reaching this threshold, lumen reduction was directly proportional to plaque growth. 
Subsequently, similar compensatory mechanisms have been proposed to explain the restenotic 
process l4, 74 and vessel shrinkage has been observed as an important determinant oflate lumen 
reduction75, 76 
Intravascular ultrasound (IVUS), due to its ability to image structures of the vessel wall 79, 80 
in vivo, has played a central role in clarifying the relative contribution of new tissue growth and 
vessel constriction to restenosis. IVUS studies have provided clinical evidence that neointimal 
hyperplasia accounts to less than 50% of lumen reduction in non-stented coronary segments81 -
84 
The term remodeling has been applied largely to describe either vascular shrinkage or 
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enlargement85 . The definition proposed by Schwartz et a185, in which remodeling is 
characterized in a continuous spectrum by any change in vascular dimension, may better 
describe this compensatory phenomenon. Quantitative angiographic studies showing that 
changes in lumen diameter after PTCA present a near-Gaussian distribution 86, 87 suggested 
that the response to PTCA is a generalized phenomenon rather than the previously held notion 
that restenosis was an "all or nothing" event. Subsequently, IVUS studies showing good 
correlation between changes in plaque and vessel cross-sectional areas have determined the 
compensatory aspect of the remodeling process after PTCA8l, 83, 84. In this regard, our group 
carried out a detailed three-dimensional lVUS analysis of the local processes of restenosis. We 
observed, albeit preliminarily, that local changes in plaque volume correlated with changes in 
total vessel (external elastic membrane) volume, although both patterns of remodeling 
(enlargement and shrinkage) were found in individual balloon-injured coronary segments 
(unpublished data). Similarly, individual variability of the remodeling process has been reported 
by Pasterkamp et al in atherosclerotic femoral arteries52. 
The restenotic process was reputed by our group to be a device-specific phenomenon 88 which 
has been recently supported by IVUS studies 89 Studies using volumetric lVUS analysis have 
further confirmed that remodeling is almost absent after stenting whereas it plays the major role 
in late lumen reduction after directional coronary atherectomy or balloon angiopl asty90-92. 
Detection of Restenosis 
Gmntzig et al. first observed that most clinical ischemic events related to vessel renarrowing 
occurred between 3 and 9 months after PTCA, mirroring the appearance of angiographic 
restenosis93 -95 . Considering that up to 30% of asymptomatic patients may exhibit angiographic 
restenosis (diameter stenosis > 50% at follow-up) 96 and that exercise electrocardiographic 
testing has limited value to detect "silent" restenotic lesions, other non-invasive tests such as 
thallium scintigraphy and stress echocardiography have been used to improve the sensitivity and 
specificity of non-invasive assessment ofrestenosis97-99. In clinical trials testing the effect ofa 
given therapy on restenosis, objective angiographic criteria of restenosis have been preferred. 
When clinical outcome is also taken into account, repeat target vessel revascularization has been 
proposed as the most specific clinical restenosis end-point among other clinical markers (i.e., 
death, myocardial infarction, symptoms recurrence or combined major adverse cardiac events -
MACE)lOO. Conversely, for clinical purposes, non-invasive assessment of recurrence of 
stenosis (symptomatic status and stress tests) in patients treated with PTCA appears an 
appropriate approach. This latter recommendation is based on a series of previous observations: 
I) Routine angiographic follow-up may have increased, albeit small, morbidity and 
mortalitylOI. 2) Asymptomatic patients with non-functional angiographic restenosis experience 
a benign course 102-104 3) The so-called occulostenotic reflexl05 leads to a higher rate of 
repeat revascularization with no clear clinical benefit at 12 months after the initial 
intervention106. 4) Late lesion regression at the dilated site may occur after both stenting and 
balloon angioplastyl07-109 Undoubtedly, these data warrant a practical strategy of "watchful 
waiting" until recurrence of symptoms or non-invasive detection of ischemia occurs. If repeat 
angiography is carried out without clear clinical evidence of ischemia, sensor-tipped guide wires 
for measurements of distal flow velocity or pressure may be useful to assess filllctional status of 
restenotic lesions in the catheterization laboratory and assist physiologic-based decision making 
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regarding the need for reintervention 102, 110, In fact, many clinical trials include the 
requirement for such testing at follow~up angio in patients with asymptomatic restenosis. 
Coronary Angiography for Detection and Quantification of Restcnosis 
Angiographically detected lesions of 50% diameter stenosis or more at follow-up has been 
historically considered as representing "restenosis" III, This apparently arbitrary cutoff point 
was, in fact, founded on good scientific evidence, being based on physiological experimental 
studies which demonstrated that when the arterial lumen diameter is reduced to 50% or less, 
coronary flow reserve becomes impeded 112, For purposes of scientific studies, many definitions 
of angiographic restenosis have been used113, The classical binary definition based 011 
percentage diameter stenosis has not been universally accepted since it does not depict the 
concept of degree of deterioration in stenosis severity since angioplasty and does not convey a 
measure of the vessel response to injury94, 100, 114, The use of the term percentage diameter 
stenosis itself carries with it the assumption of nonnal-appearing reference segments, which is 
known from lVUS studies to be an erroneous assumption79, 80,115, It seems unlikely that, in 
clinical practice, the pragmatic angiographic binary view of restenosis will be replaced by a less 
practical scientific perspective of a continuous phenomenon, although tme progress in this area 
can only be made through the adoption of such scientific approach, particularly by the use of 
IVUS analysis I 16, In view of these considerations, clinical restenosis studies have been 
adopting a more comprehensive approach in reporting findings from both perspectives 
(categorical and continuous), to determine whether the agent under investigation had restraining 
or inhibitory effect and whether the ultimate clinical/angiographic outcome has been improved 
by the use of any new therapy, Quantitative coronary angiography (QCA) has been largely used 
to determine lesion severity and define restenosis in the clinical context 117-120, since visual 
assessment may lead to overestimation of the degree of narrowing in usevere" lesions and 
underestimation of the severity in umild or moderate" lesions12l-l23, Furthermore, digital 
systems now pelmit on-line QCA in the catheterization laboratory, providing fast, easy and 
clinical relevant infonnation for patient care124, Although, angiography has been widely used 
as the guiding tool for coronary disease management, the clinician should also consider 
functional, invasive or non-invasive, assessment of the restenotic lesion before referring the 
patient to additional coronary revascularization, 
Is Restenosis Predictable? 
Identification of factors associated with higher risk of restenosis may be useful in counseling 
patients whether to select a percutaneous intervention or other therapeutic strategies (clinical 
treatment or by-pass surgery), Unfortunately, there have been inconsistencies in linking 
restenosis to baseline demographic and clinical characteristics125-128. Diabetes mellitus and 
unstable angina have consistently been demonstrated to be important clinical risk-factors for 
restenosisl 25 , 126, 129-132, Preliminary results from the Arterial Revascularization Therapy 
Study (ARTS) have further con finned that diabetes mellitus is an important independent 
predictor of late clinical events in patients treated with multivessel PTCA 133, Some anatomic 
characteristics have also been implicated with increase likelihood of restenosis; left anterior 
descending coronary artery, saphenous vein graft, small vessel diameter, lesion length and 
chronic total occlusion represent important anatomic characteristics that have been associated 
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with higher incidence of angiographic restenosisl 26, 134-139 Others have reported higher 
incidence of restenosis for lesions located proximally140 and rest en otic lesions 141, 142. 
Although, prior knowledge of the subset of patients at higher risk of rest enos is may be useful for 
clinical decision making, angiographic and lVUS studies have extensively demonstrated that the 
principal determinant of restenosis is the lumen size achieved at the end of the procedure 137, 
143 R 149. The alllount of residual plaque burden has also been considered as an important 
predictor of restenosis 143, 150, Conversely, the PICTURE study investigators 1S1 did not 
identify any lVUS parameter related to categorical angiographic restenosis. The lise of long or 
multiple overlapping stents have also been associated with increased risk ofrestenosis144, 152, 
whereas the influence of balloon inflation pressure and residual dissection on vessel renarrowing 
has yet to be cIarifiedlS3-IS5 
To help in predicting restenosis in the cath lab at the end of a procedure, our group has 
constructed simple reference charts, based on serial QCA and IVUS studies. These charts, 
derived from large cohorts of patients enrolled in prospective trials, provide useful information 
for patient care, considering that QCA and/or IVUS analysis may be performed online and that 
such parameters are partially operator dependent 137, 144. Functional parameters derived both 
from post-procedure coronary flow velocity reserve (CFR) or fractional flow reserve (FFR) in 
combination with morphological (angiography) have been shown to predict restenosis after 
PTCAIS6-IS8 In the DEBATE study lS7, distal CFR > 2.S associated with angiographic 
residual stenosis <35% identified lesions with low restenosis rate (16% versus 41%). Similarly, 
another non-randomized study lS8 has shown that patients with both FFR >0.9 and angiographic 
residual stenosis <35% had high event free-survival rate at 12 months (92% versus 69%). The 
combination of these parameters must be thus considered a relevant practical approach in 
interventional therapy and day to day practice. 
Luminal Geometry and Rcstcnosis: 
The Impol'tance of Interventional Effectiveness 
The "bigger is better" philosophy IS9, in which the lumen size obtained after PTCA will 
ultimately determine the occurrence of restenosis, has been largely accepted. One may question 
the beneficial effect of optimized intervention since neointimal response has been shown to be 
proportional to the magnitude of vessel injury 47, 160, in other words "the more you gain, the 
more you lose". Both concepts, apparently contradictory, are fundamentally correct, and the 
ultimate determinant of late lumen size will be the balance between acute gain and late loss. It is 
now clear that the "the bigger, the better" principle holds tme for any interventional device, 
although the h1vorable relationship between late loss and acute gain appears to be a device-
specific phenomenon88 . Recent studies applying the concept of optimized intervention have 
reported lower restenosis rates as compared to their "old brothers" studies using similar devices 
lOS, IS7, 161-172 Although IVUS is unequivocally useful to guide and confirm the 
achievement of an optimal lumen gain, particularly in stented segments, the risk of restenosis 
still remain clinically relevant l48 In addition, the cost-effectiveness ofIVUS guided optimized 
stent deployment has yet to be demonstrated. In the MUSIC study, applying a strict IVUS 
criteria of optimal stent deployment in a selected population, impressive long-term results were 
observed (binary restenosis rate of 8.3%)165 The CRUISE study investigators have also shown 
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favorable results after lVUS guided stenting: reduction of target lesion revascularization from 
14.9% (IVUS documented group) to 8.9% (IVUS guided)148 On contrary, final results from 
the RESIST 173 and preliminary data from the AVID and OPTICUS trials have not confirmed 
the benefit of IV US guided stenting on late outcome. 
Provisional Stenting and Direct Stenting 
The strategy of "stent-like" balloon angioplasty with a stand-by stent to be implanted whenever 
needed (so-called provisional stenting) has emerged from the impressive good long-term results 
observed in the cohort of patients treated by SA and with a post-procedure diameter stenosis < 
30% in the BENESTENT trial 174 Although others have not confirmed these resultsl75, 176, 
provisional stenting has become an attractive strategyl57, 158, 177-180, since it may represent 
reduction in costs and good long-term outcome when a "stent-like" result is obtained with 
balloon angioplasty alone. Additionally, the treatment and the long-term outcome of patients 
with in-stent restenosis remain a matter of concern 181-184. 
Before unconditionally applying the strategy of provisional stenting in daily practice, one should 
consider that routine stent implantation was cost-effective in the BENESTENT II trial, and that 
the sub-group of patients with "stent-like" result after BA had a clinical outcome still 6% 
inferior to the stented patients105, 164. Reduction in both costs and restenosis rate may be 
further obtained by applying a strategy of direct stenting (without balloon pre-dilatation), 
although such beneHt needs to be confirmed in randomized clinical trials l85, 186. 
It is unlikely that stent-like results will be achieved by BA without adjunctive IVUS or 
physiological assessment, which Illay ultimately increase the cost of the procedure 153. Indeed, 
preliminary data from the DEBATE 11 trial, ill which optimal results were guided by QCA 
(residual diameter stenosis <35%) and Doppler Flow wire (CFR >2.5) measurements, showed 
that both primary (unconditional) and provisional stenting strategies had similar one-year 
clinical outcome and primary stenting was more cost-effective. Interesting and somewhat 
puzzling was that an improvement in event-free survival at one year was further achieved by 
stent implantation after an initial stent-like balloon angioplasty. In view of these considerations, 
a strategy of provisional stenting will not improve clinical outcome or reduce costs of PTCA 
procedures, but it may postpone stenting in up to 50% of the patients, which may have some 
benefit, considering the insidious and Umalignant» problem of in-stent restenosis. 
The role of "New" Intervention Devices in the PI'evention of Restenosis 
Over the past decade several new devices (stent, directional, rotational or extractional 
atherectomy devices, excimer laser angioplasty, cutting balloon, etc) and strategies have been 
developed to limit the occurrence of restenosis, but no therapy has consistently achieved a single 
digit incidence of restenosis. 
Intracoronary stents have unequivocally been shown to result in superior acute and late outcome 
as compared to balloon angioplasty I OS, 157, 161-164, 187-191 Therefore, these metallic 
prosthesis are being used in >50% of all intervention procedures worldwide l79, 192. It is 
nevertheless important to note that stents do not inhibit, but rather enhance, the proliferative 
vascular response and that this metallic prosthesis diminishes restenosis as compared to balloon 
allgioplasty by achieving a larger residual lumen and preventing vessel shrinkage (elastic recoil 
and negative remodeling). 
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Debulking devices (DCA, TEC, rotablator, laser angioplasty) have been reported as conferring 
no superior long~tenn results as compared to conventional balloon angioplasty and somewhat 
less than stentingI68-171, 193-196 Favorable results after directional atherectomy studies using 
a strategy of aggressive debulking guided by IVUS have been reported recently 166, 167 But 
these were obtained by operators experienced with the technique of DCA and such a strategy is 
more costly, so that the use of DCA should be restricted to non-calcified lesions proximally 
located in the left descending anterior coronary or bifurcation lesions l53 , 197, 198 The SOLD 
registry l99 has suggested a potential benefit (11% angiographic restenosis) of aggressive plaque 
debulking followed by stent implantation in such selected lesions. The synergistic hypothesis of 
debulking prior to stenting 199-20 I, although not yet validated in large randomized trial, is 
supported by recent IVUS study from the same group of investigators involved in the SOLD 
registry showing that the amount of residual plaque outside the stent correlates with long-term 
outcome 1 50 
Preventive Therapies 
Pharmacological Prevention of Restenosis 
The focus of the prevention of restenosis over the past 2 decades has been through the 
application of pharmacological agents. Unfortunately, the great majority of clinical studies have 
not reproduced the promising results observed in the experimentallaboratories59-72. 
Data from the EPIC study suggested a reduction in the need for second intervention in high-risk 
patients treated with monoclonal antibody against the platelet glycoprotein IIb/Illa202 However 
this hypothesis was not confirmed in subsequent trials using either a similar medication 
(abciximab) or other antagonists of GP IIb/IIIa69, 203 A potential anti-restenotic effect of 
abciximab on diabetic patients has been observed in a sub-analysis of the EP1STENT study204, 
but these results have yet to be vaiidated205 
A small number of studies on pharmacological intervention to prevent restenosis have showl) 
satisfactory results206-211 Before sweeping changes in clinical practice these findings should 
be further confirmed. 
Local dmg delivery devices, including dmg-coated stents, and even more sophisticated cell-
based vascular gene-delivered systems have been developed 192, 212, however the clinical 
application and efficacy of such therapies remains to be demonstrated. 
'Vhat about brachythernpy for prevention of l'estenosis? 
A new therapy, intracoronary gamma-radiation, has been reported to significantly reduce re-
restenosis after successful re-stenting of in-stent restenosis2 13, Preliminary data from 
prospective studies, using either beta (BETA WRIST) or gamma radiation (WRIST, 
GAMMAI), have recently confirmed the good results of catheter-based radiation therapy for the 
treatment ofin-stent restenosis: 40-70% reduction in restenosis as compared with placebo. 
Brachytherapy, either by means of catheter based-systems or radioactive stents, has also been 
used for prevention of rest enos is in less Hmalignant" de 110VO coronary lesions 214-218. 
However, the long-term safety of this novel therapeutic modality has been argued219, and 
before incorporating intracoronary radiation in daily clinical practice some problems must be 
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solved: stent and/or radiation edge restenosis216, late thrombotic occlusions220 and potential 
delayed restenosis22 1-224. 
How to deal with restenosis if we failed to prevent it? 
Restenotic lesions have been associated with an increased risk of re-restenosis as compared with 
"de novo" lesion, However, satisfactolY results (18% restenosis rate) have been observed by 
treating restenosis after balloon with stent implantation 191, 
Conversely, treatment of in-stent restenosis represents the new challenge for the interventional 
cardiologist 153, 182. Treatment of diffuse in-stent restenosis has been associated with high (45-
80%) rates of target lesion revascularization, regardless of the device used (balloon angioplasty, 
stent, rotational atherectomy or laser angioplasty)181, 183, 184,225,226. As discussed above, 
intracoronmy radiation, is the sole therapeutic approach that has proved clinically its efficacy for 
the treatmetlt of in-stent rcstenosis, 
Future Directions 
Researchers are still seeking solutions for rcstenosis, but the cure has not yet been found, Taking 
advantages of the accumulated knowledge in the past 2 decades, many innovative approaches 
have been developed, Biodegradable stents, which "dissolves" 9 months after implantation, have 
recently been implanted in humans with promising results227, Sophisticated energy-based 
therapeutic modalities (phothodynamic therapy, sonotherapy, cryotherapy) have also emerged as 
potential solutions and clinical studies are already underway, 
Undoubtedly we have come a long way in the last decade. More patients with complex coronary 
disease are being treated percutaneously using ilUlovative strategies, many as an out patient 
basis, PTCA is safer acutely than ever and bypass surgery is progressively being reserved for 
patients when percutaneous techniques appear impossible or inappropriate, 
The frequency of significant clinical recurrence of treated lesions is certainly less than 20 years 
ago but still represents the Achilles heel of the percutaneous approach. We have not founded the 
Hmagic bullet" or the "Holy Grail" and maybe we never will since the search seems to reveal 
more and more the complexity and multifunctional nature of the pathological process leading to 
the blockage we see in the angiogram. Nevertheless we and our patients take heart from the 
progress already made and the commitment shown to find a solution for restenosis, 
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Abstract 
Aim: Leukocytes have been implicated in the restenosis process after percutaneous transluminal 
coronary angioplasty. We investigate the association of the activated status of circulating 
lleutrophils and restenosis after angioplasty. 
l\fcthods and l'esults: The population consists of 108 patients treated for single, de novo lesions 
located in native coronary arteries with elective balloon angioplasty (n~44) or stenting (n~64). 
Pre-, post-procedure and at 6-month follow-up allgiograms were analyzed by an independent 
core lab. Blood sample was collected immediately before treatment and the antigen CD66, 
which is specifically expressed by activated neutrophils, was measured, Overall, the average 
expression of CD66 was 6.4±3.6 mean fluorescence intensity. In the stepwise linear regression 
model, which included biological, clinical and angiographic variables, absolute gain showed a 
direct association (p<O.OOI) with relative late loss (Relative late loss ~ absolute late loss .,. pre-
procedure reference diameter), whereas CD66 expression was inversely associated with relative 
late loss (p=O.004). CD66 expression also showed an inverse association with relative late loss 
in the balloon angioplasty treated patients (p~O.002, n~-0.49). In the stent subgroup, only 
reference vessel diameter and acute gain were independencpredictors of relative late loss. 
Conclusion: Our results confirm the beneficial role of pre-procedure activated status of 
neutrophils in the restenotic process after balloon angioplasty. The lack of relationship between 
CD66 expression by neutrophils and relative late loss after stenting suggests that this leukocyte 
may be involved in the remodeling process. 
Introduction 
The technique of percutaneous transluminal coronary angioplasty has undergone tremendous 
improvement. However, the recurrence of coronary stenosis is still a major problem in 
interventional cardiology. Some years ago, it became clear that differences in vascular 
remodeling playa major role in the restenotic process after balloon angioplasti-4. 
The understanding of the biochemical mechanism of the rest en otic process is of clinical 
relevance, since specific therapies could be developed to reduce the unsolved issue of restenosis 
after percutaneous coronary interventions. Therefore, the contribution of leukocytes to the 
restenotic process has been investigated5-8. Recently, it has been suggested that granulocytes do 
not contribute to the occurrence of intimal hyperplasia9 confirming the findings of Rogers et al. 
about the central role of monocytes in that process iO 
Further, we have found that pre-procedure expression of the CD66 receptor by neutrophils is 
associated with a better angiographic prognosis after balloon angioplasty'. While many 
activation markers were studied, the activation status of the neutrophil relevant for the 
angiographic outcome was best characterized by the magnitude of CD66 expression'. Although 
inflammation leading to weaker adventitial layers has been suggested to induce positive 
remodeling in experimental model'" 12, the exactly mechanism (neointimal formation or 
remodeling) involved in the potential beneficial effect of neutrophils on restenosis is still 
unknown. 
The neutrophil CD66 antigen, differently from the CD II b/CD 18 receptor, is exclusively 
expressed by granulocytes and is considered to be an activation marker as wellD. The CD66 
L.1111i1y members expressed by granulocytes have been found to be associated intracellularly with 
tyrosine kinases like Lyn and Hck that mediate signal transduction from the receptor l4 . It is not 
known if CD66 could serve as a marker for a subpopulatioll of neutrophils that playa specific 
role in the mechanism of restenosis. Neutrophils express four different CD66 members 
belonging to a group of highly glycosylated proteins of the carcinoembryonic antigen family, 
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i.e" CD66a, Cd66b (formerly known as CD67), CD66c, and CD66d 1', CD66a and CD66b are 
stored in the secondary granules, while CD66c is present in the primary granules of the 
neutrophil l6-18 , Upon ligation, these molecules may regulate eDllb/CD1S-mediated adhesion 
without the functional activation of that receptor and potentiate the production of reactive 
oxygen species l9-21 , To our knowledge, the variation in CD66 expression in humans has not yet 
been extensively studied. 
The aims of the present study were first to validate the unexpected finding of our pilot study' 
concerning the inverse association between relative late lumen loss and the pre-procedural 
expression of the neutrophil activation marker CD66, and finally to discriminate in which of the 
two components of restenosis (neointimal hyperplasia and/or remodeling) activated neutrophils 
expressing the specific receptor CD66 may contribute. Thus, we determined the association of 
the expression of CD66 before the procedure and late luminal renarrowing in an independent 
group of balloon angioplasty patients, and in a population treated with stent implantation. 
Methods 
This study consists of a coholt of 108 consecutive patients successfully treated with elective 
balloon angioplasty (n = 44) or stent implantation (n = 64) at the Thoraxcenter. All patients were 
treated for single-vessel, sholt « 20 mm) and de novo lesions located in native coronary 
arteries. Patients treated during the acute phase of myocardial infarction as well as those with in-
hospital complications after the procedure (myocardial infarction, repeat revascularization or 
subacute thrombotic occlusion) were excluded. The protocol was approved by the Medical 
Ethical Committee of the Erasmus University Hospital, Rotterdam and all patients provided 
written inform consent. 
Protocol 
Sheaths (7 or 8 French) were inserted into the arterial and venous femoral vessels. Thirty 
milliliters of blood was collected from the venous sheath immediately before treatment, 
anticoagulated with 0.2% EDTA, and kept at 4°C. The method of revascularization, balloon 
allgiopiasty or stenting was based on operator's preference as well as the type of stent to be 
implanted. The devices (balloon or stent) were sized according to the reference vessel diameter 
and lesion length. The procedures were performed according to standard clinical practice, with 
high-pressure (at least 12 atmospheres) post-stenting balloon inflation. All patients received 
aspirin (250 mg/day) at least 24h before the procedure, whereas stentcd patients also received 
ticlopidine (250mg twice a day, maintained for a period of30 days after the procedure). 
Quantitative Coronary Angiography 
Coronary angiograms were obtained in each patient pre-, post-procedure and at 6-month 
follow-up. All angiograms were analyzed using the CAAS system (Pie Medical BV, Maastricht, 
The Netherlands) according to previously described methodoiogy22. Measurements were 
performed in multiple (;?: 2) matched angiographic views after intracoronary nitrates were 
administered. The contrast-free guiding catheter was selected for calibration and interpolated 
reference vessel diameter at the computer-defined minimal lumen site was automatically 
calculated. All measurements were performed off-line by an independent Core Lab (Cardialysis 
BV, Rotterdam, The Netherlands) w'hich was unaware of the biochemical analysis results. 
Continuous angiographic criteria of lumen change has been largely used in clinical trials and 
more closely reflect the magnitude of the reactive intimal hyperplasia, compared to dichotomous 
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variables such as > 50% diameter stenosis2), 24. Thus, in accordance to our pilot study, we 
choose relative late loss as the dependent variable. Relative late loss was calculated as absolute 
late loss (minimal lumen diameter post - minimal lumen diameter at follow-up) divided by pre-
procedure reference diameter. In taking the reference vessel size into account, this parameter 
may better address the impact of vascular lumen reduction compared to absolute late loss. For 
comparison, we used other angiographic variables loss index (absolute late loss divided by 
minimal lumen diameter post) and net gain (minimal lumen diameter at follow up - pre-
procedure minimal lumen diameter) as well. 
Reagents 
The monoclonal antibody (mAb) used in the flow cytometric analysis of membrane antigen 
expression was mAb CLB-granIO directed against CD66acde (the Central Laboratory for Blood 
transfusion, Amsterdam, The Netherlands). 
Flow Cytometric Analysis of membrane Antigens 
To prevent any staining-procedure-related activation the leukocytes were kept on ice during 
the entire procedure to inhibit their normal metabolic processes. Furthermore, the reagents were 
endotoxin free. Erythrocytes in the blood sample were lysed with a sterile ammonium chloride 
solution consisting of 155 mM NH4CI, 10 mM NaHC03 and 0.1 111M EDTA at 4°C. This 
procedure does not alter the expression of CD66(b) and of various other membrane activation 
markers of the neutrophil 25 . Next, the leukocytes were washed two times with sterile, ice-cold 
phosphate-buffered saline (PBS; in mM: 140 NaCI, 1.5 KH,PO", 8.1 Na,HP04.2H,O and 2.7 
KCI; pH 7.4), and finally resuspended at a concentration of 2 x 107 cells/ml sterile PBS 
modified according to Becton Dickinson (PBSBD; in mM: 43 K,HP04, 10 NaH,P04.H,O, 123 
NaCI, and 0.02% NaN) and 0.5% bovine serum albumin; pH 7.2) at 4°C. Next,S x 10' 
leukocytes were incubated with the mAhs or mouse IgGI (negative control) for 30 min at 4°C, 
washed two times with ice-cold PBSBD and then incubated with fluorescein isothiocyanate 
(FITC) conjugated rabbit F(ab'J, anti-mouse IgG, (STAR9; Seratec) for 30 min at 4°C in the 
dark. The cells were washed two times and fixed with 1% paraformaldehyde in PBSsD. The 
duration of this procedure from the time of collection until fixation amounted to 3-4 hI'. Until the 
cells could be analyzed « I wk), they were stored at 4°C in the dark. The binding ofmAb to the 
cell surface was quantified by fluorescence-activated cell sorting (FACStar, Becton Dickinson, 
Etten-Leur, The Netherlands). Five thousand events were acquired after live gating of the 
neutrophils with the use of forward versus sideward scatter. Antigen expression is presented as 
specific median fluorescence intensity. 
Statistical Analysis 
Variation in duplicate measurements (intra-assay variation) did not exceed 10%. Univariate 
linear regression analysis was performed to determine the association between relative late loss 
after treatment and each biological, clinical, angiographic, and procedure- related variables. In 
order to establish the independent risk factors, each variable that proved to be statistically 
significant (p<O.05) were entered in a stepwise multivariate linear regression model with ''j/' 
values for inclusion and elimination set at 0.05 and 0.10. \Ve also performed separate analyses 
for each different therapeutic population, balloon angioplasty and stent. The correlation between 
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pre-procedure variables (clinical, angiographic) and the level of CD66 expression by neutl'Ophiis 
was also tested using univariate linear regression. 
Baseline characteristics are shown in table L Pre-, post- and follow-up angiographic results 
are summarized in table 2. The expression of the neutrophil membrane receptor CD66 ranged 
from 0 to 22.42 mean fluorescence intensity (average value of 6.4 ± 3.6). No relationship 
between the biological markers and clinical (including unstable angina, Braunwald classification 
class I-lIlA) or angiographic pre-procedure variables was found in our study. The mean CD66 
expression was 5.5 ± 2.1 mean fluorescence intensity in the stent group and 7.6 ± 4.7 mcan 
fluorescence intensity in the balloon angioplasty group. 
Table 1. Baseline clinical characteristics 
Val'iables 
Age, years 
Gender, male, % 
Diabetes, % 
Hypercholesterolemia, % 
Smoking, % 
Hypertension, % 
Previous myocardial infarction, % 
Previous bypass surgery, % 
Unstable angina, % 
Left anterior descending artery, % 
Total (11-108) 
57 ± 9.3 
51 
5 
14 
33 
39 
18 
7 
27 
43 
Ballooll Allgioplasty (11-44) 
55 ± 8.3 
38 
11 
II 
31 
40 
3 
o 
22 
45 
Predictors of relative late loss in the total population (n ~ 108) 
Stent (11-64) 
59 ± 9.6 
60 
o 
15 
33 
39 
28 
12 
29 
40 
\Ve identified several univariate predictors of relative late loss: expression of CD66, the use of 
stent, minimal lumen diameter post, and absolute gain (table 3). No clinical variable was 
correlated with relative late loss. By stepwise linear regression, only absolute gain and CD66 
remained as independent predictors of relative late loss (table 3). Absolute gain showed a direct 
correlation with increase relative late loss, whereas the expression of CD66 showed an inverse 
association with relative late loss. 
Predictors of relative late loss after balloon a"gioplasty 
In a separate analysis, we found some univariate predictors of relative late loss in the 
population treated with balloon angioplasty (n ~ 44): expression of CD66, target site in the LAD 
and diabetes (table 3). In the multivariate regression model, target site located in the LAD and 
the expression of CD66 remained as independent predictors of relative late loss. Treatment of 
LAD was directly related with relative late loss after balloon angioplasty, whereas the 
expression of CD66 remained inversely associated with relative late loss. The pre-procedure 
expression of CD66 was also statistically significant inversely related to the conventional 
variables absolute late loss and loss index, but directly related to net gain (not shown). 
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Table 2. Off~line Quantitative Corona!,! Analrsis 
Parameters Total (n=108) Balloon angio!,lasty (n=44) Stent (n=64) 
Pre-procedure 
Reference Diameter, mm 2.84 ± 0.5 2.76±0.5 2.89±0.6 
Minimal Lumen Diameter, mm 0.99 ± 0.44 0.99±0.41 0.99±0.46 
Diameter Stenosis, % 65.7± 13.3 64.5±12.5 66.6±13.9 
Post-procedure 
Reference Diameter, mm 3.1 ± 0.57 2.85±0.6 3.2±0.5 
Minimal Lumen Diameter, I1Ull 2.36 ± 0.61 1.97±0.52 2.6±0.52 
Diameter Stenosis, % 23.6 ± 11.2 33±7 18±8 
Acute gain, n1111 1.32 ± 0.63 0.97±0.5 1.6±0.6 
Follow-lip 
Reference Diameter, nUll 2.83 ± 0.58 2.78±0.54 2.85±0.59 
Minimal Lumen Diameter, mm 1.7 ± 0.68 1.6±0.6 1.7±0.7 
Diameter Stenosis, % 42.1 ± 20.1 42.5±15 41.9±22 
Late Loss, mm 0.66 ± 0.73 0.28±0.53 0.9±0.74 
Relative Late Loss 0.22 ± 0.26 0.1±0.2 0.3±0.25 
Predictors of relative late loss after stenting 
No biological risk factor was associated with relative late loss in the stent population (n = 64). 
Scatterplots showing the association of the expression of the membrane antigen CD66 and 
relative late loss in the balloon angiopiasty and stented patients are illustrated in figure. Two 
angiographic variables were indepeildent predictors of relative late loss: pre-procedure reference 
vessel diameter and acute gain (table 3). 
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Scatterplots showing the association between the expression of CD66 antigen by 
neutrophils and relative late loss (RLL) after 6 months according to the population 
investigated: A - in balloon angioplasly patients this association can be described by the 
equation: y = 8.97 - 11.67x (n=44; p=O.OOI, R'=0.232) and n - in ,tented patients this 
association can be described by the equation: y = 5.58 + 0.17x (n=64; p=0.9, R'=O.OOO). 
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Table 3. Predictors of Relative Late Loss after percutaneous intervention 
Variable Total (n = 108) BA (n = 44) Stent (n = 64) 
Univariate Multivariate Univariate Multivariate Univariate Multivariate 
Clinical p p b II P P b II p p b II 
Age NS NS NS 
Sex, male 0.08 NS NS 
Diabetes NS 0.051 NS NS 
Unstable angina NS NS NS 
Previous MI NS NS NS 
Previous angioplasty NS NS NS 
Left anterior descending NS 0.002 0.002 0.2 0.49 NS 
Angiographic 
Pre reference diameter NS NS 0.06 0.01 ·0.17 ·0.38 
Pre minimal lumen diameter NS NS NS 
Procedure-related 
Post reference diameter NS NS NS 
Post minimal lumen diameter < 0.001 NS 0.07 NS NS 
Absolute gain < 0.0001 < 0.0001 0.159 0.375 NS 0.03 0.03 0.16 0.32 
Stent < 0.0001 NS 
Biological markers 
CD66 0.002 0.004 -2.18 -0.278 0.00 I 0.002 -2.19 ·0.49 NS 
pre = pre-procedure, post = post-procedure. 
CD66 means the expression of this antigen by circulating neutrophils before the procedure. 
Discussion 
The present investigation corroborates the results of the pilot stud/ showing that activation 
status of circulating neutrophils, as demonstrated by the expression of the CD66 antigen, is 
inversely related with late coronary lumen loss after percutaneous coronary intervention. The 
standardized regression coefficients (P) of CD66 were similar in both the present study (balloon 
angioplasty group) and the pilot investigation' (-0.49 and -0.47, respectively). However, the 
expression ofthis antigen did not show any relationship with vessel renarrowing after stenting. 
This could be relevant for the understanding of the role of neutrophils in preventing luminal 
renarrowing after angioplasty, since stent almost abolishes the contribution of remodeling to the 
restenotic ~rocess and has been considered as a pure model to investigate neointimal 
hyperplasia 6,27. Thus, the finding that activated neutrophils expressing the CD66 antigcn may 
prevent vessel renarrowing after balloon angioplasty, but not after stenting, may encourage us to 
speculate that circulating phagocytes playa role in the mechanism of vessel remodeling after 
injury. Indeed, inflammatorl mediators have already been shown to promote vessel enlargement 
in experimental model ll , I . However, limitations of angiography to directly assess vascular 
remodeling after angioplasty should be taken into account before drawing any definitive 
conclusion. Further, the study population was not randomly divided to be treated with plain 
baUoon angioplasty or stenting, which may have introduced an unwanted source of bias. 
In the process of geometric remodeling of the vessel upon vascular it~ury alterations in 
extracellular matrix metabolism, specifically collagen redistribution, appears to be an important 
factor28 • In restenotic lesions total collagen content and collagen organization are significantly 
less in comparison with nonrestenotic vessels. \Vhile smooth muscle cells and fibroblasts 
produce various matrix proteins upon stimulation by cytokines secreted by mOl1ocytes in the 
lesion, these proteins on their turn could be degraded by matrix metalloproteinases. Neutrophils 
can release a solublc factor that activates endothelial cell matrix metalloproteinase-229 . On this 
basis, a negative role of neutrophils in the remodeling process would be expected. On the other 
hand, while the exact function of CD66 is currently unknown, it is noteworthy that gonococci 
expressing distinct opacity outer membrane proteins enter granulocytes via this receptor without 
stimulating their bactericidal repertoire using the phagocytes as an intracellular niche to 
survive3l • Can this pm1icular subpopulation of neutrophils prevent the change in phenotype of 
the myofibroblasts and smooth muscle cells, or the activation of the metalioproteinase cascade? 
Presently, no adequate mechanistic answer can be given. However, if CD66-expressing 
neutrophils accumulate at the site of injury and this receptor is stimulated properly, its distinct 
signaling pathway" may lead to the beneficial action as indicated by this study. Clearly, the 
underlyitig mechanism of the beneficial effect of CD66-expressing neutrophils on late lumen 
renarrowing after balloon angioplasty requires further investigation. 
Monocytes appear to be an imp0l1ant contributing factor to neointimal formation after 
vascular i'1iury. Accordingly, the administration of antibodies to the CDItb or CDt8 receptor 
subunits was shown to prevent intimal hyperplasia upon angioplasty or stent implantation in 
experimental animal modeis IO,32, However, granulocytes also express the CDIlb/CDl8 or Mac-
1 adhesion receptor and are recruited early to the traumatized vascular waU33 .37 . Thus any 
intervention directe.d to the Mac~ I receptor would prevent the entry of both monocytes and 
granulocytes into the lesion site, in fact revealing the net effect of the separate actions of each 
individual ceIl type. In a number of experimental models of vascular injury, in which 
neutrophils predominated in the lesion, the administration of monoclonal CD18 antibodies have 
failed to inhibit neointimal fonnation9, 38, 39. This indicates that neutrophils may not be involved 
in this process. However, prevention of the local accumulation of neutrophils by using of 
antibodies blocking the granulocyte-specific CD66 receptor should demonstrate that the action 
41 
of granulocytes does not contribute to. or even may compensate. the stimulatory effect of 
monocytes on intimal hyperplasia. 
Other wellwknown angiographic risk factors. such as target lesion located at the left anterior 
descending coronary artery in the balloon population and reference vessel diameter and acute 
lumen gain in the stent group, were retained in the multivariate modeL Left anterior descending 
artery has been associated with higher restenosis rate after angiopiasty'lO. Greater acute gain has 
already been shown to stimulate proliferative response40, which may reflect the higher degree of 
vessel wall injury in this situation40, 41. Finally, reference diameter was inversely associated with 
late lumen renarrowing, which may highlight the importance of vessel size in the outcome of 
patients treated with stents42 . However, it should be considered that, by definition, vessel size is 
inversely correlated with relative lumen loss (relative lumen loss = late loss divided by reference 
diameter). No correlation between CD66 expression and unstable angina was observed, however 
it should be considered that all treatments were carried out in an elective basis. Thus, most of the 
patients were actually stable at the time of the procedure when the blood samples were 
collected. 
Taken together, this study confirms that pre-procedure activation status of circulating 
neutrophils expressing the CD66 antigen exerts a protective influence oniate vessel renarrowing 
after percutaneous coronary intervention and further suggests that these leukocytes Illay be 
implicated in the mechanislll of vascular remodeling. 
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Abstract 
Objective: To assess the mechanism of restenosis after balloon angioplasty. Design: Prospective 
study. Patients: 13 Patients treated with balloon angioplasty. Intelventions: 111 coronary sub-
segments (2-mm each) were analyzed after balloon angioplasty and at 6-month follow-up using 
3-dimensional lVUS. l\:Iain outcome mensul'es: Qualitative and quantitative lVUS analysis. 
Total vessel (external elastic membrane), plaque, lumen volume were measured in each 2-mm 
sub-segments. Delta values were calculated (follow-up - post-procedure). Remodeling was defined 
as any (positive or negative) changes in total vessel volume. Results Positive remodeling was 
observed in 52 sub-segments, whereas negative remodeling occurred in 44. Remodeling, plaque 
type and dissection were heterogeneously distributed along the coronary segments. Plaque 
composition was not associated with changes in lVUS parameters, whereas dissected sub~ 
segments had greater increase in total vessel volume than those without dissection (I. 7 
mm
3
versus ~O.33 mm3, p=0.04). Change in total vessel volume was correlated with changes in 
lumen (p<O.OS, pO.S6) alid plaque volumes (p<O.OS, r~0.64). The site with maximal lumen loss 
was not the same site as the minimal lumen area at follow~up in the majority (n= I 0) of the 
vessels. In the multivariate model, residual plaque burden had an influence on negative 
remodeling (p ~ 0.001, 9S%CI: -0.391 to -0.108), whereas dissection had an elfect on total vessel 
increase (p~0.002, 9S%CI: 1.168 to 4.969). Conclusions: Restenosis after balloon angioplasty 
appears to be determined by unfavorable remodeling. However, different patterns of remodeling 
may occur in individual injured coronary segment, which highlight the complexity and influence 
of local factors in the restenotic process. 
Recurrence of stenosis is still an important drawback of percutaneous coronary interventions. 
The restenotic process is multi-factorial and several elements have already been identified: 
thrombosis, inflammation, smooth muscle cell proliferation and elaboration/degradation of 
extra-cellular matrix.[1][2] The clinical consequences of these processes are acute recoil, 
neointimal hyperplasia and vascular remodeling as determined by angiography and intravascular 
ultrasound. 
The classical binary definition of restenosis is based on coronary angiography (> 50% 
diameter stenosis). Although clinical decision~making is in essence a "binary" process, the 
restenotic phenomenon canHot be comprehensively analyzed by luminographic methods.[3] In 
this regard, intravascular ultrasound (IVUS) has become an essential tool due to its ability to 
image structures of the vessel wall.[4] Furthermore lVUS assessed vessel wall remodeling has 
been proposed as an important factor in the recurrence of stenosis after balloon 
angioplasty. [5][6] 
The issue of restenosis has been scmtinized over the last years, but some questions persist. 
The relative contribution of remodeling and plaque growth to the restenotic process is still 
debatable.[S][6][7][8][9][IO][1l][12][l3] To assess the mechanism of restenosis, previous 
studies selected the cross~section with the narrowest lumen area pre-procedure[5], follow~up[6] 
or both.[7] Although these specific sites have unquestionable validity in the clinical context, 
they may not represent the location of maximal at1erial wall response to injury (maximal lumen 
loss). Further, whether the pattern of arterial wall response to injury is homogeneously 
distributed along the entire target segment has yet to be investigated. 
Three~dimensional intravascular ultrasound imaging with volumetric quantification allows us 
to address these issues.[14] Therefore, the present study incorporates this new technology to 
assess the mechanism of restenosis after balloon angiop[asty. 
49 
Methods 
PATIENTS 
During 1997 and 1998, patients with de novo lesions in native coronary arteries, treated 
successfully with conventional balloon angioplasty, enrolled in prospective clinical studies were 
eligible for the present investigation. Only patients with scheduled 6~month follow-up and 
complete serial three-dimensional lVUS acquisition were included. Patients treated with any 
other percutaneous device (Le., cutting balloon, direct coronary atherectomy, rotational 
atherectomy, laser ablation, stents, or radiotherapy) or those taking any specific medication 
under investigation were excluded. Angiographic inclusion criteria applied in the original 
studies consist of a reference vessel diameter> 2.5 mill and < 4.0 mm and a lesion length < 
20mm. 
Patients received aspirin (2S0 mg/day) and heparin IV (10.000 IU) before the procedure. Heparin 
was given to maintain the activated clotting time >300 sec, Aspirin was maintained after the 
procedure in all patients. Balloon angioplasty was performed according to standard clinical 
practice, and the selection of the balloon was left to the operators preference. In this cohort, the 
mean balloon artery ratio was 1.1. Postwprocedure (after optimizing the results of balloon 
angioplasty) and followMup lVUS imaging were acquired using the same motorized pullback 
system and after intracoronary nitrate inftlsion. The Medical Ethics Committee of University 
Hospital Rotterdam approved the protocol. All patients gave written informed consent. 
THREE-DIMENSIONAL IVUS ASSESSMENT 
Coronary segments were imaged with a mechanical IVUS system (CVIS, Boston Scientific 
Corporation, Maple Grove, MN) with a sheath-based IVUS 30 MHz catheter. ECG-gating image 
acquisition and digitalization was performed by a workstation designed for the 3wD reconstruction 
of echocardiographic images (EchoScan, Tomtec, Munich, Germany). Description of this system 
has been reported in detail elsewhere.[IS] In the case of image acquisition using the motorized 
pullback without ECG triggering, the complete IVUS mn was recorded in s-VHS tape for oft: 
line three-dimensional reconstruction.[ 16] 
A Microsoft Windows™wbased contour detection program, developed at the Thoraxcenter, 
was used for ofr-line volumetric quantiftcation,[17] Briefly, this program constmcted 
longitudinal sections from the data set and identified the contours corresponding to the lumen 
and media boundaries. Checking and editing of the contours of the planar images were 
performed by two experienced analysts (MAC, KK). Intrawobserver variability assessed by 
analyzing IVUS volumetric studies at least 3 months apart has been reported:wOA ± 1.1% and w 
0.65 ± 2.66% in lumen volume, wOA ± 0.6% and wO.19 ± 0.67% in EEM volume, wO.3 ± 1.0% 
and wO.95 ± 2.81% in plaque volumes using motorized pullback with and without ECG-gated, 
respectively.[IS][ 16] 
Threewdimensional· IVUS image reconstruction and quantification has been validated 
previollsly.[IS][16] This IVUS technology may confer some advantages over conventional 
lVUS assessment: 1) Visualization and quantification of the entire coronary segment (not only a 
single crosswsection) allowing longitudinal assessment of the restenotic process.[6] 2) In a 
coronary segment of 20mm length, 100 cross-section areas may be measured which permit 
accurate identification of the sites with minimal or maximal lumen, plaque andlor EEM areas. 
Since the computerized contourwdetection software automatically identifies these locations, 
comparisons between serial IVUS images can be performed in an "unbiased fashion", after both 
postwprocedure and follow~up measurements have been completed. 3) Besides the use of 
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motorized continuous pullback (with or without ECG triggering)[18], precise location and 
matching of each cross-section can be further assured by comparing the multiple longitudinal 
views displayed by the three-dimensional reconstruction (figure I). 4) After matched 
comparisons, the site with the maximal lumen loss may be readily identified, which may be 
essential for a mechanistic interpretation of the restenotic process. 
The methodology to define the segment of interest has been previously described.[19][20] By 
the use of the Rubo DICOM Viewer (Rubo Medical Imaging, Uithoorn, The Netherlands), each 
angiographic sequence showing all balloon inflations may be displayed simultaneously on the 
screen and the location of the injured segment and its relationship with anatomical1andmarks 
(aorto-ostial junction and/or side-branches) can be determined. Thus, the target segment injured 
by balloon inflation (20 111111 long segment) was defined. These coronary segments were divided 
in 2 mm long sub-segments (each of them presenting 10 IVUS cross-sections) as described 
previously.[21] In this manner, the local pattern of the arterial response to injUly can be 
investigated. 
Figure I. Stsndaro di'play of the I~sul(s by 3-1) longitudinal r~,;on.tru,tion of the IVUS cross-se,tional IInJge, using an ECG-
ga!~d puHh;l,k, Upper oot,id~ pantb: Longitudinll reconstru,lion images at posl'pro,(dLlfc (left side) and follow-up (right ,id~) 
\\1tile amH'S indicate tho analomical landmark.! (sideb[1ln,h~s and pldwn), UVVH Inside pantb: ~bt,hed no>s-,ectiollS 
imm~dia(e1y after Ine p",.:edure (kft side) and at follow-up (right side) Lol'u .,utls' Clwts display the rob'~qu.nl volumotric 
quantifkation at post-pro.:~dtlf~ (l~n ,ide) and {oHm,-up (righ1.id~)_ 
The ar~a Hlucs of Ih: hIIn~n (Iow(f linc) and lotal Hssd (upl"'lline) form the boundaries of the g"'Y zon~. which r~pr~,eJl( th~ 
plaque-medIa ,omplc~. and a single line d(pklS the absolute area \'alue Qfplaqu~'medi~ ~ompln, Black arro"s indicate the ,;1. of 
the minimallwncn area al follow_up (/liLA) 
QUALITATIVE ANALYSIS 
All individual cross-sections were analyzed qualitatively by 2 independent investigators blinded 
to the volumetric results. TIlUS, the type of plaque was defined in every cross-section, as intimal 
thickening, soft, fibrous, mixed (soft-fibrous, soft-calcific and fibrous-calcific) and diffuse calcified 
as proposed by Di Mario et al.[22][23] ADDINEach sub-segment was categorized as nonnal « OJ 
mm intimal thickening), soft, hard (fibrous and mixed) or diffuse calcified, when at least 80% of 
the cross-sections within the sub-segments were of the same type, as described previously.[21] In 
those cross-sections containing up to a 90° calcium are, the contour of the external elastic 
membrane was interpolated from the contours of the slice ill1l11ediately proximal and distal to the 
cross-section in question. Those sub-segments with side-branches involving >900 of the 
circumferential arc in more than 50% of the cross-sections or those categorized as diffuse calcified 
were excluded from the quantitative analysis. The presence of dissection, defined as a tear parallel 
to the vessel wall[22], was also noted in each sub-segment. 
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QUANTITATIVE MEASUREMENTS AND DIFINITIONS 
Total vessel volume determined by e:x.1ernai elastic membrane boundaries and lumen volume 
were measured. Plaque volume was automatically calculated by subtracting lumen volume ITom 
total vessel volume. Delta values for each measurement were calculated (delta CD.) = follow~up -
post-procedure). Relative (percent) changes of IVUS parameters (delta volume I post-procedure 
volume) were also calculated in order to correct for differences in vessel size. 
The location of the cross-section with the narrowest lumen area at follow-up was 
automatically reported. Retrospectively (after all measurements were performed), the sub-
segment encompassing this specific cross-section (minimal lumen area site) was identified and 
the matched sUb-segment of the post-procedure analysis was selected for comparison. 
Furthermore, the site with the maximal lumen loss was defined after the calculation of the delta 
values. 
Remodeling was defined as a continuous process involving any (positive or negative) changes in 
EEM volume as proposed previously.[24] In the present study, enlargement or shrinkage of the 
vessel wall was considered when total vessel volume increased or decreased, respectively, 
compared to post-procedure measurement by at least two standard deviations (± 1.3%) of the intra-
observer variability for repeat total vessel volume measurements.[ lS]I 16J In this manner, the 
potential intrinsic error of the method may be avoided.[25][26] 
STATISTICAL ANALYSIS 
Quantitative data are presented as mean ± standard deviation, whereas qualitative data are 
presented as frequencies. Continuous variables were compared by the use of unpaired Student's t 
test. Categorical variables were compared by means of Fisher's exact test. Linear regression 
(pearson's regression coefficient) was performed to assess the correlation between changes in 
IVUS parameters. Multivariable linear regression models were built to identify predictors of 
changes in plaque volume and total vessel volume among qualitative and quantitative post-
procedure IVUS parameters. A value ofp<O.OS was considered statistically significant. 
Results 
In thirteen coronary segments injured by balloon inflation, III sub-segments were analyzed 
using three-dimensional lVUS volumetric quantification. Baseline characteristics of the patients 
are shown in Table I. Nineteen sub-segments were excluded from the final analysis due to either 
diffuse calcified plaque (n~10) which precluded the quantification of the total vessel volume or 
side branches which involved >900 of the circumferential arc in more than 50% of the cross-
sections (lF9). 
QUALITATIVE ANALYSIS 
Table 2 illustrates the variability of both type of plaque and presence of dissection distribution 
along the entire target segments. Only 3 patients had the same type of plaque distributed through 
the analyzed segment, whereas the presence of dissection detected in at least one injured sub-
segment was noted in 9 patients. 
Forty sub-segments (36%) were defined as soft, 53 (48%) as hard and 18 (16%) as 
normal/intimal thickening. Plaque composition was not related to changes in quantitative IVUS 
volumetric parameters. Sub-segments with hard plaques showed greater incidence of dissection 
compared with those with soft plaques (49% versus 23.7%, p < 0.001). 
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Overall, dissection was observed in 35 sub~segments (31 ,5%), Sub~segments with dissection had 
greater increase in total vessel volume as compared to those without dissection (1.7 mm3versus ~ 
0.33 nUll', p~0.04). 
Table 1. Baseline and demographic characteristics, 
Variables 
Age (yea!'s) 
Gender, male 
Diabetes mellitus 
Smoldng 
Hypercllol esterol emia 
Hypertension 
Previous MI 
Angina Status, CCS 3/4 
Tl'eatment Site: 
Left Anterior Descending 
Circumflex Artery 
Right Co!'olla!'y A!'te!'y 
62.1 ± 5.96 
13 (100%) 
2 (15%) 
4 (29%) 
7 (54%) 
4(31%) 
5 (39%) 
10 (77%) 
5 (48%) 
4 (31%) 
4 (31%) 
MI means myocardial infarction, CCS means Canadian Class Society. 
QUANTITATIVE ANALYSIS 
Table 3 shows the mean values of changes (deltas) in lVUS parameters for all sub-segments of 
the entire target vessel, at the minimal lumen area location and at the maximal lumen Joss site, 
The correlation between remodeling, changes in plaque volume and late lumen loss are shown in 
figure 2. 
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Figure 2. Correlation between remodeling (dTVV), changes in plaque volume (dPV) and 
changes in lumen volume (dLV). 
Upper panels: Correlations in all sub-segments (n=III). Middle panels: Correlations at the sub-
segments of minimal lumen area at follow-up (n=13). Lower panels: Correlations at the maximal 
late lumen loss sites (n=I3) .• = significant correlation (p < 0.01), dTVV = delta total vessel 
volume, dPV = delta plaque volume, dLV =delta lumen volume. 
53 
Table 2. Number of sub-segments with specific IVUS parameter in each ~atient. 
Putient Number of sub- IVUS Pal'ameters 
Segments 
Tissue characteristic Balloon-induced Pattern of remodeling 
dissection 
Hard Soft Normal + 0 + 
1 8 0 4 4 I 7 I 2 
2 8 4 2 2 4 4 0 0 
3 10 0 10 0 0 10 0 7 
4 10 I 7 2 5 5 4 5 
5 10 4 2 4 6 4 3 I 
6 5 0 2 3 0 5 0 2 
7 6 5 I 0 4 2 2 4 
8 10 4 4 2 4 6 3 3 
9 10 9 0 0 2 7 0 3 
10 10 3 6 I 0 10 0 2 
11 5 5 0 0 0 5 0 5 
12 10 9 I 0 4 6 7 
13 10 9 I 0 5 5 3 
Total 111 53 40 18 35 76 15 44 
REMODELING 
Positive remodeling was observed in 52 sub-segments (46.8%), whereas negative remodeling 
occurred in 44 (39.6%). Both patterns of remodeling were observed along the entire injured 
segment in the majority of the patients (n~IO) (table 2). Although sub-segments showing 
negative remodeling had a greater amount of residual plaque volume post-procedure, the 
increase in plaque volume was greater in those sub-segments with positive remodeling (figure 
3). Indeed, sub-segments with negative remodeling showed a decrease in plaque volume. 
% 
100 
50 
o 
-50 
P<O.001 
,--->----, 
ROTW 
P<O.001 
,--->----, 
ROLV 
P<O.001 
ROPV 
o Positive 
B!I Negative 
Figure J. Comparison ofrelative changes in TVV, LV, and I'V betwcm sub-segments with negative 
(n=44) and positive (n=52) remodeling. 
TVV = total wssel volume, PV = plaque volume, LV = lumen volume, ROTVV = relative delta total 
vessel volume, Itm'v "" relative delta plaque volume, ROL V"'" relative delta lumen volume 
54 
5 
8 
3 
I 
6 
3 
0 
4 
6 
8 
0 
2 
6 
52 
Table 3, Changes in lVUS parameters after 6 months. 
Sub-segments ATVV Relative APV 
mlll
3 ATVV mlllJ 
All 0.31±4.9 0.028±0.18 1.9±4.25 
Relative 
MV 
0.175±0.38 -1.6±3.92 
Relative 
ALV 
0.066±0.25 
(n ~ III) 
MLA site 
(n ~ 13) 
MLL site 
-0.17±5.4 0.007±0.18 4.07±4.55 0.32±0.31 -4.25±4.25 0.258±0.26 
-2.86 ±5.5 -0.068±0.19 3.24±5.47 0.354±0.55 -6.08±4.3 0.32±0.21 
(n~13) 
MLA = minimal lumen area, MLL = minimal lumen loss, TVV = total vessel volume: PV = 
plaque volume; LV = Lumen volume 
MULTIVARIATE ANALYSES 
Post-procedure lVUS predictors of both changes in total vessel volume and plaque volume are 
shown in table 4. Residual plaque volume had a negative influence on remodeling, whereas the 
presence of dissection had a positive effect on total vessel volume increase, Post-procedure 
lumen dimension volume was directly associated with plaque increase (table 4). 
Table 4. Post-procedure lVUS predictors of changes in plaque volume and total vessel volume 
after 6 months. 
Dependent variables 
IVUS parameters Delta plaque volume (u~ll1) Delta total vessel volume (u~l11) 
p-value Beta 95%CI p-value Beta 95%C1 
Hard plaque composition NS NS 
Presence of dissection NS 0,002 
Post-procedul'e PV NS 0.001 
Post-pl'ocedul'e TVV NS NS 
Post-pl'ocedul'e LV 0.002 0.291 0.052: 0.225 NS 
PV - plaque volume; TVV ~ total vessel volume; LV - Lumen volume 
Discussion 
0.288 
-0.316 
1.168: 4.969 
-0.391: -0.108 
This study, assessing the local mechanism of restenosis by means of sub-segmental volumetric 
quantification of the entire injured vessel, shows the variability of both qualitative IVUS 
parameters and patterns of remodeling within the same target segment (table 2), as observed by 
Pasterkamp et al. in human femoral arteries.[27] Furthermore, in the majority (n~IO) of the 
cases the site with maximal lumen loss was not the same as the site of the minimal lumen area at 
follow-up, and the mean distance between these two specific sites was 5.3 ± 4.8 111m, These 
findings may highlight the importance of analyzing the entire injured segment for the correct 
determination of the mechanism of rest enos is in the future IVUS studies. 
Our results also confirm that unfavorable remodeling is the major determinant of lumen loss 
(figure 2). Based on average values of changes in IVUS parameters (table 3), lumen loss after 
balloon angioplasty appears to be determined mainly by an increase in plaque volume, Similar 
results were found in two recent prospective studies. [7][28] The mean lumen loss in the balloon 
angioplasty group of the SURE trial[7] and the placebo group of the MVP study[28] were 
mainly due to an increase in plaque area, Contrasting, pioneer retrospective studies have 
described vessel shrinkage as causing 50-70% of lumen loss.[5][6] It should be taken into 
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account that average values may not represent the relative contribution of each component, 
remodeling and plaque growth, to lumen loss. Using linear regression, as suggested 
previously[24], we observed that lumen loss was actually determined by changes in vessel size 
(figure 2). Whereas change in total vessel volume was highly correlated with lumen loss in all 
analyzes, delta plaque volume was weakly related to delta lumen volume (figure 2). 
Whether remodeling is an independent process or an adaptive response to compensate plaque 
growth is still debatable.[8][1O] The correlation between changes in vessel size and plaque 
volume observed in the present investigation (figure 2) suggests that remodeling after balloon 
injury may represent an adaptive phenomenon as described by Glagov et al. in atherosclerotic 
plaques.[29] In fact, this correlation is both directions: segments with positive remodeling 
showed an increase in plaque volume, whereas those with vessel shrinkage had a plaque 
reduction (figure 3). Similar findings have been reported previously.[30] These studies may 
support the hypothesis that plaque retraction may be the ultimate determinant of negative 
remodeling.[3I] However, it should be considered that other factors, such as inflammation[32] 
and shear or tensile stress[33], may exert an influence in both remodeling and plaque 
progression. 
Local tensile stress, which is determined by lumen radius, may have stimulated plaque 
progression in sub-segments with large residual lumen maintaining the baseline shear stress, as 
suggested by Glagov et al.[33][34] Similarly, shear stress may be implicated in the negative 
correlation between residual plaque volume and vessel remodeling, and in the positive influence 
of dissection on vessel enlargement (table 4).[33] However, direct measurements of both tensile 
stress and shear stress in vivo are exceedingly complex and require sophisticated and laborious 
technology to draw any definitive conclusion.[35] 
Dissection was detected by IVUS more frequently in sub~segments characterized as hard [36]. 
The previous hypothesis, based on angiographic studies, that nOI1~occlusive residual coronary 
dissection has a favorable long-term outcome may be supported by the present IVUS 
study[37J[38], since a positive influence of residual dissection on vessel enlargement was 
observed (table 4). 
Plaque composition as characterized by IVUS was not correlated with any changes in lVUS 
parameters as reported by others.[5][6] Conversely, hard or calcific plaques have been 
implicated with negative remodeling in both atherosclerotic and restenotic lesions.[21][26][39] 
Methodological differences may explain diverging results, since these latter studies[21][26][39] 
did not assessed the influence of plaque composition all changes (delta) in lVUS parameters 
over time as performed in the other studies[5][6] and in the present investigation. 
In summary, the findings of the present investigation, using 3-dimensional IVUS 
quantification of local changes in the vessel wall volumes, illustrates the complexity and 
variability of the arterial wall response to balloon injury and the importance of local factors 
(shear stress, growth factors, inflammation, degree of injury, etc) in this phenomenon.[2][ 40] 
Limitations 
The number of patients, similarly to all previous IYUS investigations[5][6], is a limitation of 
the present study. However, this is the first study employing a unique methodology to assess the 
local process of restenosis in I II matched sllb~segments injured exclusively by balloon 
inflation. 
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Three .. Dimensional Intravascular 
Ultrasonic Volumetric: Quantification of 
Itent Recoil and Neointimal Formation 
of Two New Generation Tubular Itents 
Marco A. Costa, MD, Monel Sabate, MD, I. Patrick Kay, MB, ChB, 
Pim J. de Feyler, MD, PhD, Ken Kazuma, MD, Pedro Serrano, MD, Vincenl de Valk, PhD, 
Mariano Alberlal, MD, Jurgen M.R. liglharl, Clemens Disco, David P. Foley, MB, MRCPI, 
and Palrick W. Serruys, MD, PhD 
Currently, several different designs of coronary slenls 
ore available. However, oolyo few of the new genera-
tion stenls have been investigated in large randomized 
trials. Mechanical behavior of first-generalion slents 
(POIOlOZ-Schotz, Gionlurco-Roubin) may not be applied 
to the new designs. We investigated the chronic me-
chanical behavior {recoil} of 2 stenls recently approved 
by the Food and Drug Administration (MULTIUNK and 
NIRJ. forty-eight palients with single-stent implantalion 
123 MULTILINK and 25 NIRI were assessed by means of 
volumetric 3·dimensional intravascular ultrasound anal· 
ysis after the procedure and at 6-month follow-up. In 
addition, volumetric assessment of neointimal formation 
I t has been shown that stent design may innuence the degree of ncointimal formation in animal models,1 
Thus, Ihe slow chronic expansion associated with self-
expanding stenls may yield a greater neoinlimal in-
growth in human coronary nrteries,2 r l Likewise, the 
negative clinicul and <lngiographic results of a coil 
stem observed in a recent randomized study4 compar-
ing Cook GRII and Palll1az-Schatz stents lIlay be 
influenced by the imlbility of Ihis type of coil stent to 
prevent vessel remodeling. 5 Whether in vivo mechan-
ical properties of the first generation of tubular steuts 
(PalnHlz-Schalz) could be applied to the recently de-
signed tubulnr stcnts rcmains to be elucidated. Two 
second-generation balloon-expandable tubular stain-
less sleel stents, MVLTILINK (GuidanUAuvanced 
Cardiovascular Systems, Santa Clara, California) and 
NIR (Boston Scientific. Maple Grove, Minnesota), 
have recently been approved for clinical use in the 
United States,l" The aim of our study was to investi-
gate the potential of chronic stent recoil Hud the degree 
of ncoinlimal proliferation afler implantation of these 
2 stents, 
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Cordiolysis BV, Ro1terdam, The Ne:herlond~. Dr. Kay is supported by 
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was performed. No significant chronic stent recoil was 
delecled in bOlh groups (4 MULTI LINK slenl volume: 
+5.6 ± 41 mm3 {p = NSJ and A NIR stent volume + 
2.1 ± 26 mm3 (p = NSJ). A similar degree of neoinlimal 
formation at 6 months was observed between the 2 
stenls IMUlTILiNK 46 ± 31.9 mm' vs NIR 39.9 ± 27.6 
mm3, p = NS).ln conclusion, these 2 second·generation 
tubular stenls did not show chronic recoil and appeared 
to promote similar proliferative response after implan-
tation in human coronary arteries. ©2000 by Excerpta 
Medica, Inc. 
lAm J Cordial 2000;85:135-1391 
METHODS 
From January 1998 to December 1998, 48 consec-
utive patients receiving either single MULTIUNK or 
NIR (9-celJ) stenling with intravascular ullrasound 
(IVUS) analysili after the procedure and <.II 6-month 
follow-up were eligible for this stUdy, For 3-dimen-
sional reconstruction, only patients investigated with 
IVUS imaging systems incorporating motorized trans-
ducer pullback at a constant speed of 0.5 millis were 
selected. All patients signed a written infomled con-
sent form, Before the procedure, clinical and angio-
graphic characteristics (Table J) were similar between 
groups. 
Stent deployment technique: Stent selection was 
based on operator preference, Stent size was selected 
to reach a I.l to 1.2 slenl/artery ratio by quantitative 
coronary analysis, Stent length was chosen based on 
lesion length measured by quantitative coronary an-
giography to achieve complete lesion coverage, ThllS, 
the distribution of sten! lengths in the MULTILINK 
group was 8 mm (n = I), 15 mm (n = 9), 25 mm (n = 
12), and 35 mm (n = I), In the NIR group the 
distribution ofstent lengths was 9 mm (n = 2), 16mm 
(11 = 13),25 mm (n = 7), and 32 mm (n = 3), Stents 
were delivered through 6Fr to SFr guiding catheters 
llsing Q,014-in guidcwires. After predilatation of the 
target lesion, stenls were deployed with subsequent 
high-pressure (14 to 20 atm) balloon posldilatation. 
All patients received aspirin (325 mg/day continu-
ously) and liclopidine (250 mg twice a day, main-
tained for 30 days) at least 24 hours before the pro-
TABLE I Boseline Charocleristic~ 
MULTIUNK NIR 
Voriables (n = 23) (n '" 25) P Value 
a given (.;ross-sectional ultrasound 
image. H = thickness of the coro-
llary artery slice that w<\s reported by 
this digitized cross-sectionul lVUS 
image, nnd n = the 1l1llUhcr or digi-
tized cross-sectional images el1(';OI11-
passing the volume to be measured.') 
lvleasurcmenls of neointilllal hyper-
plasia volumes have been previously 
validated. I I Volumetric analysis al-
lowed thc investigation of mcchuni-
cal performall(.;e anti neointimal pro-
liferation of the entire stented seg-
ment (Figure 1),1 The following 
postprocedure and 6-month fol-
low-up measurements were com-
pared: (I) stellt = volume, symmetry 
Age (yn) 61 ± 9 63 ± 9 0.39 
M" 21 (91%) 22 (88%) 1.0 
O1abe!es mellilus 3 (13%) 4 (l6%) 1.0 
Uns!able ongino pec/oris 10 (44%) 14 (56%) 0.47 
Mulri~essel coronary di5ease 13 (57%) 10 {40%) 0.39 
lelt anlerior descending coronary orlery 9 (39%) 11 (44%) 0.78 
SophenolJs ~ein glOf! 114%1 1 14%1 1.0 
AngiogfOphic cokilicolion {moderaie or heo'>')') 6 {27%) 3 {13%1 0.28 
lesion Iype B2/C (ACC/AHA) 14 1611 18 (72) 0.54 
Quon!ilall~e coronory ongiography 
Reference diameler (mm) 2.89 ± 0.48 2.78 ± 0.39 0.39 
lesion lenglh {mmJ 8.7 ± 3.7 8.2 ± 2.9 0.6\ 
Minimal lumen diomeler (mmJ 0.94 ± 0.40 0.92 ± 0.37 0.83 
Diomeler slenosls {%) 67 ± 13 67 ± 12 0.95 
cedure. Before the procedure, minimal lumen diame-
ter, reference diameter, and percent diameter stenosis 
were calculated off-line in 2 orthogonal projections 
using an automated edge-detection system (CASS II, 
Pie Medical Imaging B. V., Maastricht, The Nether-
lands). 
Three-dimensional intravascular ultrasound analysis: 
The use of a constant pullback speed at 0.5 I11m/s 
during IVUS image acquisitions and 3-dimcnsional 
reconstruction with longitudinal viewing facilitated 
correct matches between postprocedurc and follow-up 
images.7•s Precise idcntification of stent borders was 
also facilitated by the high echogenic characteristics 
of the stent struts. 
Immediately after the procedure and at 6-month 
follow-up, IVUS was performed aher administration 
of an intracoronary nitrate bolus. A single-element 
mechanical transducer (CVrs, Sunnyvale, California) 
was used in 70% of the patients in the MULTILINK 
group and in 64% of the NIR group, whereas a 64 
multi-element electronic transducer (Endosonics Cor-
poration, Rancho Cordova) was used in 30% and 36% 
of the patients, respectively (p = 0.8). After imaging 
acquisition, a complete IVUS run was recorded in 
s-VHS tape for off~line 3-dimensional reconstruction. 
All analyses were performed by an independent core 
lab (Cardialysis BV, Rotterdam, The Netherlands). 
Three-dimensional IVUS reconstruction and quan-
titative volumetric analysis was performed using a 
Microsoft Windows-based contour detection ~ystem 
developed at the Thoraxccnter.9 which permits analy-
sis of up to 200 IVUS cross sections (slices). This 
program has been previously validated.1O The system 
constructs 2 longitudinal sections from the data set 
and identifies the contours corresponding to the lu-
mcn, intima, media, or stent boundaries. Two longi-
tudinal and I cross-sectional views are displayed, and 
corrections call be performed interactively by forcing 
the contour through visually identified points. Given 
the slice thickness of 200 p:tn, a tutal segment of 40 
mm in length can be analyzed. 
Volumetric data were calculated by the formula: 
V :::;: !,ni=1 Ai • H, where V = volume, A = area of 
external elastic membrane (EEM) or lumen or stcnt in 
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index, and mean area; and (2) lu-
men = volume, mean area, and minimal cross-sec-
lional areu, and diameter. The volume and mean ,II'Ca 
of neointimal hyperplasia after 6 months were also 
calculated. Quantitative changes (il = follow-up-
poslprocedure measurements) were also (.;aiculaled. 
After the procedure and follow-up, stelU lengths were 
calculated by multiplying 200 /-tIll (thickness of each 
IVUS image slice) by the number of slices (cross 
sections) within the stented segment. 
Definitions: Sten! symilletry index was calculated as 
the average of all stellt symmetry indexes of each 
cross-section, which is defined as the ratio of minimal 
divided by maximal diamc\ersY- A normal index is 
defined as a value ~0.7.12 Mean stcIlI, luminal, antl 
neointimal hyperplasia areas were automatically cal-
culated as thc average of nil cross-section mean areas. 
Recoil wns defined as a decrease in the stell! volume lit 
6-month follow-up compared with postprocedure 
measurement. Neointimu\ hyperplasia was calculated 
a<; the tlifference between stent and luminal volumes at 
follow-up. 
Stalistical analysis: Statistical analysis was per-
formed using the SAS 6.12 systcm. Continuous vari-
ables arc expressed as mean ± SD. Comparisons 
between postinten'ention and follow-up measure-
ments were performed with 11 2-tailed paired t test. 
Comparisons between groups were performed lIsing 
unpaired Student's t test. A p value of <0.05 was 
considered statistically signillcmll. 
RESULTS 
IVUS measurements ilre listed in Tnblc II. Doth 
stents achieved similar postprocedural and follow-up 
volumes. No differences were observed in the mean 
stenl or IUlllcn areas. In addition, the symmetry index 
was similar between groups, with no deterioration of 
this index aftcr 6-l1lonth follow-up in both stents. 
Changes in the stent and lumen dimensions are 
illustrated in Figure 2. There wcre sigllilicant differ-
ences betwccn postprocedure and follow-up lumen 
volumes in both MULTILlNK (p «).QOI) and NIR (p 
<0.001) groups, Howcver, no recoil (pnstprocedure 
vs follow-up stelH volumes) W[lS demonstrated after 6 
months in either group (Table II). The avcrage steltt 
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fiGURE I. Standard display of the resulls by conlour deleclion method. Charts on the upper left panels display the volumetric quanti-
fication of slent {upper line}, lumen (middle line, charl B), and neoinlimal hyperplasia (lower fine, charl B) immediately after slent im-
plontalion (A) and at follow-up fB}. Longitudinal reconstruction and minimal cross-sectionol areas are depided after the procedure 
(A', A") and al fotlow-up (B', B"l. 
TABLE II Three-DimensionollVUS Measurements 
MULTIUNK 
Measurements In = 23) 
Aher procedure 
Symmetry index 0.9 ± 0.02 
Mean 5tent/lumen area (mm 2] 8.5 ± 2.1 
Minimal lumen area {mm2] 7.0± 1.9 
Stentlength (mm) 22.2 ± 10.2 
Slent/iumen volume {mmJ ] 187±96 
follow-up 
Neoinlimol formolion {mm3] 46.0 ± 31.9 
Symmetry index 0.9 ± 0.03 
Mean stenl area (mm2) 8.75 ± 2.3 
Mean lumen area {mm?] 6.6 ± 2.6 
Minimal lumen area {mm?] 4.7±2.1 
Stenllenglh (mm?] 22.0 ± J 1.4 
Stent volume (mm 3 ) 193 ± 110 
lumen volume ImmJ ) 147 ± JOO 
NIR 
In = 25) 
0.9 ± 0.03 
8.5 ± 2.0 
7.1 ± 1.9 
18.5 ± 8.4 
155±7.1 
39.9 ± 27.6 
0.91 ± 0.02 
8.71 ± 2.0 
6,6 ± 1.7 
4.9± 1.7 
)8.4 ± 9.5 
)55 ± 74 
116 ±52 
P 
Volue 
0.89 
0.95 
0.85 
0.18 
0.20 
0.49 
0.24 
0.95 
0.95 
0.69 
0.20 
0.18 
0.20 
strating a homogeneous distribution 
of the radial force. Radial stiffness of 
MULTILINK and NIR stents has 
also bee-n shown to be equivalent in 
an experimental (in vitro) study,l3 
No chronic stell! recoil at 
6-monlh follow-up was demon-
strated in this 3-dimensional IVUS 
volumetric investigation. The sym-
metry index also remained un-
changed after 6-monlh follow-up in 
both groups (Table 11), which sug-
gests that no localized stent recoil 
occurred. Because some studies us-
ing planar IVUS measurements 
showed tlmt late recoil of Palmaz-
Schatz stem rarely occurs, t4 tubular 
stents are believed not to rceoi I 
chtonically. The inability of angiog-
lengths measured with IVUS are also demonstmted in 
Table II, and no difference between postprocedurc and 
follow-up was observed in both groups. Although, the 
average slelll length was slightly longer in the MUL-
TILlNK group (p = NS) than in the NIR group, no 
difference in neointimal formation was observed be-
tween groups (Table II, Figure I). 
raphy to detect actual sten! expansion may explain 
discordant results of previous studies concerning 
chronic recoil of Palmaz-Schatz stenls. 1S For the first 
time, 3-dimcllsional IVUS with volumetric qUflntifi-
ciltion, a new tool to investigate in vivo mechanical 
behavior of coronary stents, was used and confimlcd 
the prcvious hypothesis that tubular stents do not 
recoil chronically_ 
DISCUSSION 
MULTI-I.INK and NIR, 2 second-generation tubu-
lar stents, demonstrated similar postprocedllral IVUS 
dimensions, which indicate equivalent radial force (0 
acutely support the vessel wall resistance, Both stcnts 
had it good post procedure symmetry index, demon-
65 
Differences in designs and compositions of new 
tubular stellts should be considered before grouping 
these stents in the same class. Investigations of the 
first-generation tubular stent (Palmaz-Schatz) should 
110t be translated to thc new tubular stent designs. A 
previous report has shown that Act~One (Vascular 
MULTILINK 
STENTS 
n = 23 
NIR 
STENTS 
n = 25 
Mean NIH + 2.09 mm2 
%NIH =24% 
~ ilSV 
+5.6mm' J~ 
" il SV 0. 
/+2.1mm' 
Mean NIH +2.17 mm2 
%NIH = 26% 
LV = Lumen Volume 
sv = Stant Volume 
NIH = Neolntlmal Hyperplasia 
%NIH = (NIHfStent yolume)*100 
fiGURE 2, Chart iIIu5tro~n9 quantilolive chonges (d) between postprocedure and follow-up measurements in the MUlTIUNK and NIR 
sle"1 groups. 
Therapies, Norwalk, Connecticut), a tubular nitinol 
stent with a design similar to the Palmaz-Schatz sten! 
and with greater strut thickness (0.18 vs 0.065 mill), 
had higher recoil than the other tubular stcnls,I6 
Furthermore, in vitro studies have shown that some 
coil stents may have high radial stiffness, which con-
tradicts the concept that coil slcnts have pOOf radial 
support. 1J,n In contrast, clinical investigations com-
paring the radial force of tubular and coil stellts have 
shown contradictory results.S•IS The mechanical be-
havior of coronary stellts may differ between in vivo 
and in vitro situations because of elastic properties of 
tlte arterial wall, especially when diseased vessels are 
being investigated. Thus, further IVUS investisations 
should be encouraged to assess in vivo mechanical 
properties of new sten! designs, because these may 
have an impact on vessel remodeling and neointimal 
formation after percutaneous interventions. 
Lumen loss after either MUL TILINK or NIR stent 
implantation was mainly caused by ncointimai prolif-
eration because both stents did not rccoil after 6 
months. In the 48 segmcnts analyzed in our study, no 
difference in either neointimal hyperplasia volume or 
percentage of Ilcointima formation was observed be-
tween the 2 groups. Neointimal formations observed 
with these tubular s!en!s were comparable to those 
previously reported using different stents.2,1\ 
The stainless steel tubular stents investigated in our 
study, MULTILINK and NIR, differ with respect to 
design (linked tubular wavy rings vs multicellular) 
and strut thickness (0.05 vs 0.1 111111).19 Importantly, 
the neointimal proliferative response appears to be 
similar between both groups despite the theoretical 
rheologic advantage of the thinner stnlt thickness of 
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the MULTlLINK stent over the NIR stent. In con-
trast, both stents were able to maintain their volumes 
without change after 6 months (no chronic recoil), 
even though NIR stents have thicker struts than 
MULTI LINK stents. In conclusion, these 2 second- . 
generation tubular stents did not recoil chronically and 
appeared to promote an equivalent proliferative re-
sponse after implantation in human coronary arteries. 
Study limitations: IVUS imaging was performcd 
after stent implantation, which limits the ability to 
detect coronary calcification. Thus, the assessment of 
coronary calcification in our study was made by an-
giography. which has some limitations. However, the 
influence of calcium on chronic stent recoil has not 
been demonstrated. 
The assessment of acute recoil was not performed. 
Previous reports have investigated this issue using 
either angiography or conventional IVUS.20.21 How-
ever, a small inaccuracy in these methods to detect 
acute stellt recoil cannot be completely ruled out. 
Ideally, new systems incorporating the IVUS imaging 
element on the balloon/stent catheter would be helpful 
for assessing acute stent recoil. 
Clinical and angiographic characteristics were sim-
ilar between both stent groups. However, a random-
ized study may be required to eliminate any possible 
bias in the selection of stents, and to draw a more 
definitive conclusion about the proliferative response 
promoted by these stents, 
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24. EUROPEAN CLINICAL TRIALS 
Thoraxccnter, Unil'crsit), Hospital Dijkzigl. Rotterdam, The Netherlands 
Manel Sabate, Marco A Costa and Patrick W Serruys 
The pioneering work in the field of intravascular radiation therapy was originally 
curried out in Europe. In 1992. Liermann ct al performed the first four cases of 
brachytherapy aner remoral percutaneous angioplasty. I Subsequently, animal 
experiments carried out in the USA 2,3 and Europe4 demonsh'ated the reduction 
of ncointirnal hyperplasia after cndovascular radiotherapy. The insertion of a 
radioactive delivery catheter in human coronary arteries was performed for the 
first time by Condado et al in Venezuela. 5 As a result of these pioneering 
investigations, the first clinical trials were reported in 1997: in the USA, 
Teirstcin et al demonstrated the elTectiveness of gamma therapy for the 
treatment or in-stcnt restenosis,6 whilst in Europe, Verin et al reported the 
reasibility or lIsing beta sources after balloon angioplasty.7 
In Europe, most of the trials have been carried out using beta-radiation 
sources, either with catheter-based systems or radioactive stents, Overall, the 
initial target has been the treatment of de novo coronary stenosis. However, 
recent design trials have included patients with restenotic lesions. This chapter 
sUIlHnarizcs the clinical trials carried out in Europe either as a part of larger 
trials deSigned in the USA or primarily designed ill Europe. 
l11traCOrDllOlY radiation clinical trials llsing 
catheter-based !0'stems 
The clinical trials with catheter-based systems are summarized in Table 24.1. 
Initially, these trials were aimed at demonstrating the safety and feasibility of 
heta emitters in coronary arteries. Currently, results from the dose-finding 
and placeho-controlled trials are pending. 
The GENEVA pilot clinical experience 
This was the first feasibility study performed in Europe (Geneva, Switzerland) 
and also the lirst in the world to use intl'acoronary beta-radiation in humans. 7 
A pure 9uy heta-emitter source delivered via a centering catheter (Sclmeider 
EndovascuJar Radiation System) Schneider Worldwide, Billiach, Switzerland) 
was used to deliver 18 Gy at the surface of the balloon in 15 patients with de 
novo coronary stenoses treated with balloon angioplasty. At follow-up the 
reslenosis rate was 40%. The investigators considered these to be unf..1Vorable 
results owing to an insufficient dose administered at the adventitia « 4 Gy). 
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N,ah'irv;yYtroL 
t.)Slt;fl) 
Intracoronary beta-radiation following PTCA for I'eduction of 
restenosis using the Boston Scientific/Schneider system: Dosc-
Finding Study 
This multi-center, prospective, randomizcd, non-controllcd study aimed to 
determine the efTect of four different doses of beta-radiatioll, using the 'my 
pure beta-emitting source via a centering cathetcr (Schneider Irradiation 
Therapy System, Blillach, Switzerland) on coronary stenosis. In fivc 
European centers, 18 t patients were randomized to rcceive 9, 12, IS, or 
18 Gy at 1 nun tissue depth. The preliminary analysis demonstrated a dosc-
dependent reduction in angiographic rcstenosis with an extrcmely low 
restcnosis rate in the 18 Gy ann: 8.3% in all patients (stcnted and treated 
with balloon alone) and 4.2% in paticnts treatcd with balloon alone (V 
Verin, personal communication, Congress of the European Society or 
Cardiology Barcelona, August 1999). rinal results will be available by 
November 1999. 
BERT 1.5 (Beta Energy Restenosis Trial-I.S): the Rotterdam 
experience 
BERT 1.5 stands for the European arm of the BERT trial. This trial was 
conducted at the Thoraxcenter in Rotterdam in 3 t patients rrom April 1997 
to June 1998. This feasibility study was designcd to test the 9(JSrF'uy source in 
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til at 9 {YtC-t1ms 
at J YiBf 
a hydraulic system (Bcta-Cath™ system, Novoste Corporation, Norcross, GA, 
USA). The dose was randomized to 12, 14 01' 16 Gy prescribed at 2-mm 
depth from the source axis. Twenty-three patients were treated with balloon 
angioplasty, whereas eight patients received a stent after radiation. Delivery of 
radiation was successful in all patients but one. At 6 months, the restenosis 
rate was 28% and target vessel revascularization 23%. Two thrombotic 
occlusions in patients receiving a stent after radiation were observed at the 
2.5- and IO-month [olJow-up,14 
Beta-Catl, Trial 
This prospective, randomized, placebo-controlled trial aims to evaluate the 
safety and effectiveness of the 9OSr / 90y source (Beta-Cath ™ system) versus 
placebo in de novo and restenotic lesions of native coronary arteries: Three 
centers in Europe are participating in this trial. Complete 8-month follow-up 
dala will he available in 2000. 
BRIE Trial (Beta Radiation in Europe) 
This non-randomized trial is designed to evaluate the safety and performance of 
the ~Sr/90y source (BetaCath ™ system) in de novo and restenotic lesions of 
native coronary arteries up to two vessels. This study is being carried out only in 
Europe (20 sites). Complete 8-month follow-up data will be available in 2000. 
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START Trial (STents And Radiation Therapy) 
Tllis prospective, randomized, placebo-controlled trial aims to evaluate the 
safety and performance of the 9{)SJ,/90y source (llcta-Cath ™ system) in the 
treatment of in-stenl restenosis of native coronary arteries. Two sitc~ in 
Europe are involved in this study. The enrollment phase will be completed by 
the end of 1999. One site in Europe will be involved in the START 40~20 
Trial, which is designed to assess the feasibility and elTIcacy of the 40-l11m 
long 9OSr /90y source for the tl'catmcnt of in-stent rcstcnotic lesions. 
RENO Trial (European surveillance Registry with the Novoste Beta-
Cath ™ system) 
This prospective multi-center, multi-national surveillance registry is designed 
to assess the clinical event rate of 9OSr j90y source (Beta-Cath™ system) 
combined WitIl approved PTCA techniques (balloon angioplasty, rotablator, 
laser, and stenting) in patients with coronary artery disease (native or bypass 
grafts). This study is being carried out only in Europe (50 sites) and nllilli-
vessel U"eatment up to three vessels is allowed. 
PREVENT (Proliferation REduction with Vascular ENergy Trial) 
Prospective, randomized, blinded, multi~center study aimed to determine the 
safety of the Guidant (Santa Clara, CA) beta~radiation system in human 
coronary arteries following PTCA or stent implantation. The system consists 
of a up 27~mm source wh"e, a centering spiral balloon and an automatic 
computerized aftcrloader (Nucletron BY, Waardgelde,", Veenendaal, The 
Netherlands). The enrollment phase has been completed in Europe and 6-
month angiographic and clinical rollow~up data are expected by the first 
quarter of 2000. 
INHIBIT (INtimal Hyperplasia Inhibition with Beta In-stent Trial) 
A randomized, multi-center, double-blind, sham-controlled study started in 
the USA and Europe to demonstrate the clinical safety and elTicacy of lilt' 
Guidant beta-radiation system for treatment of in-stenl restenosis. The 
enrollment phase will be completed by the end of 1999 and 9-monlh 
angiographie and clinical follow-up will be available by the end of 2000. 
DURABLE Trial (DUtch RAndomized Bl'achytherapy study for 
Long-term evaluation of Efficacy) 
This randomized, placebo-contl'olled, double-blind study is aimed to assess 
the effect of brachytherapy by means of the Guidant intravascular 
brachytherapy system, after optimal balloon angioplasty (stenosis diameter 
< 35%), elective stenting, and indicated stenting (bail-out and SUboptimal 
result) in patients with multi-vessel stentable lesions (up to two vessels) with 
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respect to MACE-free survival at t year. Nine hundred patients will be 
randomized in nine centers in The Netherlands. The enrollment phase started 
in October 1999. 
MARS (Mallillckrodt Angiopla~ty Radiation Study) 
This is the first European prospective registry to assess the feasibility and 
safety of the IS6Re liquid-filled balloon (Mallinckrodt System) for the 
treatment of de novo coronary lesions. Results at the 6-month follow-up will 
be available by the end of 1999. 
The GRANITE Study (Gamma-Radiation to Atheromatous 
Ncointima using IntracoronaryTherapy in Europe) 
This is the first trilll utilizing gamma-radiation for the treatment of coronary 
ill-stent restcnosis in Europe. Patients will be followed up for 3 years at 11 
sites in Europe including France, Germany, Italy, and The Netherlands, as well 
as one site in Australia. Tht'. radiation system (Gamma IRTTM Delivery System, 
Cordis, Miami, FL) consists of a ribbon of radioactive 19211" seeds (up to 
SS mm in length) that will be delivered to the target lesion via a delivery 
catheter with a dosed end lumen and using a hand-cranked 
containmcnt/delivery device. The radioactive ribbon will be left at the 
angioplasty site for between 1 Sand 2S min to deliver the prescribed dose. 
Intracoronmy radiation clinical trials llsing 
radioactive stents 
The clinical trials utilizing radioactive stents have demonstrated safety and 
clfcctivencss in preventing neointimal proliferation in a dose-related manner. 
Howevcr, a new phenomenon has become evident: restenosis at the edges of 
the high activity radioactive stent, coined the 'candy wrapper' effect. 8 The 
clinical trials using radioactive stents are summarized in Tahle 24.2. 
mls Tl'ial (Isoslent fol' Restenosis Intel'vention Study) 
This feasibility registry involved three centers in Europe in which 40 
radioactivc stcnts with an activity of 0.75-1.5 fLCi were implanted. This trial 
demonstrated feasibility and safety with a restenosis rate that ranged between 
17% (Rotterdam)' and SO% (Milan). JO 
European IIp Dose-Response Study 
This dose-finding study is being conducted in five centers in Europe. 
Radioactivc stcnts of fOllr ranges of activity have been utilized: 1.5-3.0; 
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3.0-6.0; 6.0-12; and 12-20 floCi. The Milan group (n = 82 palienls) reporkd 
a suppression of the ncointimal hyperplasia in a dose-related manner (between 
1.5 and 12 lLCi). Edge restenosis (candy wrapper') was observcd in 36% for 
1.5-3.0 floCi, 38% for 3.0-6.0 floCi, and 50% for 6.0--12·floCi aclh'il)' 
levels, 10 Currently, the Milan group is evaluating the usc of stenl activities up 
to 20 ~Ci.,The Heidelberg group enrolled II patients for radioacth'c slcnt 
implantation of activity levels between 1.5 and 3.0 fLCi. Target vcssel 
revascularization was 36%, mainly at the articulation of the Palmaz-Schatz 
stent,ll In Rotterdam, 40 patients have been evaluated after 6.0-12.0-fLCi 
radioactive stent implantation. To date, 18 patients have returned for 
angiographic foHow-up. No rcstenosis (> 50% diameter stenosis) was 
observed within the stent. However, at the edges of the stcnl the rcslcllosis 
rate reached 55%, leading to target vessel revascularizatioll in 30% 01' the 
patients (AJ Wardeh, personal communication). Data from the Vicnna 
experience will be available al the end or 1999. 
Two trials have been designed to address the problem of cdge rcstenosis. 
The Cold End Study is aimed to determine the e!Bcac), and safel), or lhe 
321' 25-mm Fischell fiX stent, of which both 5-mm ends arc inactive ('cold 
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ends'). Conversely, the Hot End Study is aimed to determine the efficacy 
and safcty of the 32p 18-mm Fischel! BX stent, of which both 2-mm ends 
present with higher activity'('hot ends') as compared with the inner 14 mm, 
which has a total activity ranging from 4.5 to 9 ,...,Ci. These two studies are 
filii! in the enrollment phase. 
Conclusions and jiltlJre perspective 
The use of cndovasculal' beta-radiotherapy in Europe demonstrated that this 
therapy is safe and feasible. Furthermore, preliminary results of a dose-finding 
stud), with the Roston Scientific/Schneider system have been ver), promising (V 
Verin, personal communication). This beneficial effect of radiation in preventing 
I"<'slenosis may he explained partially by the positive influence of brachytherapy 
on the remodeling process. 12 ,13 However, some detrimental clinical 
consccillences of intracoronary radiation may also he recognized from the 
European experience. The edge effect, also named 'candy wrapper eITect', was 
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reported by Albiero et al after radioactive stent implantation. 10 Further, the 
occurrence of late coronary thrombosis has been associated with radiotherapy. 14 
This phenomenon may be the consequence of delayed endothelializatioll, 
persisting dissections lS or the inability of tubular stents to follow vessel 
enlargement promoted by radiation leading to late stent malapposilion.16 
Potential solutions for Ulese problems include Ule use of new designs of 
radioactive stents or hybrid techniques (catheter-based + radioacthtc stcnt)17 
in addition to the usc of prolonged antithrombotic therapy. Also, the 
avoidance of conventional stent implantation may be considered in the setting 
of catheter-based endovascular radiotherapy. 
There are still several unanswered questions which should be resolved 
before determining the potential of this new technique. First, the usc of beta 
or gamma sources or a combination of both. Secondly, the usc of centering or 
non-centering devices. Further, to determine the best vehicle for radiation: 
solid (wire or train of seeds), liquid (filled-balloon) or gaseous. Equally, the 
clinical effect of the dose-rate (radioactive stent~low dose-rate vcrsus 
caUlCter-based radiation-high dose-rate). Finally, the target tissue must be 
defined, as well as the minimal effective dose to be delivered. Hopefully, ,ancr 
Ule completion of ongoing trials in Europe, as well as in the USA, many or 
these issues will be answered. 
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Abstract 
Objectives: The aims of the study were to determine the incidence of relocation of the minimal 
luminal diameter (MLD) after il-radiation therapy following balloon angioplasty (BA) and to 
describe a new methodological approach to define the effect of brachytherapy on treated 
coronary stenoses. Bacl{grouud: Luminal diameter of coronary lesions, may increase over time 
following angioplasty and irradiatation. As a resuit, the MLD at follow-up may be relocated from 
its location pre-intervention, which may induce misleading results when a restricted definition of 
the target segment by quantitative coronary angiography (QCA) is performed. Methods: Patients 
treated with BA followed by intracorollary brachytherapy according to the Dose-Finding Study 
constituted the study population. A historical cohort of patients treated with SA was used as 
control group. To be included in the analysis, an accurate angiographic documentation of all 
instrumentations during the procedure was mandatory. In the irradiated patients, 4 regions were 
defined by QCA: vessel segment (VS), target segment (TS), injured segment (INS) and irradiated 
segment (IRS). Results: Sixty-five patients from the Dose-Finding Study and 179 control 
patients were included. At follow-up, 1vfLD was relocated more often in the radiation group 
(78.5% versus 26.3%; p<O.OOOI). The rate of >50% diameter stenosis differed between the 4 
pre-defined regions: 3.1% in the TS; 7.7% in the INS; 9.2% in the IRS and 13.8% in the VS. 
COllciusiollS: Relocation of the MLD is commonly demonstrated after BA and brachytherapy 
and it should be taken into account during the analysis of the results of radiation clinical trials. 
Introduction 
During the past 1O years the eft1cacy of percutaneous interventions in preventing restenosis 
after percutaneous interventions has been assessed by the LIse of quantitative coronary 
angiography (QCA) (1-4). This technique of analysis has become the gold standard for the 
assessment of coronary angiograms in the context of scientific research due to its superior 
accuracy and objectivity as compared to visual and hand-held caliper measurements, as well as 
possessing a better illter- and intraobserver variability (5,6). Conseque~ltly, the percent diameter 
stenosis has become the usual output of this analysis and the value of 50% has gained widespread 
acceptance to define the presence of restenosis in the treated coronary segment (7). Intravascular 
ultrasound (IVUS) studies demonstrated that restenosis after balloon angioplasty (BA) is mainly 
due to neointimal hyperplasia and vessel shrinkage at the site of the injury (8-10). 
Pioneers in intracoronary radiation therapy have demonstrated that in a majority of patients the 
luminal diameter at the site of the treated lesion may increase during the foHow-up, rather than 
decrease (II). Three-dimensional lVUS analysis has shown that this phenomenon is induced by 
positive remodeling of the vessel wail at the site of the irradiated segment (12). As a result, the 
minimal luminal diameter (MLD) of coronary segments treated with brachytherapy following 
percutaneous interventions may be relocated at follow-up frOIll its location pre-intervention. A 
restricted definition of the target segment by QCA could induce misleading result's and make any 
comparison to previous non-radiation studies unfair. This study was aimed to (I) determine the 
incidence of the relocation of the iVILD after B-radiation therapy following successful BA and, (2) 
describe a new methodological approach to accurately analyze and report the effect of 
brachytherapy on the treated coronary artery. 
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Methods 
Patient selection 
Patients eligible for the siudy were those successfully treated with BA followed by 
intracoronary radiation according to the Boston Scientific/Schneider Dose-Finding Study (13). 
The purpose of this trial was to determine the effect of various doses of 13-irradiation on coronary 
artery restenosis after BA with or without stent implantation, in patients with single de novo 
lesions of native coronary arteries. The isotope selected was the pure f3-emitting 90y and patients 
were randomized to receive doses of 9,12,15, or 18 Gray (Gy) at hnm tissue depth. The delivery 
of radiation was carried out by the use of the Schneider-Sauerwein Intravascular Radiation 
System (14). In brief, this system comprises (I) a flexible coil made of titanium-coated pure 
yttrium afi1xed at the end of a thrust wire between proximal and distal tungsten markers, (2) a 
centering catheter which is a segmented balloon consisting of 4 interconnected compartments 
which allows centering of the source lumen relative to the arterial lumen, and (3) a computerized 
afierloader which allows automated advancement and positioning of either the dummy or the 
active source (J 4). 
QCA analysis and definitions 
QCA analysis was performed off-line by an independent corelab (Cardialysis, Rotterdam, the 
Netherlands). All angiograms were evaluated after intracoronary administration of nitrates. The 
analysis was performed by means of the CAAS II analysis system (Pie Medical BV, Maastricht, 
The Netherlands). Calibration of the system was based on dimensions of the catheters unfilled 
with contrast medium. This method of analysis has been previously validated (4, 15-16). The area 
of interest was selected after reviewing all cinefilms performed during the index procedure. Any 
angiographic sequence showing the lesion pre-intervention, positions of angioplasty balloon, and 
radiation source may be displayed simultaneously on the screen using the Rubo DICOM Viewer 
(Rubo Medical Imaging, Uithoorn, The Netherlands). The ECG tracing is also displayed in any 
angiographic sequence. By selecting frames in the same part of the cardiac cycle, we were able to 
define the location of the radiation source and angioplasty balloon relative to the original lesion. 
The analyst defined a coronary segment bordered by angiographically visible sidebranches which 
encompassed the original lesion, angioplasty balloon and radiation source. This segment was 
defined as the vessel segment (VS). (figure I) The MLD was determined in the VS pre-
intervention by edge detection and was averaged from the two orthogonal projections. Reference 
diameter was automatically calculated for the VS by the interpolated method (4). The percent 
diameter stenosis was calculated from the:MLD and the reference diameter (7). At the time of the 
procedure, all angioplasty balloons, when deflated, were filmed in place with contrast injection in 
the same projections as were the VS. After successful BA, intra coronary brachytherapy was 
performed. Both the location of the centering balloon and the active wire in place were filmed in 
the same projections as performed previously. The proximal sidebranch within the VS was used 
as an index anatomical landmark. Distances from this proximal sidebranch to: (1) the inner part of 
the proximal tungsten marker; (2) the proximal marker of the angioplasty balloon; (3) the 
proximal margin of the obstruction segment; (4) the distal margin of the obstmction segment; (5) 
the distal marker of the angioplasty balloon; and, (6) the inner part of the distal tungsten marker 
were computed by the CAAS software. The !mge! segment (rS) was encompassed by the 
proximal and distal margin of the obstmcted segment. The segment encompassed by the most 
proximal and most distal marker of the angioplasty balloon defined the injured segment (INS). 
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CAAS software. The target segment (I'S) was encompassed by the proximal and distal margin of 
the obstructed segment. The segment encompassed by the most proximal and most distal marker 
of the angioplasty balloon defined the illjured segment (INS). The segment encompassed by the 
inner part of the 2 tungsten markers defined the irradiated segment (IRS). (figure I) All regions 
of interest were superimposed on the prc-, post-procedural and follow-up angiograms, 
Geographical miss was defined for those cases where the entire length of the injured segment 
was not fully covered by the IRS (17). 
Using the software of the CAAS system the analyst is able to perform a subsegmental analysis 
within the VS. The segment is automatically divided into subsegments of equidistant length (on 
average, 5.0±0.3 mm). The subsegment containing the MLD was taken as the index segment and 
enabled relocation of the MLD to be defined (figure 2). Relocation pre-post was defined as those 
cases where the MLD of the VS post-treatment was located in a different subsegment in the 2 
orthogonal projections from that of the index procedure. Relocation post-flip was defined as 
those cases where the MLD of the VS at follow-up was located in a different subsegment in the 
2 orthogonal projections from that post-procedure. Relocation pre-fttp was defined as those 
cases where the MLD of the VS at follow-up was located in a different segment in the 2 
orthogonal projections from that at the index procedure (figure 2). 
Additionally, the analyst computed the MLD in every region of interest and calculated the 
acute gain, late loss and the frequency of>50% diameter stenosis on a regional basis. Acute gain 
was defined as MLD post-treatment minus MLD pre-intervention. Late loss was defined as 
MLD post-treatment minus MLD at follow-up. Restenosis was defined as diameter stenosis 
>50% at follow-up. 
Control Group 
A historical cohort of consecutive patients treated with BA from the BENESTENT II trial (18) 
presenting with matched views and correct angiographic documentation, was used as the control 
group. VS, TS and relocation of the MLD were defined in this cohort as above described. 
Figure 1 PRE POST FUP 
Subsegment 
analysis 
Computer 
defined 
analysis 
A. Target segment (TS) is betl· .. ~n proximal and distal margin of toe target lesicn ~utoma!ical[y defined by the 
quantitative coronary angiography syslenL Vcssd .segment (VS) is bordered by \isible sidebranches, which encompass 
the target segment (TS), and the position of the angioplasty balloon and radiation SOUf(e. A'. Original lesion in the 
middle part of the right ((llOnary artery before interwntion B. Injured segment (INS) is ddined as the segmeut 
encomp:lSSed by the most proxima! and most distal maIker oflhe angioplasty balloon. B'. Arro\H indicate the markers 
of the denated lIIlgioplast)' balloon filmed in place \\ith a wnlrilSt injeclion. C. The segment encompassed by the inner 
part of the 2 tungsten markers of the radiation delivery s)"stem defined as the irradiated segments (IRS). C'. Arrows 
indicate the inner parts of the radiation source tungsten markers filmed with a contrast injectiolL 
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Statistical analysis 
Data are presented as mean ± standard deviation or proportions. To compare qualitative 
variables, the Chi-square test was carried out. To compare quantitative variables, the Student's 
test was performed. All tests were two-tailed and a value ofp<O.05 was considered statistically 
significant. 
Baseline characteristics 
One hundred and eighty one patients were included in the Dose-Finding study. Of these, 51 
patients received a stent. The remaining 130 patients treated with BA alone followed by 0-
radiation were eligible for the study. By comparing the technician worksheet with the angiograms 
recorded, the analyst was able to identify those patients in whom all balloon inflations and source 
positioning were filmed and all target views were matched. Using this systematical approach, 65 
patients who did not accomplish these technical requirements to perform an accurate QCA, were 
excluded from the study. Thus, the study population comprised the 65 patients presenting with 
complete and correct angiographic documentation. All patients, regardless of the dose prescirbed 
(9,12,15, or 18 Gray (Gy) at Imm tissue depth), were pooled together. 
Of 41 0 patients enrolled in the balloon ann of the BENESTENT II trial, 179 presenting with all 
the above mentioned technical requirements constituted the control group. Baseline 
characteristics of both the study population and control group are described in the table 1. No 
differences were observed between the 2 groups. 
Table 1. Baseline Characteristics 
Age, years 
Gender, male 
Treated artery: 
Left anterior descending 
Left circumflex 
Right coronary 
Coronary risk factors: 
Systemic hypertension 
Diabetes mellitus 
Smoking 
Hypercholesterolemia 
Family history 
Dose: 
9 Gy 
12 Gy 
15 Gy 
18 Gy 
All p-NS. Gy indicates Gray. 
Dose-Finding Group 
(n~65) 
64±9 
46 (70.7%) 
28 (43.1%) 
7 (10.8%) 
30 (46.1%) 
35 (53.8%) 
12 (18.5%) 
33 (66.1%) 
38 (58.5%) 
23 (35.4%) 
18 (27.7%) 
II (16.9%) 
20 (30.8%) 
16 (24.6%) 
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Control Gl'OUp 
(n~179) 
62±IO 
137 (76.5%) 
80 (44.7%) 
22 (12.3%) 
77 (43%) 
89 (49.7%) 
27 (15%) 
123 (68.7%) 
98 (54.7%) 
60 (33.5%) 
Figure 2 
A. Subsegmental analysis before procedure. Vessel segment (VS) was automatically divided into S-
mm subsegments by the CAAS n system. The original lesion is located at segment No.5 pre-
procedure as the arrow indicates. A" Computer defined analysis pre-procedure. n. Subsegmenlal 
analysis at post-procedure. Minimum lumen diameter is located at segment No.6 (arrow). 
Il'. Computer defined analysis post-procedure. C. Subsegmental analysis at follow-up. ?>.·Hnimum 
lumen diameter is located at segment No.7 (arrow). C"Computer defined analysis at follow-up. 
Incidence and location of the relocation of the MLD 
Relocation pre-post of the MLD was defined in 36 patients (55.4%) in the Dose-Finding 
COhOli and in 62 pts (34.6%) in the control group (p~0.005); relocation post-fup was defined in 
37 patients (56.9%) in the Dose-Finding cohort and in 59 patients (33.0%) in the control group 
(p~O.OOI); and, relocation pre-fup in 51 patients (78.5%) in the Dose-Finding cohOli and in 47 
patients (26.3%) in the control group (p<O.OOOI). Geographical miss was identified in 2 patients 
(3%). At follow-up, 45 patients (69.2%) presented with an increase in the value of MLD at TS, 
whereas 20 patients (30.8%) demonstrated either a decrease (18 patients) or no change (2 
patients) in the value ofMLD at TS. The location of the MLD in cases of relocation is presented 
in the table 2. This new MLD was most commonly located within the IRS and INS, followed by 
those regions within the VS but outside the IRS and the INS. Typically, when the new MLD was 
located outside the INS and IRS, distal subsegments were most often involved rather than the 
proximal ones (88% vs. 12%, respectively). 
Table 2, Location of the relocated MLD 
Within INS - IRS 
Outside INS - IRS 
Within IRS--{)utside INS 
Within INS--{)utside IRS 
(geographical miss) 
Relocation pre-post 
(n~36) 
19 (52.9%) 
9 (25%) 
6 (16.6%) 
2 (5.5%) 
Relocation post-fup 
(n~37) 
23 (62.2%) 
10 (27%) 
4 (10.8%) 
0(0%) 
INS indicates injured segment; IRS indicates irradiated segment. 
Methodological implications of the relocation of the MLD 
Relocation pre-fup 
(n~51 ) 
24 (47%) 
18 (35.3%) 
8 (15.7%) 
1(2%) 
QCA data derived from the analysis of the pre-defined regions are presented in the table 3. 
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Table 3. QCA data from the 4 pre-defined segments 
TS INS 
rvILD pre, mm l.O6±O.2 l.O6±O.2 
MI..D post, mill 2.17±O.5 1.99±O.4 
MLD flip, mm 2.36±O.5 1.97±O.5 
%DS fup 20.3±11 33.2±11 
illS 
l.06±0.2 
2.00±0.4 
VS 
1.06±0.2 
1.91±0.4 
1.97±0.5 1.84±0.5 
33.4±ll 37.9±10 
Acute gain, mm 1.12±0.4 0.93 ±O.4 O.94±0.4 0.85±0.4 
Late loss, mm -0.18±0.4 O.OI±O.4 O.03±O.4 0.07±0.3 
Restenosis rate, n (%) 2 (3.1) 5 (7.7) 6 (9.2) 9 (13.8) 
Segment length, nun 5.0+0.3 18.7+4.2 22.9+3.5 36.9+8.4 
DS indicates diameter stenosis; fup indicates follow-up; INS indicates injured segment; IRS 
indicates irradiated segment; MLD indicates minimal luminal diameter; pre indicates pre-
intervention; post indicates post-intervention; TS indicates target segment; VS indicates vessel 
segment. 
DisclIssion 
Incidence and causes of relocation of the lVlLD 
This study demonstrates that the relocation of the "MLD is a common phenomenon in coronary 
segments treated with BA followed by intracoronary beta-radiation therapy. Although relocation 
of the MLD at follow-up was significantly more frequent in the irradiated group, control patients 
treated with "plain old balloon" angioplasty demonstrated also a notable incidence of relocation. 
This phenomenon noted after radiation was witnessed in previous studies that showed that the, 
restenosis process affected the entire vessel segment which was dilated and not just the 
obstructed segment (19,20). To overcome this problem, the TOSCA group devised the concept 
of target lesion work length, defmed as the length of contiguous target segment exposed to 
balloon inflation (21). In addition, the relocation of the MLD may explain the mismatch between 
good angiographic results of previous radiation trials and the poor clinical outcome (i.e., high 
target vessel revascularization rates) observed in these studies (22). 
Further, as changes in the reference diameter may occur during the follow-up period, the use of 
the percent diameter stenosis measurements is questioned as nn accurate estimate of lesion 
severity (19,20). In this regard, 2 thirds of our study population demonstrated an increase in the 
value of the pre-intervention tvn..D. In the radiation group, increase of vessel dimensions at the 
site of the index MLD may play an important role in the relocation of the MLD. 
Previous three-dimensional intravascular ultrasound observations demonstrated that the vessel 
wall enlarges after catheter-based radiation therapy either following conventional BA or stent 
implantation 02,23). This vessel enlargement was able to accommodate the mean increase in 
plaque volume, resulting in a net increase in the irradiated luminal volume at follow-up. 
In our study, the tvn..D was mainly relocated within the IRS and the INS and outside the INS 
and the IRS (typically at distal segments). In such regions, the presence of pre-existing plaques 
which became angiographically apparent or progressed after the treatment and tapering of the 
vessel may have accounted for the relocation of the MLD. On top of these causes of relocation, 
we cannot exclude the influence of the natural atherosclerotic process on this phenomenon in the 
context of patients with coronary risk factors by inducing development of new coronary lesions in 
any of the pre-defined regions of interest. 
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Methodological consequences of relocation 
When the analysis was restricted to the TS, this lumen gain at follow-up resulted in a negative 
mean late loss and a very low restenosis rate (3.1%). The TS represents a region which was 
injured by the angioplasty balloon and theoretically presented with the peak stress and vessel 
stretch after BA. Further, this segment was fully covered by the radiation source in all cases. 
Thus, the results of the analysis of the TS may demonstrate the effect ofbrachytherapy in optimal 
conditions. On the other side of the spectmm, when the analysis included the entire VS, both the 
late loss and the restenosis rate were significantly higher (table 3). This latter analysis was 
performed in most of the historical trials aimed to determine effectiveness of Hew therapeutic 
agents on restenosis process after BA (24-27). This traditional approach is driven by the concern 
that hemodynamic effects (i.e. flow limiting lesion) symptoms and outcomes are likely related to 
the location of the new rvtLD, irrespective of precise anatomic concordance with its location pre-
intervention, The meticulous analyses proposed are likely to give new insights on the 
pathophysiology of this new therapy and we believe that these are highly recommended during 
feasibility in-vivo and in-vitro studies. In clinical radiation trials, the traditional VS approach 
should be the common angiographic endpoint, and further analyses of the above defined regions 
of interest may complement the results of the study. In this regard, the efficacy of the therapy 
itself would be determined by the results at the TS, whereas the eftectiveness of the radiation 
therapy would be defined for the entire VS, which includes both the desired (i.e. lumen 
enlargement) and the side effects (i.e. edge restenosis). 
Limitations 
The definition of relocation of the MlD depends decisively on the accurate documentation of 
all steps followed during the procedure. This was accomplished only in 50% of the cases treated 
with BA in the Dose Finding Study and in 44% of the historical control group. 
The QCA data presented in this study represent only the results of the pooled cohort of patients 
enrolled in the Dose-Finding study and not the entire population. 
Conclusions 
Relocation of the :MLD is a common phenomenon after successful BA foHowed by 
illtracoronary beta-radiation. This feature may induce controversial results related to the 
methodology used in the QCA analysis and should be considered when reporting the results of 
subsequent radiation studies. The new methodological approach proposed may be useful to 
determine the potential and limitations of this new technique. 
Appendix 
The participating centers and investigators of the Dose-Finding Study Group are listed with the 
number of included patients under parentheses. 
University Hospital, Geneva, Switzerland (57): Verin Vitali, MD, Youri Popowski, MD, 
Delafontaine Patrice, MD, Kurtz John, MD, Papirov Igor, PhD, Sergey Airiian, MD, Philippe 
Debmyne, MD, Ramos de Olival Jose, MD. 
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Cardiovascular Center, Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium (54): Wijns William, "MD, 
(Principal Investigator), de Bruyne Bernard, MD, Heyndrickx Guy, wID, Verbeke Luc, wID, 
Piessens Marleen, PhD, De Jans Jo, MSc. 
University Hospital, Essen, Germany (26): Baumgart Dietrich, MD, Sauerwein Wolfgang, MD, 
Erbel Raimund, MD, von Birgelen Clemens, MD, Haude Michael, MD. 
University Hospital, Kiel, Germany (22): Lins Markus, MD, Simon Ruediger, MD, Kovacs 
Gyorgy, MD, Thomas Martin, MD, Herrmann Gunhild, MD, Wilhelm Roland, MD, Kohl Peter, 
MD. 
Kings College Hospital, London, United Kingdom (22): Thomas Martin, MD, Caiman Francis, 
MD, Lewis Niel, PhD. 
Data Monitoring: Thaler Thomas, MD (Boston Scientific) 
Angiographic Core-Laboratory and Data Analysis: 
Teunissen Yvonne, PhD, (Clinical Trial Manager), Spierings Astrid, Van derWiel Connie, Kloek 
Gitte, MSc, Disco Clemens, PhD 
Critical Events Committee: Dekkers Jaap, MD, Serruys Patrick, MD, PhD. 
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Geographic Miss 
A Cause of Treatment Failure in Radio-Oncology Applied to 
IntracoI'onary Radiation Therapy 
Manel Sabate, tvfD; Marco A. Costa, MD; Ken Kozuma, MD; r. Patrick Kay, MEChB; 
\villem 1. vall der Giessen, MD, PhD; Veronique L.M.A. Coen, MD; Jurgen M.R, Ligthart, BSc; 
Pedro Serrano, MD; Peter C. Levendag, MD, PhD; Patrick \y, Senuys, MD, PhD 
Hackgrotuuf-A recognized limitation of endovascular J3-radiation (hempy is the development ornew stenosis at the edges 
of the irrudiutcd area. The combination of injury and low-dose radiation may be the precursor of this phenomenon. We 
translated the radio-oncological concept of "geographic miss" to define cases in which the radiation source did flot fully 
cover the injured men. The aims of the study were \0 determine the incidence antI causes of geographic miss and evaluate 
the impact of this inadequate treatment on the outcome of patients treated with intracoronary ,a-radiation. 
Methods alld Results-We analyzed 50 consecutive patients treated with ,a-radiation after percutaneous coronary 
intervention. The prescrihed dose ranged between 12 and 20 Gy at 2 mm from the source axis. By means of quantitative 
coronary llngiogmphy, the irradiated segment (IRS) and both edges were ),Iudied before and after intervention and at 
o-month follow-up. Edge~ that were injured during the procedure constituted the geogmphic miss edges. Twenty-two 
edges were injured during the intervention, mainly because of procedural complications thai extended the treatment 
beyond the margins of the IRS. Late Joss was significantly higher in geographic miss edges than in rRSs and uninjured 
edges W.84±O.6 verslIs O.15±OA and O.09±OA mm, respectively; P<O.OOOl). Similarly, restenosis rate was 
signii1canlJy higher in the injured edges (10% within IRS, 40.9% in geographic miss edges, and 1.9% in uninjured edges; 
P<O,OOI), 
COllciliSiollS-These duta !'iupport the hypothesis that the combination of injury and low-dose ,l3~.radiation induce~ 
deleterious outcome. (CirculatioJl, 2000;101:2467·2471.) 
Key Words: geographic miss _ radioisotopes _ balloon _ angioplasty _ stents _ angiography _ resteno~is 
E nuovasl,'ttlar radiation therapy is a novel technique aimed at preventing r~~tcn(lsis after perclltaneous coronary 
intervention. I-,l Rndiation can he delivered to the coronury 
urtel)' by means of catheter-oased systems or radioactive 
stell!s,-t A potential druwoack nf' this treatment is the devel-
opment of new ~tenp!ic lesions al both edges of the irradiated 
segment (IRS). This so-called "edge effect" was originally 
described after high-activity (>3 ItCi) radioactive stell! 
implalltalioJl.·'<· Ho\\'cwr. this phenomenon is not cxdu~i\'e 
10 ruuioactivc stellts and may abo affect coronary segments 
treated by means of catheter-based systems.7 The pathuphys-
iology of the edge effect may be the result of ves~el wall 
injlll)'~-In concomiwllI with' low-dose radiation at the edges of 
the irradiated area."·I~ In rudin-oncology, the term to denne 
a cause oftreutment failure due tolo\\' dose was coined by the 
r ... lanche.\ter Clinic as "geographic miss." In .\lIch cases, a 
small part of the treatment zone hus either escaped radiation 
or heen inadequatelY irnu.liuted hecause the total volume of 
the tumor was not <lppreciated and hence an ifl~ufficient 
nHlrgin was taken. ' ,1 This concept is translated in inter\'en-
tional cardiology to dei1ne those coronary segments thaI were 
injured but received low~dose radiation. Typically, this phe-
nomenon occurs when the edges of the IRS, where. by 
detinilion, the dO . .,e is rather 10\\', are injured. 
The aims of the study were (I) 10 determine the incidence 
<lnd causes of geographic miss in the treatment of patienls 
with intl'acoronary ,l3-rudiation by u,e of a cathder-ba~cd 
system and (2) to evaluate the impact of this inadequate 
treatment on the angiographic outcome of these patients. 
Methods 
P"lient Selection 
We retrosp.;clively nn~IYlcd 50 consecutiw palienh treated at Ollr 
in';[iwtion with catheter~b:J.~ed /3-radialinn by means of the Del:J.-Cath 
~yslem (NoVo,te Corp). Palient'> included in the radiation pflllm:ol 
were those with objecti\'c signs of ischemia and pre,ence of 
R.;.;~iI·.;d t\ll,1,'lhl .In. Pi!)'}; r':l'i,ion Ic(.;il'.:d Decem\>er Il 1999; acceptcd Deccmher 22, 1999. 
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significant de novo lesions (n=39) or recurrent in-sten! reslenosis 
(n= I I). A detailed description of the radiation system ha~ been 
reported e!sewhereY The radiation sour~'e train conr.;ists of a series 
of 12 cylindrical seeds that contain the radioisotope "'Srf"Y source~ 
and is bordered by 2 gold radiopaque markers separated by 30 mm.l~ 
Procedure 
The medical ethics committee of our institution approved the 
investigational use of p-radiation, and all patients signed an in-
fonned con~ent fonn. Percutaneou<; intervention wa, performed 
iKcording to standard clinical practice. Typically, coronary lesions 
were treated initially with balloon angioplasty (BA). After successful 
BA_ the target coronary segment was irradiated. This could be 
followed by additional stent implantation when clinically indicated. 
Lesion length measured on average 11.4±4 mm, the mean balloon 
length wa, 20.0±3 mm, and Ihe number of batJ(l!ln innations was 
2.9± I .6. Patients received aspirin (250 mg) and heparin (10000 IV 
IV) at the initiation of the procedure, and an additionlll dose of 
heparin was administered 10 maintain the activated clotting time 
>300 ~econd~. After the procedure, a~pirin war.; continued indefi-
nitely. In patients who also received stent implantation, ticlopidine 
wa, initiated and continued for ~15 days after the pwcedure. The 
radiation dose was prescribed at 2 mm from the SOUrl'e axis. The 
pre~crjbed dose for the 1r-eatment of de novo lesions was mndomly 
assigned to 12, 14, or 16 Gy for protocol requirements. For the 
treatment ofin-stent restenotie lesions, the prescribed dose was 160r 
20 Gy if the reference diameter, by quantitative coronary angiogra-
phy (QCA). measured 53.25 mill or >3.25 mm. respectively. The 
mean dwelt time to deliver these dose, wa, 143±44 seconds. 
Definitions 
The IRS was defined as the area encompassed by the 2 gold markers 
of the radiation source train. It was identified on angiography by a 
contrast injection wito the source in place. The edges of the IRS were 
defined a, the 5-mm-long segments prmimal and di~tal to the 
angiographk location of the gold markers. The edge~ that were 
touched by the angioplasty baUoon or received llew stent implanta-
tion during the procedure were defined as geographic miss edges. 
hel'au,e they repre,enl injured segments receiving low-dose radia-
tion. Uninjured edges were those that were not traumatized during 
the intervention. To determine whether the edges of the IRS were 
injured, a few steps were followed: during the 'procedure, every 
balloon inflation or additional stent implantation was filmed in the 
same projection, as was the radiation source. This approach allowed 
us the correct matching of the dne films in the omine analy.si<;. 
Either cine loop showing balloon inflation, stent implantation, and 
radiation source may be displayed simultaneously on the sueen with 
the Rubo DfCOM Viewer (Rubo Medical Imaging). ECG tracing is 
also displayed in either cine loop. By selecting those frames in the 
same pJrt of the cardiac cycle, we were able to define the location of 
the radiation source relative to the injured area. 
QCA Analysis 
The IRS and both edges were analyzed by QCA before and after 
intervention and at 6-month follow-up. All angiograms were evalu-
ated after intracoronary administration of nitrates. The offline anal-
)'si~ of 2 orthogonal projection'> was performed by means of the 
CA,\S II analysis system (Pie Medical BV). Calibmtion of the 
system was based on dimensions of the catheter.; nnt filled with 
contra,t medium. This method of analysis ha, been previously 
\'alidated.I~171lIe following QCA parameters were computed in the 
IRS and both edges: minimal luminal diameter (MLD), which wa~ 
computer defined; reference diameter, which was obtained by an 
interpolated methodl~l1; and percentage diameter stenosis. Binary 
reste-nosis was defined in every are,1 as diameter stenosis >50% at 
follow-up. Acute gain wa~ deli ned a, MLD after treatment minus 
MLD before intervention. Late loss was defined as MLD aftcr 
treatment minus MLD at follow-up. Relative late loss was defined as 
late loss divided by reference diameter. ,g 
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Statistical Analysis 
To compare continuou~ vuriuble\ between IRS. geugraphic Illis~ 
edges, and uninjured edges, I-WilY ,\NOVA with post hoc analysis 
for Illultiple colllpari,ons wa, pCrfllnllcJ. (fnp,lired S\lIJcnt's t !I.'.,t 
wa~ performed to compare C(llltilHl(lll~ \'ariilnlc, hctwccn pnl)..imal 
alld &,tal geographic Illi" cdgc~ and nctwccn p.l\knh in \\I\OUl the 
geogmphk mi~s was indll('ed by balloon dililtation or stent implan-
tation. To compare the binary restenosis oet\\'ecn gWUP\_ Ihe .\) test 
was performed. All tesl~ were 2-tailed. und tl value of P<O.05 \\'[l$ 
comillcred stnli,IiL'Jlly signilkant. 
Resulls 
Baseline Chal'actel'istics 
Fifty irradiated coronary arteries <Inti 100 edges in 50 patients 
were eligible for the study. However, 26 edges were excluded 
because of the ostial location of the proximal -end of the 
source in the right coronary artery (n= 12) or overlapping of 
I of the edges with side branches (n= 14). Tlws. finally, 74 
edge areas and 50 IRSs were studied. Mean uge was 55.J±\} 
years, and 38 patients (76%) were male. Smoking was the 
most frcqucnt coronary risk fm:tor, involving 33 patients 
(66%), followed by dyslipidemia in 27 patients (54%) and 
hypertension in 24 patients (48(,f,). Eight patients (IMO were 
diabetic. The left anterior descending coronllry artery was 
treated in 21 patients, the left circumtlex in 10, the right 
coronary artery in 18, lind a ~tlphellou~ vein graft in I. Twelve 
paticnts received a stent in a bailout situation. 
Incidence and Causes of Geographic l\-liss 
Gcogruphic miss was observcd in 22 edges (J1.9 f/d induced 
by balloon dil<ll<1tion (n= 13) or additi(lllal stt.'nt imphllltlllilltl 
(n=9). The remaining 51 cdgt.'s (<is.I)':''') were defined liS 
uninjurcd cdgcs. Thc locution of the geographic miss was in 
the proximal cdge in II patients (50%) and in the dis!<l1 
margin in II patients (5oc,f.). The following rcasons were 
responsible for this phenomenon: (I) development of procc-
duml complications that e.\tcndcd the treatment beyond the 
margins of the IRS (unexpected geographic miss, 11=1)); (2) 
lack of availability of <I longer rmliation SllUrl'e (>30 nun) ill 
paticnt~ with diffuse recurrcnt in-s\(~nt restenosis in whom 
radiation was given on a compassionate-use basis (11=8); und 
(3) lack of accurate matching; ie, the injured segment front 
pre\'iou~ ballnon innutions wu~ nnt approptiately covered by 
thc source (11=5). An cxumplc of 1I paticnt with geographic 
miss induced by a balloon dilatation ill the proximnl margin 
is depictcd in Figure l. 
QCA Analysis 
QCA data are presented in the Table. As expected, IRSs 
dernonslralcd, on avcrHge, u highcr ncute gain than both 
injured and uninjured edges. However, geogruphic miss 
edges presented, on average. with .~ignificantly higher late 
loss lind relative late loss. Restenosis was (Jernonstrnted in 5 
C<l'ies (10%) within the IRS, in I) ClL~('S (.JO.9?d ill the 
geographic miss edges, and in I cll~e (1.9%) ill the uninjured 
edges (P<O.OOI). No difference in the pattern of the late loss 
between the 3 areas was ob~cr\'ed itt de novo lesions 
compared with recurrent ill-stent restellotie IeSi(lllS (Figllt'e 2). 
In the geographic miss edges,.J edge restenmes (~.j.'7d were 
located at the proximal edgcs, whereas the other 5 (56r;() 
were located <It the distal edges. Mean relative late loss was 
cOll1paruhle hetween those edges, with geographic miss 
locllted proximal or distal to the IRS (0.31 ±0.2 versus 
0.34±O.2, respectively; P=NS). Those edges in which the 
geogmphic miss was due to additional Slent implantation 
presented. Oil uverage. higher nClite gain than those due to 
balloon dilatation (O.70±0.4 versus 0.21 ±0.3, respectively; 
P=O.O(5). However. mean late loss and mean relll(ive late 
loss were l'OlllpambJe hetween both causes of geogrnphic 
miss (O.1J5±O.1J mill and O.J6±O.3. respectively, after stent 
vcrsus O.77±0.3 mOl nnd O.30±O.1 after balloon dilatation; 
both P=NS), 
Discllssion 
This study reports on the initial experience of our center with 
the use of intmcnTOnary f3-nu.liatioll. By means of a cureful 
OGA Data 
IRS 
(n=50) 
MlD be/ore intervention, mm 1.20±0.3 
MlO after Intervention, mm 2.02:':0.4 
MlD at follow-up, mm 1.87:':0,5 
Reference diameter, mm 2.69:':0.6 
%DS befole intervention, % 54.9:':13 
%DS after Intervention, % 28.4±9 
%DS at follow-up, % 33,3±11 
Acute gain, mm D,81±0.4 
late loss. mm 0.15±0.4 
Relative late loss 0.06±0.1 
FIgure 1. GeographIc miss Induced by 
balloon dilatation. A, Lesion located in 
proximal segment of left anterior 
descending coronary artery_ B, Balloon 
dilatation performed during intervention 
(black arrowheads indicate area Injured by 
balloon). C, Radiation source train In 
place. Irradiated area is delimited by gold 
markers (white arrowheads). D, Final 
resull: proximal traumatized edge present-
ed a resldual Iype B dissection. E, At 
6-month follow-up: obvious reduction in 
lumen at geographic mIss edge. 
retrospective angiogmphic analysis of all patients treated with 
the same radilltion system, we sought to define the ef(ecl of 
the injury on those areas located at the margins of the source 
where the delivered dose is potentiillly rather low. Up to 
31.9% of the patients presented with the predefined technical 
error, called geographic miss. This concept requires the 
concurrence of 2 conditions: low-dose radiation and injury. 
Any other clinical situations that do not include both condi-
tions cannot be called geographic mi.'>s. For imtance, (I) the 
effect of injury on coronary segments not being irradiated 
(proximal or distal to an IRS but in areas in which the 
calculated dose is almost 0) should fall into the category of 
normal restenotic process; (2) the effect of low-dose radiation 
in areas that have lIot been injured may be defined as the pure 
radiation edge effect, hecause in illtracoronary radiation, the 
Geographic Miss Uninjured Edges 
Edges (n=22) (n=52) P 
2,02±0,6 2.1O±0.6 <0,0001 
2.43±0.5 2.12±0.6 0.01 
1.59±0,6 2,02±0.5 0.006 
2.50±0.6 2.55±0.7 NS 
19.8±14 17.9±11 <0,0{)01 
19.9±10 20,8±11 0.0003 
44,3±22 24.3±tO <0.0001 
0.4\.±0.4 0.0\±0.3 <0.0001 
0.B4±0.6 0.09±0.4 <0.0001 
0,32±0.2 0.02±0.1 <0.000\ 
%DS indicates diameter stenosIs. Data are mean:':SO. 
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Figure 2. Difference in late loss between IRS, geographic miss 
edges, and uninjured edges. De novo lesions and in-stent reste-
nosis demonstrated same degree 01 late loss between 3 groups. 
edges of any IRS will always receive low-dose radiation; and 
(3) finally, the effect of a full prescribed dose on segments 
presenting with or without injury is the situation in which the 
physician may be able to irradiate (with full dose) the entire 
injured segment and include some uninjured margin. A key 
issue in the definition of geographic miss is to define those 
segments receiving a low dose. These may vary between 
sy.~(ell1s and sources used. With the Deta-Cath system, the 
[ongitudinal distance of the 100% isodose is 26 mm. Because 
the f3-emitting ?;'SrPOY has an acute falloff of dose related to 
the distance,19 the last 2 mm within the markers of the source 
~hould be considered as having received a lower than pre-
scribed dose. In fact, the dose received at [ mIll from the 
100% isodose is 86% of the prescribed dose, and at 2 mm, 
60% of tile prescribed dose (inner part of the gold marker), At 
3 mm, the dose is 30% of the prescribed dose: at 4 mm, 13% 
of the prescribed dose; and at 5 mm, 5% of the prescribed 
dose. We defined the IRS as the segment encompassed by the 
2 gold markers, which included the last 2 mm within the 
mllrkers with a lower than prescribed dose (up to 60% of 
the prescribed dose). By Ihi,~ definition, late loss and reste-
nosis rate were significantly lower than those of the injured 
edges (analyzed from the inner part of the g~!d marker). 
Furthermore, the 5 cases of restenosis within the IRS were 
located at the site of the initial IvtLO. These results may 
reflect the fact that the dose at these last seeds of the source 
was high enough to avoid the edge effect after the edges h~d 
probably been injured during the procedure, especially when 
a 20-1ll1ll-long balloon was used. Thus, the region receiving a 
low dose may be defined, for this system and source, as the 
5-mm-long segment located 2 mm farther from the 100% 
isodose boundary, that is, beyond the inner part of the gold 
marker. In this regard, we believe that the injury should be 
completely restricted to Ihe segment of the 100% isodose 
curve of the radiation source (26 mm) and that the last 2 mm 
at both extremities of the source and within the gold markers 
may be considered relatively but probably not completely 
safe, Finally, any injured segment covered by or beyond the 
gold marker (up to 5 mm) mllst be considered 10 be at high 
risk of failure at follow-up. 
From the perspective of these findings and future technical 
developments in the field, the following recommendations are 
advisable. Filming every single balloon inflation performed 
during the procedure would allow one to define the injured 
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area, More than ever, tenae,ious attention to detail in position-
ing the radiation catheter encompassing the entire injured 
area must be mandatory. The development of longer SOllrces 
(>30 mtn) would allow one to Ireat diffuse JeSillllS and 
completely cover those areas in which an extension of the 
treatment was indicated hecause of procedural complications. 
Equully, the use of online QCA in the decision-making would 
avoid appreciation errors due to visual assessment of the 
target area and subsequent underestimation or overe,~tirnatjon 
of balloon lengths. Finally, the selection of the most suitable 
fluoroscopic projections (eg, less foreshortening, no overlap-
ping) would avoid error!' in the quantification of the region of 
interest. 
The facts that the locations of most or the re,~teillJ.~e.~ were 
in geographic miss edges and that late loss in those aretls was 
unexpectedly high must raise an alarm about the ddeterious 
effect of the combination of injury and low-dose radiation. 
This hypothesis may be supported by the fnct that the late loss 
observcd ill those injured edges is higher than that reported in 
recent clinical trials after either BA or ~tent imp[antation!'UI 
and higher than that demonstrated in the uninjured edges. 
8alloOlI overstretch injury has been lIsed as nn experimental 
model to study the restenosis process. H_IO The response of the 
vessel wall to injury involves both neointilllal hyperplasinlt.'1 
and vessel remode!illg. lU .!1.1.1 The stimulatory effect of low-
dose radiation after BA on smooth muscle cell proliferation 
has been reportcd previollsly.11 In the low-dose radiation 
group of this swine model (10 Gy), neointima was composed 
of smooth muscle cells, with a IlHtrked increilse in inflamma-
tory cells and less medial and intimal fihrosis than in the 
higher-dose groups (15 and 20 Gy) and the control group. It 
was suggested thai at low dose, inadequate fibrosis was 
induced to prevent effective smooth muscle cell migration 
and to act as a diffuse barrier for mediators of chemotaxis. 
chemokinesis, anti r.:dlular prolifemtion. ll Similarly. after 
low-activity radioar.:tive stent illlplalltation (I MCi) in a 
porcine model, neointimal hyperplasia WIIS signil1cantly 
greater than that after nonradioactive control stents. ll If 
ongoing intravasculur studies reveal that edge restenosis is 
mainly due to plaque increase, the former hypothesis that at a 
low dose, inadequate medial and intinwi fibrosis to avoid 
migration and prolifcflItilln predominates lIlay become a 
plausible explanation. Conversely. if negative remodeling is 
the main contributor to the lumen [0)0<;, the excess of inOam-
matory cells demonstrated at low dose may be responsible for 
subsequent adventitial fibrosis and vessel shrinkage. The 
development of the so-called "candy wrapper" after radioac-
tive stent implantatiQn~ lIlay represent the clinical paradigm 
of the combined deleterious effect of low-dose mdiatiotl and 
injury. The latter is secondary to the tmgioplusly balloon used 
for predilatation and postdiiatntion of the radioactive stent. In 
this regard, a higher balloon-to-artery ratio was associated 
with the presence of this phenomenol\.~ 
Future lrials must address the benefit of new teChnical 
developments in the field (lise of square deployment bal· 
loolls; hot-end, cold-end stentsl"; longer sources with smaller 
radiation delivery catheters) to minimize the impact of injury 
at the edges after either mdioaeti\'e stent- or catheter-based 
systems. 
Stud" Limitations 
In thi~ study, only I type of radiation delivery catheter using 
the {:I-source "'Srr'Y was evuluuted. Thus, the effect of either 
other eutheter-oa\ed .\yslems using centering balloons and 
Llifkrent sources or the y-wdiotherapy on the geographic 
miss edges cannot be extrapoluted from our results. 
The Hctual dose at the margins of Ihe radial ion source has 
not been ('aklilale{1. A low th)~e al these edges was assumed 
because the i~otope 'MSrf"y demonstrates an acule fulloff 
reluted t(Jlhe distunce from the 100% isodose boundary,'Y 
This angiographic stuLly wa~ aimed nt defining the concept 
and the clinical implicati(Jm of the geographic miss. To 
del1ne the medmnbrn of the unexpectedly high late loss and 
the l'orrellidon between radiution dose and plnque extent [It 
the margins of the IRS, intravascular ultru>.ound studies must 
be carried out. 
The location of tile segment rel'eiving a low dose may v[lry 
between ~ysteJl1s and sources. Thus, Ihe eonfidence margin to 
be taken nlay VUT)' lll'l'ordingly, 
The position of the ~oun:e relative 10 Ihe various balloon 
inl1alions wns asses~ed by l'onlparillg still frames at the snme 
purt of the cardiac cycle from cineungiograms performed in 
the same projections, However, small inaccuracies in the 
det1nition of the IRS and the edges, derived frolll the axial 
movement of the mdiation source during the cardiac cycle, 
cannot be completely ruled out. 
This ~tlldy was not pJ;ll'ebo-eolltrol!ed. ThllS, the eflcct of 
Ihe sham source on the balloon-injured coronary segments 
has not been determined. 
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CHAPTER 8 
The Effect of 32p Beta-Radiotherapy on Both Vessel 
Remodeling and Neointimal Hyperplasia after 
Coronary Balloon Angioplasty and Stenting. A Three-
dimensional Intravascular Ultrasound Investigation. 
tvlarco A Costal, "t\1D, Manel Sabate1, MD, Pedro Serrano', MD, Wim J. van def Giessen1, MD, 
PhD, Ken Kozuma', l'v1D, Veronique L.M.A. Coen', MD Jurgen M.R. Ligthart" Alex Wardeh', 
MD, Peter C. Levendag', MD, PhD, Patrick W. Sermys', MD, PhD. 
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The Effect of 32P Beta-Radiotherapy on Both 
Vessel Remodeling and Neointimal Hyperplasia 
After Coronary Balloon Angioplasty and Stenting: 
A Three-Dimensional Intravascular Ultrasound 
Investigation 
Marco A, Costa, MD, Manel Sabate, MD, Pedro Serrano, MD, 
Wim 1. van der Giessen, MD, PhD, Ken Kozlllna, MD, I. Patrick Kay, MBChB, 
'Veronique L.M.A. Coen, MD, Jurgen M.R. Liglharl, Alex Wardeh, MD, 
'Peler C. Levendag, MD, PhD, Patrick W. SemlYs, MD, PhD 
ABSTRACT: Il1lracoronary radiation Is a promis-
ing therapy to decrease restenosls after percutaneous 
1111('t\'('nllon. The aim of this pilot study was 10 deter-
mine the mechanism of int!'aeoronary bela-radiation 
after baUoon allgioplasty and stentlng in It double-
blind placebo-controlled randomized fashion. Twenty-
six patients were randomized to either placebo (n ", 6) 
or 3 doses (28, 35 and 42 Gy) of bcla-radlatlon (n "" 20) 
using the Guidan! brachytherapy system (27 I11lU long 
IIp source wire). Of these, 21 patients underwent post~ 
procedure and 6-month follow-up three-dimensional 
Intravascular ultrasound (IVUS) assessment. Volu~ 
metric quantification was performed by means of a 
seml-automatcd contour detection system after an 
ECG-gated motorized pullback IVUS Imaglng'and 
thrce~dlmenslonal reconstruction. We compared the 
volumetric changes (11) of total ycssel \'oilime (TV V), 
plaque \'olume (PV) and lumen volume (LV) after 6 
Illonths between placebo (dummy wire) and irradiated 
patients. In addition, the \'olume of neolntlmal hyper-
plasia was quantified within the stellted segments. 
There was an opposite behavior of TVV and LV 
change betweell placebo (ATVV = -24 mm3 and ALV = 
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-42 mml) and Irradiated (ATVV = +18 mm' and (ilLV 
= +5 mm3) patients. The meall neolntimal formation 
wllhln the stented segment In the irradiated patients 
(n = 7) was 1.9 mm' (1.5%). Our results suggest that 
beta-radiation affects vessel remodellng after percuta-
neous Inten'ention and inhibit neoinflmal formation In 
stented patients. 
J INVAS CARDIOL 2000jI2:113-120 
Key words: brachythe-rapy, neolnt1mal hyperplasia, 
remodeling 
Restenosis after percutaneous intervention has been 
reduced with the advent of coronary stentsY However, 
further reduction in the incidence of restenosis appears 
to be difficult using conventional approaches, 
The introduction of intravascular ultrasound 
(IVUS) in the clinical practice has refined our knowl~ 
edge about the mechanism of reslenosis, Thus, the 
restenolic process can be divided in two major compo-
nents; vessel remodeling and neointimal formation. 
The fanner predominates after balloon angioplasty 
(BA), whereas the latter is the main cause of in-stent 
restenosis,J·t 
Intracoronary radiation is a promising therapy to 
decrease restenosis after percutaneous intervention. 
Stimulated by animal studies showing inhibition of 
neointimal fomlation by radiation/-J two randomized 
trials have shown the reduction of restenosis by treat-
ing reslenotic lesions with gamma radiation,1;9 Further, 
a non-randomized study has shown the safety and fea-
sibility of bela radiation, with a satisfactory (15%) rate 
('().':JJA, el al. 
of restenosis in de 1101'0 lesion treated with balloon 
angioplasty.'o 
Recent IVUS investigations suggested that bela 
radiation after BA may affect vessel wall remodel~ 
jng. 11-13 These findings have been corroborated by some 
experimental studies. 1l.1! However, the relative contri-
bution of radiation on vessel remodeling and neointi-
mal fonnation remains to be clarified. 
The aims of this pilot study were: I) to assess the 
effects of beta radiotherapy 011 coronary segments suc-
cessfully treated by BA or stenling; and 2) to compare 
the behavior of irradiated and non-irradiated (sham) 
coronary segments 6 months after trcatment by means of 
a volumetric three-dimensional (3-D) IVUS assessment. 
METHODS 
Patient selection. In this double-blind feasibility 
and safety study, 26 patients were randomized to either 
sham (placebo) or 3 different doses of beta-radiation 
(28, 35 or 42 Gy, as calculated at 0.5 111m into the ves-
sel wall). The Medical Ethics Committee of the Uni-
versity Hospital Dijkzigt has approved the lise of 
intracoronary radiation. All patients gave written 
infomled consent. 
Radiotherapy system. The Guidant Brachytherapy 
System (Guidant Corporation, Santa Clara, California) 
used in this study includes a 0.018" nitinol wire with 
27 mm of IIp source at its tips. The use of a centering 
spiral balloon (27 mm long) allows the administration 
of prescribed dose homogeneously in the vessel wall as 
well as distal vessel perfusion during balloon inflation 
at a maximum inflation pressure of 4 atmospheres 
(atm). Automated source delivery unit controls dose 
delivery and source withdrawal, providing "hands-off" 
radiation delivery.'6 The duration of the treatment and 
dose necessary to reach 0.5 mm into the vessel wall are 
calculated using the mean reference vessel diameter by 
IVUS immediately prior to radiation delivery. 
IVUS 1H1nlysis system. The segment subject to 3-D 
reconstruction was examined with a mechanical IVUS 
system (ClearView, CVIS, Boston Scientific Corporation, 
1·1aple Grove, Minnesota) with a sheath-based IV US 
catheter incorporating a 30 MHz single-element transduc-
er rotating at 1800 rpm (Ultracross, CVIS). An ECG-
gated image acquisition and digitization was perfonned 
by a workstation designed for the 3-D reconstruction of 
lVUS images (EchoSc3n, Tonltec, Munich, Genlluny).1! 
IVUS i1'nages were acquired coinciding with the peak of 
the R wave, which eliminates the artifacts caused by the 
movement of the heart during the cardiac cycle. 111en, thc 
IVUS transducer was withdrawn every 0.2 nun tt) acquire 
the next image coincident to the R-wave.'7 
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A Microsoft Windows"'-based contour detection 
program, developed at the Tboraxcenter, was used for 
the 3-D volumetric quantification. " The feasibility and 
intra- and inter-observer variability of this system have 
been validated in clinical protocols.'~:<' Briefly, this 
program constructed longitudinal sections from the 
data set and identified the contours corresponding to 
the lumen and media and stCllt boundaries. Careful 
checking and editing of the contours of the planar 
images werc performed by two independent experts 
who were blinded to the treatment assignments. 
Volumetric data wcre colculoted by the formula: 
{V = L~(i' 11 Ai '" H}. where V = volume. A = area of 
external elostic membrane (EEl\'f), lumen, stent or 
plaque in a given cross-sectional ultrnsound image, H 
= thickness of the coronary artcry slice, that was 
reported by this digitized cross-sectional IVUS image, 
and n = the number of digitized cross-sectional images 
encompassing the volume to be measured." 
The methodology to define the treated segment has 
been previously describedY Angiog'ram was per-
fonned after positioning the radioactive source in the 
centering balloon and the relationship between 
anatomical landmarks and the two radiopaque markers 
of the radiation source were noted aner contmst injec-
tion (Figure 1). Typicolly, the aorto-ostial junction and 
the side-branches were used as landmarks. The 
anatomical landmark closest to cither of the source 
markers was used as a reference point. During the sub-
sequent IVUS imaging pullback, this reference point 
was recognized and used for selecting the area of inter-
est: 27 mill for the irmdiated segment analysis. In a 
separate analysis we selected only the segment covered 
by stents within the irradiated area. This was facilitated 
by the highly echogcnic characteristics of the stenl 
stnUs. At follow-up, correct matching of the region of 
interest was perfonned by comparing the longitudinal 
reconstruction to that post-procedure (Figure 2). 
Procedure. All patients received aspirin (250 
mg/day) and intmvenol1s heparin (10,000 IU) before the 
procedure and stented patients also received ticIopidine 
(250 JUg/day). Heparin was given to maintain the acti-
vated clotting time> 300 seconds. BA and stenting 
were perfonned occording to standard clinical practice. 
In the stented patients, high-pressure post-balloon infla-
tion was perfonned guided by IVUS. The diameter of 
the centering balloon was choscn based on IVUS Illean 
reference vessel size (average of the mean distal and 
proximal reference dimneters). This measurement WaS 
perfonned after optimization of the results of balloon 
angioplasty or stenting. Thus, Ihe centering balloon wos 
placed in the target segment ond infloted to 4 atm. After 
testing the perfusion of the distal corollary segment and 
checkillg the correct location of the centering balloon 
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Figure 1. (A) Pre-pmcedIITt' (lrlgiogrmn of the lefl anlerior descending arlery (LAD); (D) Angiogram 10 wrify Ihe correci posirion of Ihe 
s/u'mll-<'!lI<'ring hlllo(lll and SUllTa wire, Dis/(ll perfH5ion is also confinned as wdl as Ihe aMlornica/landmarks for 3-D IVUS raanstnlc-
lion of the in'aJi(!f~d st'.I;Il1elll; (C) POll-t!rocedrlre angiogram of the LAD demonslmles good angiographic resull; (D) Six-monlhfollow-up 
angiography IddlOfif reSlellOsis. 
by contrast injection (Figure I), the radioactive or 
"dummy" source wire (27 mm) was placed in the cen-
tering balloon by means of the automatic delivering 
system, Afterwards, repeat angiography and IVUS pull-
back were carried out. A continuolls motorized pull-
back al a speed of 0.5 mm/seeond was first carried out, 
followed by an EeG-gated pullback at a stepwise of 0.2 
Hlln/step, Intracoronary nitrates were administered 
immcdiately prior to each of the IVUS pullbacks. At 6-
month follow-up, further IVUS analysis of the treated 
area was pertonned. 
Quantitath'e 3-U IVUS analysis. The following 
volumetric measurements wcre obtained: total vessel 
(EEM) and lumen. Plaque volume was automatically 
calculated by subtracting lumcn volume from the total 
vessel volume. 
In stcntcd patients, after sclecting only the seg-
ment covered by stent, we also calculated neointimal 
hyperplasia, which was calculated by subtracting 
lumen volume from stcnt volume. III vil'o measure-
ment of neointilllal formation after stenting has been 
previously validaled. lI Plaque volume outside the 
stent was also calculated by subtracting stenl volume 
from total vessel volume within the stented segments. 
The assessment of EEl'."f in stented patients has been 
reported,~~ Although in this previous report the delin-
eation of EEM was not possible in some patients due 
to the stenl shadowing, in our study the delineation of 
EE!\.·j boundary was possible in all stcntcd patients, 
When the EEM boundary was not visible in a single 
cross-sectional view, the computer interpolated it 
from the contours of the immediately previous and 
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following cross-sections, In addition, the usc of 3-D 
reconstmction with multiple longitudinal views facili-
tates the visualization of vessel stmctures outside the 
stent. In all cases, the stenled segment was covered 
by the radiation or dummy source wire, 
In order to assess the volumetric changes of the ves-
sel stmcturcs after 6 months, the delta value for each 
measurcment was calculated (delta (6.) = follow-up-
post-procedure). 
StalisUcal analysis. Quantitative data arc prcsented 
as mean ± standard deviation. The comparisons 
between the volumetric data of placebo versus irradiat-
ed patients and stenl versus BA patients (in the irradi-
ated group) were performed using an unpaired 
Student's I-tcst. A value of p < 0,05 was considered 
statistically signiticanl. 
RESULTS 
All patients have completed 6-month clinical follow-
lip, Of these,S patients (I placebo) did not undergo 
IVUS at 6 months: 2 irradiated paticnts presented sub-
acute thrombosis, one presented late (3 months after the 
procedure) thrombotic occlusion and another irradiated 
patient had a severe restenotic lesion demonstrated by 
angiography, The lesion was located in an area not cov-
ered by radiation, proximal 10 the irradiated site where a 
balloon was inflated to treat a proximal dissection. Thus, 
only a manual IVUS pullback was performed in this 
patient prior to reintervention. The nOll-irradiated patient 
was asymptomatic with a negative stress lest at the time 
offol!ow-up but refused angiographic restudy. 
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Figure 2. (A) Post-procedure 3,D lVUS imtlging 11!1d t'O/wnelnc ljlldlHificalion. Left pand: Olle plmwr (JosHwiull dell' is dis/,Itl)'l'd 
and the lumen (inner line) and EEM (outer line) area OTC delineated. Top right pand: one langill/dina/l'relt' is di5pla)'~d tdth the llI11l/umi, 
ca/landmark (side branch"" arrowhead) used to tielennine the segment for l'ohm1Clric quantifica!ion. Lumen (md EE/v! boundaries are 
delineated in the segment of interest, Bottom right panel: II gT(lphic displays the COllsecUlit't: (IT<'(lS of the entire 5('1 of jilwwr ill1(1ges - wed 
for I'o/umerric qlwllti!ication. The {'(lIt/fS of the plaque area are Sh01!~l ru a gra)' fidd b..>Ul't'e!I fit·o lines (w5scI and lumen (!TCdS) , The 
dbsalwe mille of Ihe plaql!e arCt] ((111 be deril'ed from this !idJ, but is (lisa disl)ldyeJ as singie black line. (B) 3-D NUS inwging and mlll-
metric lJll(ltllification at follow-tip. The corrt'(."/ Jntltdl is detennincd on longitudinal (lnd t)/dtwr deli'S using tile anatomical /alldmmk 
(ammhead). Lumen and ~·,;'5SeI boundaries are delineoled in both planar and langill/dina/dews. The grdphic of Ihe l'essel, lumen lHld 
plaque areas is also disp/a)'ed. 
lllUs, the results of this study consisted ofa cohort of 
21 patients with successful post-procedure and 6·month 
3-D IVUS assessment. Sixteen patients were actually 
treated with radioactive source, while 5 patients received 
placebo treatment. In the radiation group, 6 patients 
received 28 Gy, 5 patients received 35 Oy and 5 patients 
received 42 Gy. An additional slent was imphmted aner 
BA in 7 patients (44%) in the irradiated group and 3 
patients (60%) in the placebo group (p = NS). All patients 
were discharged 011 day 2 after Ihe procedure without 
complication. The medication at discharge consisted of 
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aspirin (250 I11g/day) and liclopidine (250 mg/day, only 
for stented patients). The dwell timc for delivering the 
prescribed radiation dose ranged from 1.5-8.0 minutes. 
n\Cre was no complication related to the radiation treat-
ment protocol. Clinical and demographic characteristics 
were similar between placebo and irradiatcd patients 
(Table I). Post-procedure and follow-up IVUS measure-
ments are summarized in Table 2. At 6-month follow-up, 
we observed a smaller minimal lumen area (r.,·ILA) and 
greater percentage of plaque area in the placebo group 
compared to irradiated group. 
.l!P Beta-Radiotherapy After Corollary Bal/ooll Angioplasty and Stentillg 
Table 1. Baseline nnd Jcn1Clgrnphic characteristics 
Variable Irradiated (n ~ 16) Placebo (o = 5) p-value 
Age (years) 
Gender (male) 
Diabetes 
Smoking 
59.2 (9.6 
11 (79%) 
56 ( 10.9 
4(80%) 
o 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
o 
H yperc holesteHllel1l i a 
Hypertension 
Family History of C()WOfU,' mtery disease 
Previous mY(lcar.liill infarction 
Canadian CnJio\"lscui:1l Soderi' angina status, 3/4 
Treatment site at left anterior descending artery 
Rcstenotic lesion 
6 (38%) 
9 (56%) 
5 (31%) 
6 (38%) 
7(44%) 
12 (75%) 
7 (34%) 
4 (25%) 
2 (40%) 
3 (60%) 
o 
2 (40%) 
3 (60%) 
5 (100%) 
3(60%) 
1 (20%) 
NS = not significant 
Table 2, Posl-proceJure and (ol!ow-up J-dimensional intravascular ultrasound measuremems. 
Elague burden 
TVV(mm1} PV {mml } LV {mml } MlA {roml } at MlA (%) 
I\))t FU PoSt FU Post FU Post FU PoSt FU 
Irmdiatcd 
(n = (6) _385 ± 110 403 ± 1J3 198 ± 63 214 ± 74 18S ± 60 190 ± 63 4.8 ± 1.6 4.7 ± L3 63 ± 9 64 ± 9 
rlaceho 
(n '" S) 415 ± 101 391 ± 98 21O±58 228 ± 69 205 ± 62 163 ± 44 4.7 ± 1.2 3.3 ± 1.3 60 ± 16 76 ± 14 
p-value NS NS NS NS NS NS NS 0.046 NS 0.042 
NV '" total vessd volume; PV = plaque \'olume; LV = lumen volume; MlA = mean lumen area; ro~t = post-procedural; FU '" follow-up 
Volumelric changes (il) aflel' 6 months: Placebo 
ycrsllS irradiated. As illuslrated in Figure 3, the volu-
metric change of the total vessel volume (,1TVV) 
occurred in an opposite direction between irradiated 
and placebo patients. While the irradiated patients 
demonstrated a positivc ,1TVV (increase of the TVV at 
follow-up), placebo patients demonstrated a negative 
,1TVV (decrease oflhe TVV at follow-up). Equally, an 
opposite behavior was observed regarding the volumet-
ric changes of the lumen volume (ilL V). The placcbo 
group demonstrated a negative ,1LV, whereas irradiated 
patients showed a positive L1LV (p = 0.01). However, 
plaque volume (L1PV) increased in both groups in a 
similar degree (positive L<.PV). There was no relation-
ship between prescribed doses and volumetric changes. 
Irradiated patients: Steul versus balloon Anglo-
plasty. In the analysis of the entire (27 111m) irradiated 
segment, stented patients (n = 7) demonstrated similar 
vohmlelric changes after 6 1110111hs compared to BA 
palients (n = 9), as illustrated in Figure 4. It is of inter-
est to note that in the stented patients, PV consists of 
the total amount of plaque outside and inside the stent. 
In addition, Ihis analysis quantified the entire irradiated 
segment including segments covered and uncovered by 
stents. 
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Analysis of the stcnted segment (Irradiated 
paticnts). In this analysis, only the segments covered 
by stent were selected for volumetric quantification. 
The average sten! length (segment analyzed) was 18.1 
± 6.36 mm. Post-balloon dilation was performed in all 
cases at a mean pressure of 14.6 ± 3.2 atm. At follow-
up, we observed a neointimal hyperplasia volume of 
1.89 ± 2.99 n1m) with a mean percentage neointimal 
fonnalion of 1.47 ± 2.49%. The TVV within the stent-
ed segment demonstrated a non-significant increase 
after 6 months (post-procedure TVV of 260 ± 68 mm) 
versus 272.2 ± 97 nunl at follow-up; p = NS). The 
plaque volume outside the stent also demonstrated a 
non-significant change at follow-up (post-procedure 
PV of 131 ± 32 mml versus 141 ± 63 mml at follow-
Up;'p = NS). Stent volume remained unchanged (no 
recoil) after 6 months (129.5 ± 39 mm) post-procedure 
versus 131 ± 39 mm) at follow-up; p = NS). 
DISCUSSION 
This pilot investigation demonslrates that beta radi-
ation affects vessel remodeling after percutaneous 
intervention. Til addition, neointimal fomlation within 
the stented segment was almost absent in ollr irradiated 
popUlation. However, the small size of our stented 
COSTA. el a1. 
Figure 3. Three-dimensional inlral'llSCtll11r IIltrasound analysis of stented coronary segments. l'osl-PHJrl'duTC /ongiwditlill (A) I1Ild 
planar (A') llieU's, as I('ell as follow-up longitudinal (8) and (!Ianar (B') dews are displayed. Lumen and S/Ctll Ju'hill' lines). (1IH./ 
l.esse/ bOllndaries (black line) are delineated in the planar image (md in one of the /ongitudlrw/l'ie!l'.l. AI /!l!lOW-Uf! (11, 8') ) lI'e (HI 
observe the delineation of neointirnal h)'perp/mia befll'eell the lumen and stem bOllndmies (It'hile lines), The t'islwliz,uion uf the 
EEM bOl/ndar)' behind the stent tind neoin/llllal h)·perplasia are ilIustraled in Ihe /ongiltldin(l/ I'iell's Wit/lOut Cmlf,)ltrs (U {(,t'li as the 
anatomical landmark (side branch urilh a SPOI of calcium in the astillm) !/Sed for correcllllarc/l bt'lII,t't'n pvst-/JroceJurt.' (Hld fvll(J\('~ 
tip anal)·ses. 
population should be taken into account before draw-
ing any definitive conclusions. 
Considering that vessel shrinkage accounts for 
about 50-70% of the mechanism of restenosis after 
conventional BN and radiation has been shown to 
reduce the restenosis rate in the setting of BA,IO the 
conclusion that radiation affects vessel remodeling 
seems logical. Clinical I! and experimental data i4.!! have 
already suggested the influence of radiation on vessel 
remodeling. 
IVUS analysis of patients enrolled in the BERT trial 
has also suggested that radiation Illay prevent vessel 
shrinkage after BA. II .ll The use of single cross-section 
planar IVUS images limited the study of Meerkin et al. 
assessing the influence of radiation on vessel remodel-
ing. The four coronary aneurysms reported by Conda-
do et al. exemplified the extreme expression of this 
phenomenon in a series of patients receiving high 
doses of gamma radiationY 
In accordance to the findings of the present study, a 
recent clinical investigation from our group using the 
same methodology has demonstrated that beta radia-
tion using a 9°S r/Y source influences vessel wall 
remodeling after BA.1l In 21 patients analyzed, there 
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was a significant increase of the total vessel volume 
after 6 months in patients enrolled in the BERT 1.5 
triaL'l However, the exclusion of stented patients in 
this previous study did not allow further insight into 
the mechanism of radiation on the inhibition of neoin-
timal prolifemtion. 
The opposite p<lttem of change in total vessel vol-
ume between the irradiated population (positive 
6TVV) and placebo (negative ilTVV) observed in our 
study may confinn the inl1uence of radiation on vessel 
wall remodeling. In addition, the combination of a 
smaller total vessel volume and bigger plaque volume 
at follow-up accounted for the reduction of lumen 
observed only in the placebo group. Similar pattents of 
structural vessel changes have been previously report-
ed after conventional percutaneous intervention in nOI1-
irradiated coronary segments.\ 
On the other hand, gamma rlldiation has been 
shown to decrease the illciJen<:e of restenosis in stcnt-
ed patients treated for in-stent restenosis/·~ Once ngnin, 
another 10gicnl conclusion mny rise in favor of radia-
tion inhibiting neointimal formntioll. Clinical and 
experimental reports have emphasized the effect of 
gamma radiation on inhibiting neointimal fonnation.~-~ 
np Bela-Radiotherapy After CorollalY Ballooll Allgioplasfy alld Sfelltillg 
D Irradiated 
(n'" 16) 
.Pla<:ebo 
(n =: 5) 
Figure 4. Volumetric Changes (11) of the total W55el (TVV) , 
ptuJlle (PV) , ond h!mcu (LV) in!hc target (27 mm long) coronary 
segments ofrer 6 months. Comp..l,ison bttllWIl irrMid/oo and pltu:e-
Lv f\l!ienls. p =: 0.065 for dTVV; p '" 0.01 for &'V. 
D Stent (n '" 7) 
• Balloon (n '" 9) 
Figure 5, Volumetric Chml,i;~S (d) of the total I't'ssel (1VV), 
t,!tulll~ (PV) , Ilnd l1un<'n (LV) llithin the i17Miaced coroMr), seg-
1Il~tH (27 1)1111 llIl'g) oller () monlhs. Comparison Ilo.?tttwJ\ hlllooJl 
1l1lgiop/rut)' and 5tellll~l/ie!lls. p::: NS for t1n'v, 1I1-'V, Ilnd &.V. 
In our stented population, the amount of neointimal 
formation was only 1.89 mm\ which suggests that beta 
radiation also inhibits neoilltimal fonnation after con-
ventional stenling. 
The assessment of plaque growth outside the stent 
is a novelty In thc setting of brachytherapy. A previ-
Ol1S rvus study iHls demonstrated the progression of 
plaque mass within and surrounding conventional 
stents." Howcvcr, a recent report investigating 15 
non-irradiated stented coronary segments did not 
demonstrate plaque growth outside the stene l In our 
III 
study, the plaque volume outside the stellt and TVV 
showed a non-significant increase of 10 and 12 mOl) 
after 6 months, respectively. Further IVUS studies 
should investigate the influcnce of radiation on 
neointimal formation, plaque growth (outside the 
stent), as well as vcssel remodeling in stented 
patients. 
This pilot study contributes to a beller under-
standing of the complex interaction between radia-
tion and vascular stmctures. By comparing for the 
first time three-dimensional IVUS parameters of 
beta-irradiated and non-irradiated coronary seg-
ments, our study demonstrates that radiation affects 
vesscl remodeling after percutaneous intervention. 
In addition, this seminal study suggests that beta 
radiation may also inhibit ncointimai formation after 
stenting. ft is nevertheless of interest to note that to 
date only a few reports are available using serial 
IVUS investigation after either beta radiation in the 
setting of BA or gamma radiation in the setting of 
stenting. Thus, the confirmation of these findings by 
a .large popUlation study with vntH'T\etric IVUS 
assessment is required . 
Study limitations. The size of thc population is the 
major limitation of this pilot study, which has insuffi-
cient statistic power to demonstrate some differences. 
However, this is a pioneering investigation using 3-
dimcnsional intravascular ultrasound to assess the 
effects of bcta-radiation after either balloon angioplas-
Iy or stenling. In addition, this is the first study to com-
pare irradiated versus non-irradiated coronary 
segments by means of a volumetric assessment in a 
randomized fashion. The similarity between our find-
ings and those prcviously reported on either irradiated)) 
or non-irradiated coronary segments) may endorse our 
conclusions. 
The difficulty to assess patients with severe 
restenotic lesions is a limitation of the methodology 
used in this study. Thus, the assessment of the mecha-
nism involved in an "aggressive" vessel wall reaction 
after intervention, as observed in one patient of this 
study, cannot be perfonned. 
Although the prescribed dosc was not related to 
any' vessel stnlctural change aftcr 6 months, the actu-
al dose received by the target segments was not cal-
culated in this study, limiting any dosimetric 
consideration. 
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Abstract 
Bacl<ground: The edge effect, late lumen loss at the margins of the treated segment, has become 
an important issue in the field of coronary brachytherapy. The aim of this study was to assess the 
"edge effect" in non-injured margins adjacent to the irradiated segments after intracorollary 
catheter-based f3-irradiation, l\lethods and Results: Fifty-three vessels were assessed by means 
of three-dimensional intravascular ultrasound at post-procedure and 6-8 months follow-up. 
Fourteen vessels (placebo group) did not receive radiation (sham source), whereas 39 were 
actually irradiated. In the irradiated group, 48 edges (5-mm in length) were identified as nOI1-
injured, whereas 18 non-injured edges were selected in the placebo group. \Ve compared the 
volumetric IVUS measurements of the non~injured edges of the irradiated vessels with the fully 
irradiated nonwstented segments (IRS, n=27) (26~mm segments receiving the prescribed 100% 
isodose) and the non-injured edges of the placebo patients. The lumen decreased (6-1111113) in the 
non-injured edges of the irradiated vessels at follow-up (p~O.OO I). We observed a similar 
increase in plaque volume in all segments: non-injured edges of the irradiated group (19.6%), 
non-injured edges of the placebo group (21.5%) and IRS (21.0%). Total vessel volume (TVV) 
increased in the IRS between 3 groups. No edge segment was subject to repeat revascularization. 
Conclusions: The edge effect occurs in the non~injured margins of radiation source train in both 
irradiated and placebo patients. Thus, low~dose radiation may not play an important role in this 
phenomenon, whereas non-measurable device injury may be considered as a plausible alternative 
explanation. 
Intl'oduction 
The !ledge effect", a lumen loss at the segments adjacent to the treated site, is a new 
phenomenon in the field of interventional cardiology. Although, it may also occur after 
conventional treatment (Le. stent implantation)I,2, it has become an important issue after the 
introduction of intracoronary brachytherapy in the clinical practice. 
Recently, the edge etTect has been reported in patients receiving (adioactive stents with 
intermediate activity (3 to 12 ~lCi). Neointimal formation was inhibited in a dose-dependent 
manner within the stented area, but proliferation and unfavorable remodeling at the stent 
margins was demonstrated3. The authors dubbed this angiographic finding as the "Candy-
Wrapper" effect. Further, the edge effect has been observed in patients treated by means of 
catheterwbased p~radiation4,S. In a three-dimensional (3-D) volumetric intravascular ultrasound 
(IVUS) investigation, our group has observed a decrease in lumen volume at the edges of the 
irradiated segment due to an increase in plaque volume not accommodated by vessel 
enlargementS. In all three reports, the authors have hypothesized that the "edge effect" was due 
to the combination oflowwdose radiation and balloon-induced injury in the segments adjacent to 
the irradiated site. Indeed, the potential stimulatory effect of low-dose radiation after injury has 
been demonstrated in animal studies6,7. 
Considering that the coronary segments adjacent to the irradiated site will invariably receive 
lower dose of radiation to some extent, an important issue remains to be clarified: Does the 
"edge etTect" also occur in non-injured segments? In order to address this issue, we I) assessed 
the mid-term (6-8 months) geometrical change of the non~injured edge segments in the 
irradiated coronary vessels and 2) compared these edge segments with both irradiated segments 
(IRS) and non-irradiated (sham source), non-injured coronary segments by means of a 
volumetric 3-D IVUS assessment. 
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Methods 
Study Population 
From April/97 to Marchl99, 56 de novo lesions of 50 patients were treated with catheter-based 
intracoronary B-radiation using the Beta-Cath System™ (Novoste Corp., Norcross, GA). IVUS 
analyses of 10 vessels (7 patients) were not included in this study due to the implantation of 
multiple stents overlapping outside the irradiated area. In addition, 3D-IVUS analysis was not 
carried out either at post-procedure or at follow-up in 7 vessels (7 patients): 2 had severe restenosis 
(l diffuse restenosis, 1 in-stent restenosis, not related to their edges), 3 presented thrombotic 
occlusion, and 2 other patients without recurrent angina refused follow-up angiogram. The placebo 
group consists of 14 patients successfully treated with conventional balloon angioplasty or single 
stent implantation during the same period. In these patients, the radiation delivery catheter was also 
introduced in the target coronaty m1eries, but a dummy source train was used instead of radio active 
source accordiilg to randomization. 
Thus, the study population consists of36 irradiated patients (39 vessels) and 14 non~irradiated 
placebo patients (14 vessels), who underwent successful 3-D ECG-gated IVUS analysis 
immediately after the procedure and at follow~up. Patients were treated due to ischemic~related 
symptol11s or positive stress testing. Those with myocardial infarction within 72 hours before the 
treatment or left ventricular ejection fraction < 30% were not included in this study. 
Angiogl'aphic inclusion criteria consists of a reference vessel diameter> 2.5 mill and < 4.0 mm 
and a lesion length < 20 111111. 
The Medical Ethics Committee of the University Hospital Dijkzigt approved the use of 
intracoronary radiation. All patients gave written informed consent. 
Radiotherapy System 
The source train of the BetaMCath™ S~stem consists of a series of 12 independent cylindrical 
seeds, which contain pure f3~emitting °SrfOy, and is bordered by 2 gold markers (30~mm in 
length). The longitudinal distance of "fuIP' prescribed dose (100% isodose) coverage measured 
by radiochromic films is approximately 26 l11m (Novoste Corp, data on file, personal 
communication). The profile of the catheter is 5 French and the source train is not centered. 
figure I. Isodose rMe C(lntour map and udiation 'OurN train 
Left side: Isodos~ ",Ie contour mJp at a dopth of! 89 mm (10 mG,'ls conlour In!e''als) as de,cnlxd by NIST 
(Th~ Nllionll Imtitute of Stand3rds 3nd T~dmology) This d~ptll (! &9 mm) ill",uates an isc,JQ,C modd to 
les~mble th~ radius of Ihe corM.11)' Ml~I)' 'HII "the longitudirul dos~ fall·off 1Il3)' b~ n!Japoh!ed flo'" this 
graphic, Right si&: Radiation SNrn:~ train Central pan oflne <oun:;~ train (26 mm) rocei,~< appro~ima!d)' fulJ 
dose 
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Procedure 
All patients received aspirin (250 mg/day) and heparin IV (10.000 IU) before the procedure, 
whereas stented patients also received ticlopidine (250 mg/day) for 30 days. Heparin was given to 
maintain the activated clotting time >300 sec. BA was performed according to standard clinical 
practice, After successful angioplasty, intracoronary fJ-radiation was performed as previously 
describedB, and repeat angiography and IVUS motorized pullback were carried out. If stenting was 
indicated due to a residual stenosis> 30% diameter stenosis or dissection, a stent was implanted 
with high-pressure post-dilatation and IVUS guidance. Finally, repeat angiography and IVUS were 
carried out. Intracoronary nitrates were administered immediately prior to each of the IVUS 
pullbacks. At tollow-up (6-8 months), further lVUS analysis of the treated vessel was performed. 
The prescribed doses were 0 Gy (14 vessels), 12 Gy (8 vessels), 14 Gy (9 vessels), 16 Gy (9 
vessels) and 18 Gy (13 vessels). 
IVUS image acquisition analysis system 
The methodology of3D-lVUS image acquisition and quantitative analysis has been described 
previously5,9, In brief, the segment subject to 3-D reconstruction was examined with a 30:MHz 
single-element mechanical transducer IVUS system (ClearView, CVIS, Boston Scientific 
Corporation, Maple Grove, MN). ECG-gated 3-D lVUS image acquisition and digitization was 
performed by a computerized workstation (EchoScan, Tomtec, Munich, Germany) 10. IVUS 
images were acquired coinciding with the peak of the R wave, which eliminates the artifacts 
caused by the movement of the heart during the cardiac cycle, The IVUS transducer was 
withdrawn in 0.2 n1lll/step by an ECG-triggered pullback device. 
A Microsoft Windows™-based contour detection system, developed at the Thoraxcenter, was 
used for 3-D volumetric quantification 11, This program constructed 2 longitudinal sections from 
the data set and identified the contours corresponding to the lumen, media and/or stent 
boundaries. Volumetric data were automatically calculated by the formula: V= Ini=1 A x H, 
where V = volume, A = area of external elastic membrane (EEM), lumen, stent or plaque in a 
given cross-sectional ultrasound image, H = slice thickness of the cross section (O.2mm), and n 
= the number of digitized cross-sectional images encompassing the volume to be measured ll . 
Oft:line analyses were performed by three independent experienced analysts (KK, MC, MS), 
who checked and edited all the contours of the planar images, The accuracy of this method has 
been validated in vitro (phantom) and in vivo 12, Intra- and inter-observer variability of this 
system has also been determined in clinical protocols9. Intra-observer variability assessed by 
analyzing lVUS volumetric studies at least 3 months apart has been reported:-OA ± 1.1% in 
lumen volume, -OA ± 0,6% in total vessel volume, -0,3 ± 1.0% in plaque volume using ECG-
gated motorized pullback. 
The methodology to define the treated segment in the irradiated patients has been previously 
described S. An angiogram was performed during contrast injection after positioning the delivery 
catheter and the relation between anatomic landmarks and the two radiopaque markers of the 
radiation source were noted. Typically, the aorto-ostial junction, side branches and/or stent were 
used as landmarks. During the subsequent IVUS imaging pullback, this reference point was 
recognized anci used for selecting the 3D-mm long segment where the radiation sou-rce train was 
placed and both 3-mm distal and proximal edges (36-mm long segment in total). At follow-up, 
correct matching of the region of interest was performed- by comparing the longitudinal 
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reconstruction to that post-procedure. The longitudinal distance of the 100% isodose is 
approximately 26 mm, as illustrated in figure 1. Thus) we defined the target irradiated segments 
(IRS) as the segments covered by the 26-mm full activity central part of the radiation source 
train) and the edges of the IRS as the adjacent (distal and proximal) 5-mm coronary segments, 
which consisted of the 2-mm inside the gold markers and 3-mm proximal or distal including the 
gold markers (Figure I). IRS containing stents (n~12) were excluded from the analysis. 
The 5-mm edge segments selected in our study received low-dose radiation since J3-emitting 
"SrPOy source has an acute fall-off of delivery dose related to the distance i3, 14 For instance, the 
highest prescribed dose in our study was 18 Gy, and the calculated longitudinal dose per millimeter 
from the 100% isodose boundary is expected to be: 15.5 ± l.0 Gy at I mm, 1l.0 ± l.0 Gy at2 nll11, 
5.5 ± 0.5 Gy at 3 mOl, 2.4 ± 1.0 Gy at4 nll11, and less than I Gy at 5 mm. 
In order to select the non-injured segments, all locations of deflated balloons, stent delivery 
system, inflated balloons, and radiation source train were recorded in the angiogram. The deflated 
balloon, stent delivery system and delivery radiation catheter were also filmed during contrast 
injection. All angioplasty balloons used in this study had 2 radiopaque markers in both extremities. 
Each cineframe of angiograms which show the position of inflated balloon, deflated balloon 
markers, stent delivery system and the radiation source train can be displayed simultaneously on 
the separated screen during off-line analysis, using the Rubo DlCOM Viewer (Rubo Medical 
Imaging, Uithoom, The Netherlands). A continuous ECG recording was also displayed, which 
permitted the selection of images in the same moment of the cardiac cycle. By identifying the 
relationship between landmarks and device radiopaque markers, we were able to select only the 
balloon or stent injured fully irradiated coronary segment (covered by the 26-mm central part of the 
radioactive source train). Thereby all the injured edge segments were excluded. At follow~up, it 
was also possible to determine the non-injured edge segments by the same method, since all the 
follow~up cinefilms were taken in the same views as pre- and post-procedure. Tllis angiographic 
analysis was performed independently by 2 cardiologists (KK, Me). Only the edges, which both 
investigators regarded as non-injured segments were finally considered as non-injured edges. There 
was only 10 % disagreement in the definition of injured irradiated edge segment llsing this 
methodology. The J-mm stent edges were also considered as injured segments since the balloon 
of the stent delivery system may protrude about 2-3 mIll outside the stent. 
Quantitative 3-D IVUS Analysis 
Total vessel volume (TVV) determined by EEM boundaries and lumen volume (LV) were 
measured. Plaque volume (PV) was automatically calculated by subtracting LV from TVV. In 
order to assess the volumetric changes of the vessel structures after 6-8 months, the delta value for 
each measurement was calculated (delta (i'l) ~ follow-up - post-procedure). To eliminate the 
influence of the vessel size and the length of the analyzed segment, which affects volume 
calculations, percent delta change (delta volume / post-procedure volume) was also calculated. 
Remodeling was defined as a continuous process involving any (positive or negative) changes in 
TVV I5 . In the present study, remodeling of the vessel wall was considered when TVV increased or 
decreased, compared to post-procedure measurements by at least two standard deviations (± 1.3%) 
of the intra-observer variability. By using this technique, the potential intrinsic error of the method 
may be avoided 16, 17 
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Figure.J. ComYjRsolIS of the percent \'olume changes among IRS 
and tlufR£\Wk\judd edges of both irradiated and placebo palienls. 
PV = plaque volume, TVV = total vessel volume, LV '" lumen volUme, 
IRS = fully irradiated segments, pts = patients 
Statistical analysis 
Quantitative data are presented as mean ± standard deviation. Comparisons between post-
procedure and follow-up IVUS parameters were compared by means of paired student's t test. 
Comparisons of the NUS data among 3 groups (non-injured edge of the irradiated vessels, IRS, 
and non-injured edge of the placebo group) were perfonned using one-way analysis of variance 
(ANOVA) test. Bonfen'oni test was applied for comparison between each groups. The difference 
between proximal and distal edge was compared by two-tailed Student's Hest. The correlation 
between percent change in plaque volume and prescribed dose, corrected by the mean total vessel 
area at the edges based on 3-D NUS measurement, were tested by Pearson Correlation. A value of 
p<O.05 was considered statistically significant. 
Table 1. Clinical and Lesion characteristics. 
Age,y 
Male, n (%) 
Coronary Risk, n (%) 
Smoking histOlY 
Dyslipidcmia 
Diabetes Mellitus 
Hypertension 
Family history 
Unstabele Angina, (%) 
Multivessel disease, (%) 
Irradiated (n~36) 
57±9 
27 (75) 
26 (72) 
21 (58) 
4 (11) 
14 (39) 
17(47) 
13 (36) 
12 (33) 
Treated Lesions, n 39 
Vessel Location, n (%) 
Placebo (n~14) 
57±9 
3 (93) 
II (79) 
7 (50) 
2 (14) 
2 (14) 
7 (50) 
5 (36) 
1 (7) 
14 
LAD 15 (38) 6 (43) 
p value 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
LCX 10 (26) 3 (21) NS 
RCA 14 (36) 5 (36) 
Stent Implantation 12 (31) 7 (39) NS 
Maximum Balloon Size,nllll 3.63 + 0,6 3.63 +0.5 NS 
PTCA - percutaneous transluminal coronary angioplasty, LAD - left ffilterior descending coronary 
artery, LCX = left circumflex coronary artery, RCA = right coronaty artery 
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Baseline clinical, demographic and angiographic characteristics were similar between 
irradiated and placebo patients (Table I). No myocardial infarction or death was observed in this 
popUlation during 6-8 months follow-up. Target lesion revascularization was performed after 
follow-up angiogram in 6 vessels in the irradiated group (16%) and 2 vessels in placebo group 
(14%). The non-injured edges were not involved in any of the restenotic lesions that required 
further intervention in both groups. 
Forty-eight edge segments (20 distal and 28 proximal edges) and 27 irradiated segments without 
stent were analyzed by 3-D volumetric IVUS in the irradiated population. Thirty edges were 
excluded from this analysis. The reasons for exclusion were as follows: ostial location of the 
proximal end of the source (n~ II), overlapping of one of the edge with large side-branches (>2.0 
nlln diameter) (n~5) or stent (n~6), injury of one ofthe edges by angioplasty balloon (IF4), lack of 
follow-up IVUS analysis using the ECG-gated motorized pull back (IF4). 
In the placebo group, 18 edges (II distal and 7 proximal edges) were examined by 3-D 
volumetric IVUS. Ten edges were excluded because of the following reasons: ostiallocatioll of the 
proximal end of the dummy source (IF6), overlapping of one of the edge with large side-branches 
(n~l) and injury of one of the edges (n~3). 
Table 2. Volumetric measurement of 3-D IVUS 
IRS Non-Injured Edge Non-Injured Edge 
Irradiated vessel placebo 
(IF27) (IF48) (n~ 18) 
20st follO\v-u2 Eost follow-u2 Eost follow-u2 
p,~ mmJ 196±56 234±69* 32±I5 36±I6* 27±I4 3I±I5 t 
TVV,mmJ 441±136 480±159t 81±32 79±31 65±21 67±24 
LV, mmJ 245±IOI 247±114 48±22 42±21§ 38±15 37±16 
* p < 0.001, t P - 0.06, t P - 0.004, § P -0.001, IRS - irradiated segment with filII-dose, 
Post = post-procedure, PV = plaque volume, TVV = total vessel volume, LV = lumen volume 
All 3-D IVUS volumetric measurements ofPY, TVV and LV are listed in Table 2. Some degree 
of atherosclerosis (~15% plaque burden) was observed in most of the non-injured edges in the 
post-procedure IVUS analysis but no edge (radiation or placebo group) had more than 50% 
plaque burden. Compared to post-procedure measurement, there was a significant increase in PV 
in the non-injured edges of the irradiated vessels (fiPV = 4 mm3) at follow-up. Since TVV on 
average decreased by -2 mm' (p ~ NS), LV decreased at follow-up in the non-injured edge of the 
irradiated vessels (i1LV = -6 111111\ In the placebo group, there was also a tendency of plaque 
increase at follow-up (MY ~ 4 mmJ ) in the non-injured edge of the placebo group (p ~ 0.06). 
Comparisons among the geometric changes of 3 groups (IRS, non-injured edges of the irradiated 
vessels and non-injured edges of the placebo group) are demonstrated in Figure 2. The percent 
increase in PV was similar among IRS, non-injured edges of the irradiated vessels and those of 
placebo group (+21.0% vs. +19.6% vs. +21.5%, respectively). TYY increased in IRS significantly 
between 3 groups (+9.4% at IRS; -1.0% at non-injured edges of the irradiated vessels; +3.8% at 
non-injured edge of the placebo, p~0.021). The difference was observed only between IRS and 
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non-injured edges of the irradiated vessels by post-hoc test (]>=0.017). Percent changes in LV were 
different (+1.7% vs. -10.0% vs. -2.5%, respectively, p~0.049) among 3 groups. LV tended to 
decrease in non-injured edges ofirradiated patients compared with IRS (p~0.053). 
Comparisons between the geometric changes of the proximal and distal non-injured edges are 
shO\vn in figure 3. Although there was no statistical difference in geometric change between distal 
and proximal edges, the percent increase in PV tended to be greater in the proximal edges 
compared to the distal edges (+27.0% vs. +9.2%). 
Finally, there was no correlation between the percent increase in PV and prescribed dose 
corrected by mean vessel area at the edges (p ~ 0.76, r ~ -0.046). 
Discussion 
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Tilis is the first study investigating the geometric changes of non-injured margins of endovascular 
catheter-based radiation therapy. The edge effect, a decrease in lumen volume at follow-up, was 
observed in the non-injured edges of the irradiated vessels (table 2). However, plaque proliferation 
induced by low-dose radiation may not fully explain the occurrence of this phenomenon, because 
plaque volume similarly increased in the non-injured edges of placebo group (Figure 2). 
Lumen loss was observed in the non-injured edges of the irradiated group. The decrease in LV 
observed in these edges was mainly due to the lack of positive vessel remodeling (i.e. no 
remodeling)15 to accommodate the plaque increase, which occurred similarly in all analyzed 
segments. Likewise,lurnen also decreased (2.5%) in the non-injured edges ofthe control group, but 
in this case we observed some degree of vessel enlargement (3.8% increase in TVV). TIle 
facilitation of favorable positive remodeling15 promoted by radiation may explain the preservation 
of lumen dimension (1.7% increase in LV) observed only in the IRS. Both phenomena, positive 
remodeling stimulated by intravascular radiation after balloon angioplasty and difterent patterns of 
vascular remodeling (positive, negative or no remodeling) in non-ilTadiated coronary segments, 
have been reported previously5, 18-20. 
Although the stimulatOlY effect of low-dose radiation on plaque proliferation has been 
demonstrated in injured animal arteries6,7, no enhanced plaque growth was observed in the nOll-
injured edges compared to placebo. Plausible explanations for the PV increase in the non-injured 
edges of both ilTadiated and placebo groups would be the non-measurable vessel injuries; guiding 
catheter (Le. deep engagement) during the procedure or the devices when crossing coronary 
segment (guide-wires, stents, balloons, IVUS catheter and the 5F radiation delivery catheter). 
Indeed a tendency of greater plaque increase was observed in the proximal edges, where these 
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types of injury may occur more frequently, although it might have been hypothesized that the 5-
French radiation delivery catheter could induce higher injury to the distal part due to the tapering of 
the vessel. 
It is nevertheless important to emphasize that this phenomenon occurred in segments not injured 
by balloon inflation, which may highlight the importance of the use of less aggressive approach: 
avoidance of deep catheter engagement, guide wire entrapment Of rough device introduction 
against resistance especially in tortuous vessels. To avoid device-induced injury, low profile and 
more flexible radiation delivery catheters will be a worthy development for catheter-based 
brachytherapy. 
The 10% lumen loss observed in the edges of the irradiated vessels had no clinical impact, since 
no repeat reva~cularization was performed due to non-injured edg~ stenosis. However, this finding 
may have important implications if plaque grows locally (Le. I or Z mm short segment) or lumen 
reduction occurs in small or diffuse diseased vessels in general treated population. 
In conclusion, the edge eftect occurs in the margins of catheter-based p-radiation that were not 
injured by balloon inflation. This phenomenon was basically due to plaque growth without vessel 
remodeling. Our findings suggest that low-dose radiation may not be implicated in the cause of the 
edge effect, and clinically not-assessable device injury would rather be considered as a plausible 
explanation for this phenomenon. Clinically, the "edge eirect" observed in our mid-term follow-up 
lVUS study did not represent a drawback of the catheter-based intracofOllary p-radiation. 
Limitations 
The number of the placebo patients was relatively small. However, the use of the "state-of-the 
art" 3-D IVUS technology in our study may overcome this limitation, since a smaller number of 
patients are necessary to demonstrate statistical differences in studies using volumetric IVUS 
parametersZ1 . 
Minor inaccuracy in the selection of the segments of interest cannot be completely nded out, 
although the methodology applied in our study was the most appropriate at this time. Ideally, 
intervention devices incorporating IVUS imaging elements would be the solution for this 
drawback. 
In a human clinical study it is not possible to quantify the degree of vessel injury (i.e. injury 
score)22, which would provide further insight about this issue. 
The actual dose received at irradiated and edge segments may have some implications in the 
geometric changes of the edges, and would be interpreted as a limitation of our investigation. 
However, our study was not aimed at establishing a threshold of dose to be delivered to the 
irradiated target site, since an adjacent coronary segment will invariably receive low-dose of 
radiation. 
The 6-8 months follow-up period of this study may be too short to demonstrate the long-term 
arterial response to the radiation treatment. Increased risk of accelerated atherosclerosis 
progression after radiation therapy for malignancy has been reportedZ3-Z7. Further, a recent 
report has shown that continuous low-dose rate irradiation delivered by radioactive stent 
promotes "atheromatous" neointimal formation28. Then, one question still remains to be 
elucidated: Does endovascular radiation have any influence on the progression of 
atherosclerosis, especially in the adjacent non-target irradiated segments? 
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CHAPTER 10 
Positive Geometric Vascular Remodeling is seen after 
Catheter-Based Radiation Followed By Conventional Stent 
Implantation, But Not After Radioactive Stellt Implantation 
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Abstl'act 
Background: Recent reports have shown that intracoronary radiation affects not only lleointimal 
formation but also vascular remodeling. Given the difterent way in which radioactive stents and 
catheter-based techniques deliver beta-radiation one may expect different patterns of remodeling 
after each technique. 
Method and Results: vVe analyzed remodeling in 18 patients after conventional stent 
implantation (C), 16 patients after low activity (LA) radioactive stent implantation, 16 patients 
after higher activity radioactive stent implantation (HA) and finally 16 patients who underwent 
catheter-based beta-radiation followed by conventional stent implantation (CBS). Intravascular 
ultrasound with 3 - dimensional reconstruction was used post stent implantation and at 6 -
month follow - up to assess remodeling at the stent edges and within the margins of the stent. 
Baseline, vessel and procedural characteristics were similar between groups. In - stent neointimal 
hyperplasia was inhibited by HA (neo-intimal volume ~ 9.0mm3) and by CBS (neo-intimal 
volume = 6.9mm3) compared with LA (neo-intimal volume = 21.2mm3) and C (neo-intimal 
volume = 20.8mm3), p=O.OOS. No difference in plaque or total vessel volumes was seen behind 
the stent in the C, LA or HA groups. However a significant increase in plaque behind the stent 
(+ 15%) and TVV (+8%) was seen in the CBS group. At the stent edges, no edge restenosis was 
witnessed in the C, LA or CBS groups. Edge restenosis was seen after HA implantation and 
appeared to be due mainly to an increase in plaque and to a lesser degree to negative remodeling. 
Conclusions: Distinct differences in the patterns of remodeling exist between conventional, 
radioactive and catheter-based radiotherapy with stenting. Users of radiation need to be alerted 
to the deleterious remodeling seen at the stent edges after higher - dose radioactive sten! 
implantation and behind the stent after catheter-based radiation and stenting. 
Illtmduction 
In our enthusiasm to control vessel recoil and remodeling after balloon angioplasty (BA), stent 
implantation has become increasingly popular. With conventional stenting we have eliminated 
recoil and remodeling as components of the restenotic process. However this has been at the cost 
of exacerbating neo intimal proliferation secondary to chronic vessel wall irritation, leading to in-
stent restenosis\,2. 
Intracoronary radiation has been developed in an attempt to decrease restenosis after BA and 
stent implantation. Two parallel technologies, one employing radioactive stents3•7, the 
other catheter - based radiation8•lO, have been the subject of both animal and human studies. 
Given the different dose rates and total doses delivered by each method, intuitively one may 
expect different patterns of remodeling subsequent to each approach. 
Whereas the effect of catheter-based radiation after BA on vascular remodeling has been 
described 1I, the response of the arterial wall to catheter-based radiation and subsequent stent 
implantation is not described. Preliminary studies have reported the effect at the stent edge after 
radioactive stent implantation'"'. These reports did not encompass the response behind the stent in 
the arterial wall however. 
The aim of this study was to describe the response of the coronary artery to radiation and 
stenting, by looking at the stent and its edges after radioactive stent implantation and also after 
catheter - based radiation with stent implantation. 
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Methods 
Patient Selection 
We analyzed geometric vascular remodeling in 4 groups of patients: 
w those who had undergone implantation of 32p radioactive stents at activity levels of 
0.75-1.5IlCi (Isostent'" Inc., San Carlos, CA, USA). 
- those who had undergone implantation of 32p radioactive stents at activity levels of6.0-
121lCi (Isostent™ Inc., San Carlos, CA, USA). 
- those who had undergone conventional stent implantation after suboptimal BA 
(clinically significant dissection or residual stenosis> 30%) and catheter-based radiation. 
- those who had undergone conventional stent implantation after suboptimal BA. 
Stents analyzed were from patients with single native vessel coronary artery disease, normal left 
ventricular function and objective evidence of ischemia. All groups were matched for patient 
baseline characteristics, vessel size, lesion and stent length. Stents placed in the ostial position or 
adjacent to major side - branches, such that the stent edges were unable to be analyzed, were 
excluded from analysis. Only patients who had completed 6 - month angiographic and IVUS 
follow - up were included. 
Implantation technique 
The same group of cardiologists, using a similar technique implanted all stents. 
Predilation of the lesion was performed, followed by stent implantation using either a pre -
mounted stent or the Johnson & 10hnson Intervention Systems delivery system (Johnson & 
Johnson Interventional Systems Co, Warren NJ, USA). Higher - pressure balloon inflation to 
ensure good strut apposition to the vessel wall was then peformed. At this time we used a shorter 
balloon to ensure that the edges of the balloon did not extend beyond the limits of the stent. 
Intravascular ultrasound was used to ensure optimal stent deployment. 
l\'ledicatioll 
Patients received 250 mg aspirin and 10000 international units heparin at the initiation of the 
procedure and the activated clotting time was maintained at > 300 seconds. All patients received 
aspirin 80mg daily indefinitely and ticlopidine 250 mg BIO for 2 weeks (C) or c1opidogrel 75mg 
daily for 12 weeks (LA, HA and CBS), afier stent implantation. 
Radioactive stcnts 
The BX'" stent (Isostent™ Inc., San Carlos, CA, USA) was the only radioactive stent 
implanted in tills trial. It was 15mm in length and available in diameters of 3.0 & 3.5 mm. The 
BXTM stent was made radioactive by Phosphorus-32 (32p). The initial activity of the stents was 
measured and thereafter it was calculated at what date the activity had decreased to 0.75-1.5 IlCi 
or 6-12IlCi, suitable for implantatioll The dose delivered over 100 days at I !Um from the stent 
surface was calculated for each implanted stent. 
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Catheter-based radiation system 
The Beta-Cath System (Novoste Corp., Norcross, GAl was used to deliver B-radiation (90Sr/JO y) at 
the site of coronary intervention. Dose was prescribed precribed at 2111111 depth from the center of the 
source. The device consisted of 3 components: (I) the transfer device which stored the radiation 
source train and allowed the positioning ofthese sources within the catheter; (2) the delivery catheter, 
which was a 5 French (F) multilumen oveHhe~\vire non~centered catheter which used saline solution 
to send and retum the radiation source train; and (3), the radiation source train which consisted of a 
series of twelve independent cylindrical seeds which contained the radioisotope 90Sr sources and was 
bordered by 2 gold radiopaque markers separated by 30 nUll. Other device and procedural details have 
been previously published by this group. II 
Definitions 
Stent Edges: Stent Edges were defined as those volumes axially 5mm proximal and distal to the 
final stent stmt. An edge restenosis was defined as an angiographic restenosis > 50% at 6~month 
follow-up located at either stent edge. An edge - effect was defined as any stent-edge 
renarrowing. 
Patients with balloon - injured edges that failed to receive radiation in the catheter - based 
radiation group were excluded. In other words no stents implanted in areas of geographical miss 
were included in this study. 
IVUS image acquisition analysis 
After the final balloon inflation and administration of intracoronary nitrates, ECG~gated IVUS 
pullback was performed. This was repeated at 6 month folloW-Up. The segment subject to 3-D 
reconstmction was examined with a mechanical NUS system (ClearView, CardioVascular Imaging 
System, CVIS, SUllllyvale, CAl with a sheath-based NUS catheter incorporating a 30 MHz single-
element transducer rotating at 1800 rpm. The NUS transducer was withdrawn through the stationary 
imaging sheath by an ECG~triggered pullback device with a stepping motor. 12 IVUS images were 
aquired coinciding with the peak of the R wave, which eliminates the artefacts caused by the 
movement of the heart during the cardiac cycle. After each image acquisition the transducer was 
withdrawn O.2mm to aquire the next image coincident with the R - wave. The ECG~gated image 
acquisition 'and digitation was perfomled by a workstation designed for the 3~D reconstmction of 
echocardiographic images 12 (EchoScan, Tomtec, Munich, Gennany). A Microsoft WindowsnCbased 
contour detection program, developed at the Thoraxcenter, Rotterdam was lIsed for the automated 3-
D analysis of up to 200 IVUS images.13 This program constnlcts two longitudinal sections and 
identifies the contours corresponding to the lumen-intima and media~advenlitia boundaries using a 
nllnimum~cost based software algorithm. The feasibility, reproducibility and the inter~ and 
intraobserver variability oftllis system have been previously validated in clinical protocols!]. 
Quantitative IVUS analysis 
At the stent edges the area encompassed by the lumen-intima and media-adventitia boundaries 
defined the luminal and the total vessel volumes, respectively. The difference between luminal and total 
vessel volumes defined the plaque volume. Within the boundaries of the stent total vessel volume 
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volume (TVV), stent volume, neointimal hyperplasia (NIH), plaque behind the stent (PBS~ TVV -
stent volume) and lumen volumes were obtained. 
The assessment ofTVV or EEM in stented patients has previously been reported l4• Although, 
in this previous report the delineation of TVV/EEM was not possible in some patients due to 
stent shadowing, in our study the delineation of EEM boundary was possible in all stented 
patients. When the TVVIEEM boundary was not visible in a single cross - sectional view, the 
computer extrapolated it from the contours of the immediately previous and following cross -
sections. In addition the use of 3 - dimensional reconstruction with multiple longitudinal views 
facilitates the visualization of vessel structures outside the stellt. 
Table 1. Clinical Characteristics 
Conventional LA HA CBS 
Patient No 18 16 15 17 
Age (mean) 58 (42-76) 60 (43-74) 59 (42-75) 57 (45-74) 
Male (%) 70 66 70 60 
Prior MI (%) 40 40 45 40 
Unstable angina (%) 60 50 65 55 
Smoking (%) 40 55 40 40 
Hypercholestrolemia (%) 60 62 65 55 
Family history (%) 33 42 30 40 
Hypertension (%) 40 42 30 33 
Diabetes (%) 5 5 10 6 
Statistical analysis 
Quantitative data are presented as mean ± standard deviation. Volumetric data derived from the 3RD 
reconstl11ction of the NUS imaging were compared immediately after treatment and at fol!owRup 
using the twoRtailed paired Student's t-test. Comparison between groups was perfOlmed using one-
way analysis of variance (ANOVA). A value ofp<0.05 was considered statistically significant. 
The Medical Ethical Committee of the University Hospital Rotterdam approved the study and 
all patients provided written informed consent before the procedure. 
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Figure 1. 
Remodeling within the margins of the stent. 
'" = p < 0.05; post vs follow-up, t = P < 0.05 between groups. 
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Results 
Baseline Chal'actel"istics 
Eighteen patients were enrolled in the conventional group (C), 16 patients in both the 0.75-
I.5~[Ci (LA) and 6.0-12~[Ci (HA) radioactive stent groups and finally 17 in the group employing 
catheter - based radiation plus a stent (CBS). In the conventional group 10 MuItilink and 8 NIR 
stents were implanted. Baseline characteristics are similar between all groups and are described in 
Table I. Lesion and procedural characteristics are described in Table 2. No statistically significant 
differences were seen between groups in the parameters described in Table 2. A comparison of 
volumetric data measured at the stent edges and within the margins of the stent is presented in 
Tables 3 and 4. 
Table 2 Procedural charactel'istics 
C LA 
Vessel 
LAD 10 9 
LCx 4 3 
RCA 4 4 
Lesion length (mm) 9.6 ± 3.3 12.1 ± 3.8 
Steut length (mm) 14.6 ± 3.8 15.0 
Balloon length-post 14.8 ± 3.4 14.4 ± 2.8 
Fin~1 balloon size (mm) 3.2 ± 0.4 3.1 ±0.6 
Max inflation pressure l I I.5 ± 2.4 11.6 ± 2.6 
Max inflation pressure2 14.6 ± 3.2 15.2 ± 2.4 
Balloon-to-artery ratio 1.04 ± 0.05 l.l2 ± 0.06 
Max inflation pressure l = balloon at time of stent implantation 
Max inflation pressure2 = balloon inflation within stent 
In sten! inhibition of NIH 
HA 
9 
4 
3 
10.1 ± 3.3 
15.0 
14.1 ±2.6 
3.4 ± 0.5 
10.2±2.8 
15.8 ± 1.7 
l.l0 ± 0.06 
CBS 
9 
4 
4 
11.9 ± 4 
15.2±4.1 
15.1 ± 3.6 
3.2 ± 0.5 
12.2±2.6 
15.4±3.3 
1.12 ± 
0.05 
Intra - stent NIH was decreased after higher - activity radioactive stent implantation and CBS 
(p~0.008, ANOVA). Lower activity radioactive stents had an eftect similar to that of 
conventional stent implantation (see Table 4 and Figure I). 
Behind stent 
Conventional stents and both low and higher activity radioactive stents demonstrated an 
absence of remodeling behind the stent, with no significant changes in TVV or plaque volumes. 
This is in contrast to the CBS group which demonstrated a significant increase in plaque (post Vs 
follow-up: + 15%, p~0.002) and an increase in TVV (post Vs follow-up: + 8%, p~0.003). Inter-
group comparison showed that this change was significanl, (Table 4, p ~ 0.0 I). Further 
comparisons of changes within and between groups are demonstrated in figure 1. No chronic 
recoil of the stent was seen in any group. 
131 
Table 3. Mean (SD) volumes for the edge proximal and distal to the stent (10nlll1 length) 
Edge (mOll) LV LV TVV TVV Plaque Plaque 
post FIUP Post FfUP Post FfUP 
C 67.7 (18.9) 58.3 (19.3)' 124.4 (32.6) 116.5 (34.1)' 56.7 (22.6) 58.2 (23.1) 
LD 75.2 (39.0) 67.3 (34.4)' 126.6 (58.0) 116.4 (49.0)' 51.4 (24.5) 49.1 (21.0) 
HD 74.9 (23.0) 63.0 (23.7)' 126.2 (44.9) 117.6 (46.2)' 51.3 (16.4) 54.6 (16.1) 
CBS 72.6 (27.7) 61.1 (26.3)' 133.2 (48.5) 138.9 (46.5)! 60.6 (26.1) 77.8 (28.6)'1 
* ~ P < 0.05 Post vs Follow-up (FIUP). t ~ p < 0.05 between groups (ANOV A). 
Stent edge 
No significant difference between groups was seen at baseline (post stent implantation). All 
groups demonstrated late lumen loss at the stent edge. At the stent edges remodeling is similar 
after both conventional and low - activity radioactive stent implantation, In these groups there is 
evidence of a decrease in TVV, with little change in plaque as a cause oflate lumen loss (Figure 
2). At higher activity levels of radioactive stent the presence of stent edge restenosis 
becomes apparent. In the 32p group a target segment restenosis (angiographically > 50%) was 
observed in 7 patients at the stent edges. This was more common at the proximal edge (6/7). The 
major mechanism of such restenosis appears to be due to an increase in plaque at the stent edge. 
In non R restenotic patients the edge effect appears due to a decrease in TVV and to a lesser 
degree, an increase in plaque (Figure 3). 
After CBS the edge effect is largely due to an increase in plaque, with no negative remodeling 
seen (plaque increase: CBS Vs LA. HA. C, P ~ 0.045). No patients with edge restenosis after 
catheter - based radiation was seen in our series of patients. 
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Figure 2. 
Changes in volumes allhe sten! edge 
* = p<0.05, post \'s follow.up, t = between groups: p < 0.05. 
t = p is no! significant for !J.LV all groups and for!J. PV in C, LA and HA. 
Table 4. Mean (SD) volumes for the stent 
Stent LV LVII' TVV TVV PBS 
(111m3) Post F/UP Post FiUP Post 
C 113.9 (29.7) 92.8 (28.7) 256.1 (73.2) 257.3 (67.4) 142.2 (54.1) 
LA 127.3 (42.6) 105.5 (40.1) 266.6 (96.5) 264.5 (98.3) 139.3 (59.1) 
HA 122.4 (20.0) 11 1.7 (24.3) 267.8 (66.9) 265.3 (65.1) 145.4 (49.1) 
ens 128.6 (41.3) 121.8 (41.6) 258.9 (73.6) 278.0 (89.8)' 130.3 (34.2) 
* - p< 0.05 Post vs Foliow-up. t - p < 0.05 between groups ANOV A. 
No significant difference between groups was seen at baseline (post). 
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PBS 
FfUP 
143.7 (49.4) 
137.8 (63.7) 
144.6 (45.3) 
149.3 (49.8)' 
NIH 
20.8 (11.5) 
21.2(12.1) 
9.0 (8.6)t 
6.9 (6.6)t 
10 
mm-I 
., 
·10 
." ilLY 11 TVV h,PV 
Fig'" "a.n'la 113 Re-stenoDc t'ijge ys NOn-Restenotic (6,O-12.0j.lCi activity level stents). 
Note greater lumen loss seen in the rcstenotic group. This is caused by an increase 
in plaque (p<O.05) and a less profound denease in TVV (p<Q,Q5). ,',TVV is similar 
in both groups. 
'" '"' change in volume (post \'5 follow-up), • '" p<O.05 post \'S follow-up 
Stent activity and dose prescribed 
Mean stent activity at implantation (LA) was 1.1 +/- 0.3 uCi. Mean stent activity at 
implantation (HA) was 8.6 +/- 1.6 uCi. For CBS mean dose prescribed was 16.7 +/-2.0 Gy. 
Discussion 
The development of NIH within the stent witnessed at 6 - month follow - lip is well 
appreciated1.5, however the changes that occur at the stent edges or indeed behind the stent struts 
have not been the focus of attention until recently'. This paper is the first describing the 
difference in vascular remodeling seen after radioactive stent implantation and catheter - based 
radiation plus stenting, using modern conventional stents as a benchmark. The key findings are 
as follows: 
The degree of inhibition of NIH after the implantation ofa radioactive stent with activity of6.0-
12f'Ci and CBS was similar. 
There was no significant remodeling behind the stent after conventional or radioactive stent 
implantation; however the CBS group demonstrated both an increase in plaque behind the stent 
and TVV. 
At the stent edge three patterns of remodeling are seen at 6 - month follow - up: firstly a 
shrinkage in TVV and LV after C and LD radioactive stent implantation. These two subgroups 
were not associated with stent edge restenosis in this series. After HD stent implantation a 
pattern similar to C and LD is seen in those edges that remain non - restenotic, however in 
restenotic edges plaque increase is the major contributor to lumen loss. In the CBS group a 
similar lumen loss to the other groups is seen, however this occurs secondary to an increase in 
plaque and without a loss in TVV. 
Neoilltimal Hyperplasia 
In our study neointimal formation was inhibited after higher dose radioactive stent 
implantation and after catheter - based radiation plus stenting. The former contrasts with the 
recent study by Carter et al. using 32p stents in the porcine model 16, but is in keeping with earlier 
studies of Hehrlein6 using the rabbit model and recent repOlis by Albiero4 in which a dose -
dependent inhibition of NIH was noted. 
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Mechanism of relllodeling behind the stent 
Catheter-based radiation 
After conventional and radioactive stent implantation little positive or negative remodeling is 
witnessed behind the stent. In stark contrast to this, is the increase in plaque behind the stent and 
TVV seen after catheter -- based radiation and stenting. Part of the key to understanding this 
process may be acquired from understanding the healing process after BA. Wilcox and co -
workers17,18 describe the presence of early proliferation of myofibroblasts expressing contractile 
proteins in the adventitia surrounding the porcine coronary artery after BA. Tracing studies have 
indicated that the same cells migrate and form part of the neointima. \Vilcox hypothesizes that the 
adventitial myofibroblasts constrict the artery at the angioplasty site much in the same way as 
myofibroblasts participate in scar retraction in dermal healing. The source of these lllyofibroblasts 
Illay be distant to the immediate site of injury including pericardial, adipose and intra-myocardial 
layers 19. 
Radiation treatment of porcine coronary arteries after BA up - regulates p21 synthesis in 
adventitial cells, especially myofibroblasts. Such induction is dose - dependent and sllstained for 
at least 7 days after radiation. Additionally radiation inhibits the expression of growth factors, 
reduces proliferation of adventitial myofibroblasts, decreases the production of a - actin by the 
adventitial myofibroblasts, preventing the formation of the myofibroblast scar around the 
angioplasty site and negative vascular remodeling17,20. Data from Fareh and co ~ workers21 
suggest that inhibition of migration but not of cellular proliferation may occur at lower doses of 
radiation. Therefore cells may remain in situ, unable to migrate but able to grow in the presence 
of a weakened external elastic membrane. After one week the effect of the radiation diminishes 
and cellular proliferation, possibly as a reaction to the presence of the stent, continues behind the 
stent in the context of positive vascular remodeling. In our cohort of patients no cases of stent 
malapposition were seen at follow ~ up although our group has described this as a risk of 
ongoing positive vascular remodeJing22,23. 
Radioactive stellt 
The objective of using the radioactive stent is not to neutralise myofibroblasts in the adventitia. 
Rather it is the prevention of the migration and invasion of myofibroblasts from the adventitia 
through the stent struts and into the lumen. As is seen in the HA group this is accomplished due 
to the continuous and low dose rate provided by the radioactive stent. Due to the range of the 
'radioactive fence' created, adventitial cells remain intact without upregulation of growth factors 
and inhibition of contractile proteins. Consequently no remodeling is seen behind the radioactive 
stent at either activity level. 
Edge Remodeling 
Hoftlnan" has previously described negative remodeling at the stent edge and of the 
stentlvessel wall after conventional stent implantation. In our study we have been able to 
precisely describe the decrease in TVV as the dominant contributor to non - restenotic lumen 
loss at the stent edge and to confirm the absence of recoil and remodeling in modern stents at 6-
month follow - up. Recent reports suggest that the edge effect and edge restenosis may be due to 
an increase in plaque at the edge and to a component of negative remodeling as one moves axially 
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from the stent4. However, the edge response after catheter - based radiation and subsequent 
conventional stent implantation were undefined until the current paper. 
Edge restenosis: is this the result of low - dose radiation? 
Radioactive stents have a limited radioactive range of effect. Whereas those cells behind the 
stent struts may be well fenced at the doses discussed, cells proximal and distal to the extremity 
of the stent, in injured areas treated by the balloon (up to 3mm outside the stent)", may not be 
effectively covered by the range of the stent radiation. The latter phenomenon is a further 
example of geographical miss2S. 'Vhether there is a proliferative effect on tissue secondary to low 
- dose radiation at the edge of the radioactive stent has yet to be proven in clinical trials. 
Certainly there is evidence from animal work that low dose radiation may induce a proliferative 
effect on tissue26. If the edge restenosis is the result of an aberrant response by non~injured 
healthy or diseased tissue subjected to radiation, then this may suggest that low~dose radiation 
has a stimulatory effect on non~injured tissue. 
Implications fOl' the future: Dealing with the edge effect 
If the edge effect is the result of balloon-induced trauma and low dose radiation then limiting 
the trauma outside the stent and expanding the irradiated area beyond the injured area should be 
attempted. For radioactive stents conceivably the most practical approach may be to extend the 
area of irradiation beyond the injured area using a Chot~end sten!'. This involves literally 
concentrating the greatest activity of the stent at the stent edges; such stents are already 
undergoing multicenter trials. 
If the edge restenosis were purely the result of negative remodeling induced by low-dose 
radiation in an injured area, then the lengthening of the stent by a non - radioactive, cold - end 
would be a logical solution to prevent remodeling at the extremities. If plaque constitutes a large 
percentage of the healing process manifested by the restenosis then cold~end stent implantation is 
unlikely to work as neointimal proliferation may occur at the edges of the radiation within the 
stent (an in~stellt candy-wrapper), 
In the event that excessive vascular remodeling is present after catheter - based radiotherapy, 
then a self - expanding stent may playa useful role. The appeal here is that via direct stenting the 
injury caused by balloon pre - dilation will be avoided and the self expanding stent would be 
permitted to expand, minimizing geographical miss and stent malapposition22,23. 
Limitations 
This was a retrospective, non - randomised study of individuals who had completed 6 - month 
follow - up and in whom lVUS examination was possible. Individuals who had a total occlusion 
or in whom the IVUS catheter could not be passed under acceptable clinical circumstances were 
not included. 
No edge restenosis was seen in the CBS group, unlike in the HA radioactive stent group, 
however both the CBS and the HA radioactive stent groups reflected the larger parent 
populations from which they were selected in all other features. 
The dosimetry (catheter - based) described in this paper relates to prescribed doses only and 
does not necessarily reflect the dose delivered 2mm from the source in the adventitia. Description 
of dosimetry is beyond the scope of this paper, however previous work by the authors, using a 
similar radiation source and study population, suggests that delivered dose, residual plaque 
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burden and tissue composition playa fundamental role on the volumetric outcome at 6-month 
follow-up after catheter - based ll-radiation therapy and BA". 
Conclusion 
Distinct differences in the patterns of remodeling exist between conventional, radioactive and 
catheter - based radiotherapy with stenting. Users of radiation need to be alerted to the 
deleterious remodeling seen at the stent edges after higher - dose radioactive stent implantation 
and behind the stent after catheter - based radiation and stenting. 
Radiation, whether it be catheter or stent - based has forced the interventional community to 
look closely not only at effective inhibition of intimal proliferation but also the adverse response 
ofthe artery to the combination of injury and radiation. 
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CHAPTER 11 
Late Coronary Occlusion 
after Intracoronary Brachytherapy. 
Marco A Costa', MD, Manel Sabat"', MD, Wim J van der Giessen', MD, PhD, I Patrick Kay', 
MEChB, Pavel Cervinka', MD, Jurgen MR Ligthart', Pedro Serrano', MD, Veronique LMA 
Coen', tvlD, Peter C Levendag', MD, PhD, Patrick W Serruys', IvlD, PhD. 
'Thoraxcenter, Dijkzigt University Hospital, Rotterdam, The Netherlands. 
'Daniel den Hoek, Cancer Center, Rotterdam, The Netherlands. 
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· Brief Rapid Communication . 
Late Coronary Occlusion After 
Intracoronary Brachytherapy 
fvlarco A. COS la, MD; Manel Subate, MD; \Vim J. vall der Giesscll, MD, PhD; I. Patrick Kay, MBChB; 
Pavel Ccrvinkn, MO; Jurgen M.R. Liglharl, BSe; Pedro Serrano, MD; Veronique L.M.A. eoen, MD; 
Peter C, Levendag, MD. PhD; Patrick W. Scrruys, MD, PhD 
llackgrmmd-Intmcoronary brnehytherapy appears to be a promising technology to prevent rcslt'nn~i~. Presently, limited 
uilla are ilvuilahlc regarJing the latc .~afe(y of this Ihernpeutic modality. The aim or the study \VIIS 10 delermine the 
incidence of latc (> I monlh) thrombosis after PTCA and radiolherallY. 
Methods al/d Rest/lfs-From April 1997 [0 March 1999, we successfully trealed 108 palienls with PTCA followed 
by intrucoronary [I-radiation. Ni~ely·one patients have completed (l( len;t 2 months of clinicul follow-up. or these 
patients, 6.6% (6 putients) pre,ented with sudden thrombutic events confirmed by :.mgiography 2 lU 15 month, afta 
intervention (2 balluon angioJllasty and 4 stellt). Some factors (overbpping stents, unhenled dissection) Jlluy have 
triggered the thrombosis process, but the timing of the event is extremely unusunl. Therefore, the effect of radiation 
on (lelnying Ihe healing prol'ess nnd Ilwinlrtining rl thrombogenic cmonnry ~urfa~e is propmed as the most plausibk 
l11e~hllnhl11 III e.~plrtin such lute cverlls. 
Conelusions-Lute and sudden thrombosis nfter PTCA fulluwed by inlraruronary r:ldiuthcwpy is a new phenomenon 
in interventional cnnJiology. (Circulal/oll, 1999;100:789.792,) 
Key Words: thrombosis _ angiopln'ilY _ radioisotope, 
Thrombotic occlusion ufter PTCA is assodnted wilh incn.'n<;ed morhidity nnd mortality rates. I Current tech-
nique; of ~tenting foll(lwed hy antiplaldet (hewpy havc 
dramatically redu('ed Ihe incidence of this cvent to < 1.5%.1--' 
See I) 780 
Intruc<1runnry r;!di~liun h u pr<l!ni~ing nell' lherapy to 
prevent re~tcnnsi~. Rn'cnt randumized Idab de[1ulIl,twled 
:I redu~lillf1 in Ihe re~lenll~h fale ,lilt! l1laintcn~nce uf 
benefjl~ up In 2.yeJr follow.lIp.'-" Pre,enlly, limited dal~ 
;He ul',\il"ble regarding lung.lerm "llfely uftcr intracuru· 
nury bruchylhcrupy.-',1 Although wbacule Ihrnmbmis hu .. 
been reported afler radi(llhcrnpy,u.~ the incidence uf lulc 
thrombotic evenis h~s not been determined. 
Thc aim of thh ~1\Idy Wi!' to dm:urncnt Ihe incidence of 
];He I> I ll\mllh) Illnllnbulic !'v!'nb ;liter ele!'live PTCA 
folluwed by inlravuwular radio!hcrllpy. 
Melhods and Resulls 
From April 1997 10 MMdl 1999, IIJR ('llIl\ecutive patien!'i 
I\'ele ~tlL'cc"f\1l1y lr'ealed wilh cHthelcr-b;l,ed inlnlnlronary 
p-rudiulion nt the ThoruH.::nler (Rnllcrdum, The Nether-
land~). nle Mcdk:ll EthiL'al CUll1l1lillee approved the u~e of 
rudialion thempy lind informed comenl W;JS oblnincd from 
e,'cl)' palicnt. AI! patients presented wilh stoble angina 
peclOris and single I'c'>5cl di,eu'ie. Ilr,JchylhcfJpy lI'a, pcr-
furmed millg the Beta·Calh 5)',lem INuvu,te Corporalion)I" 
(n=76 patients, 32 stents and 44 b~l!oon nogiopla.\l)' tBAj). 
or the Guidant inlmVil-'iculnr brnchYlhernp), syslem IGuidnnt 
Curpuraliun Va'L'III;lr Inlcrvcntiun)l! '(n=32 p,1I\ent', tJ 
Stenl~ Jnd I') BA). BA ami _,tcnling wcrc perfurmed llc'c',ml-
ing 10 'Iamhtnl tcdlni!)llc,. Inlrov,I\Cu!aT ul'r.Jsllund OVUS) 
was perfurmed after r;!uialion wilh a mechnnical u!lraluund 
calheter ICVIS, llu~lun Scieminc). O([~!inc qUnnti1Jlive ((Jr· 
on;11)' un!)iogrJphy W;J.~ pcrformed uling CAAS 'y,tem (Pie 
Medic;!1 Im~ging I1V). Si)"'f11onlh angingmphic (l11d JVUS 
follow-up \\'IL~ s~hedu!ed in all patients. 
All ratienl~ were di;chOlfted without complication,. NinelY· 
nne /l.Ilienh COlllpkh:d nl ku.,t 2'l11onlh clink;11 fnllllll'-up. We 
nblervcd I L'a'l' tlf '1Iha~llle Ihnllllbu,h ("currin£, IS d.l)" lltkl 
stenting, '1 hi, p.llknt Ic'<,c'il'~d ,In I X-IiUll )1)l1g ,lent (jlll,ltli);.!,·.! 
nt 10 ntm) wilh (lptimallVUS result. Tklopidine withdrnwfll (J 2 
d~}'s nncr stcnting) wn~ the plausible explan~tion of thrombosi> 
in thi~ (<lse. 
Sh patienl' {o.M{,j rrelelll~d wilh ~uddeo late thrmn· 
bolic ~'()ron;lry uL·cJu,inn. Two of them were treated with 
IlA and the remaining 4 received an udditionul 'tent ufler 
radinlinn. Their clinical dwracleristic_, ure summariled in 
R~""i,~J M.,y 1Il. I'!')<), r~\hil'lI n:,d~~J j"n,· 12. 1~'!'J; a'CCI'I~J jun~ 24,1')')9. 1',,,,,, lh"I.,,,,~,,t". (M,A,C" MS .. W.J_,',d,(i .. U'.K .. I',l' .. j,M,rU._.I''s .. I'.W So>. [)ii~/i)!ll!"i"""il)' Ih"l'il.,l .. ""r 1l.",id ,k<lIlL"'~ COL''''"' 
Cenur IV.I •. M.A.C, P.LL), HlLlICf\bm. 'rh~ Ncllo",bnd, 
C""c'I'''''Ll.;n~e I" 1'101' r~lfkl W_ Scn,,),. lI<~J ILl' Ih~ rkp~rtm~nt ILl' JnICfwnliom.,1 ('.1IJj,'ILL~)·. l1nil~r,ilr rh"pi!J! lJijlfigl·Tlll'T.l\,'Cll1a 
IlJ4IH, Or. M"I~\\','I~rrkill.4U-JHl5{)D Holl~JJ~tll. nl( Nelh~rt~nJ,. "'-mail "'lru),~,,-."J .w,,,1 
o t')Y\I Am~rican He~rl As\udJlion, Inc 
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CUnlcal and Anglographlc Variables 
Variables 
Ace, Y 57 58 
" 
73 52 62 
So< Mala Female Male Female Female Female 
Pre·procedure 
TaIget vessel lex RCA lex LAD RCA RCA 
Ty~ollesloo , B B A A 
flO,mm 2, 2.8 2.67 2.66 2'" 26 
MLO, mm 0.9 1.12 0.64 1.09 055 055 
as, % 66 6D 76 60 77 78 
lesloo length, mm 13 15 18 11.2 9.6 9.7 
Procedure 
Hr3chy1MraP)' s)'Stem 8eta·tath Guldant Beta·Cath Beta·Calh Beta-Calh Bela·Calh 
S1JLN"C€ length, mm 30 27 30 30 30 30 
Prescritold dose, Gy 12' 35' 12' 14' 18' 14' 
StenVanglQptasty Stent Bal!oon Balloon Slenl Slenl SIMI 
Tolal slenllenglh. mm 
" 
25 25 16 
PQslprocedure 
Oissectlo!1/lyptl No 
"'" "'" '" 
No No 
MLO, mm 2A7 2.07 2.15 2.4 234 2.4 
as, % -, 26 21 9.' 17 
Clinical su<:cess y" Yo, y" y" y" y" 
follow-up 
Event VF Inlerior MI Posllaleral MI Anterior MI Inferior MI InleriorMI 
TIme, ma 15 to 
" Mliplalelel medicaUon Yo, y" Yo, 
'" 
Yo, y" 
Assoclaled ractors lOl1~ slcnt OissecliOll DisseClion at 6·mo Aspirin wiThdrawal No No 
leX Ind~aTes left Circumflex artery, RCA, light coronary artery,lAD,lefl anterior destending artery, RD, reference diameter: /.!LO. 
minimal kJmen diameTer, OS. diameter SleFlOsis; VF, ~entllcu!al f;tlflI1aUon: and MI, m),OC<:lfdral infarction 
°Al 2 mm from the SOllrce; tat 0.5 mm into the vessel wall. 
The Table. No dinical or anatomic characteristic appeared 
to be rdated to lhc~e evenl~. 
In palient I. nverlapring 9· and J2-mm NIR stent~ 
(Mcdinlll Lid) were optimally ill1pl~nTed U~ a\~c.\~ed by 
IVUS. Patients 2 and 3 (BA) showed Iype B disse"tion~ 
without compromising now postpron":dure. Patients 4 
ami .5 both re"cived a Multilink 25-mm ~Ient (Advanced 
Cardio\"a~"ular SYSlcm~/Guidanl), and patient (J rc(civct! a 
NIR 16·mm stent with optimal angiographic re.<.ul\<.. Steut 
patienTs were discharged on aspirin (250 ll1g/d) and tido· 
pidine 1250 mg BID for 15 day~ in paticnts 3 and4, nnd fm 
30 day.<. in ca<.e<. 5 and 6). BA patients recciv"d a<.pirin 
~fone. 
Patient I was readmilled with ventricular fibrillation 2 
momhs after the procedure, whereas. patients 2, 5, and 6 
~u<.lail1ed infcrinr myn"ardial infarctions (MI) between 2.S 
and 3 month, after the treatment. The irradiated segmenT 
\\'a\ occluded at 6'll1onlh angiogram in ralient~ I and 2 
(Figure I). Thrombotic occlusion wa~ successfully treated 
by primary angiopla~ty in palien\.<. 5 and 6. 
In patient 3, the 6-month IVUS conlrol re\'c~1cd a 
persistent (unhealed) submedi~1 dissection (rigure 2) with 
no signs of restenosis. Nine months I~!er, Ihi~ patient 
sustained a posterolateral MI whkh w~, treated wilh 
thtornbolytics. Two wecks urler lhi~ tre'limenl. an ;mgin. 
grant perfllrmed tlecatl~e or re(OtrCIlI ;1I\~ina ,hnwctl til,' 
Heclu~jun in the irn!tlial~d area. Silttil;uly. lhe (H1Huuh 
IVUS control of patient 4 showed no neointimat h)'perpln-
siu. Pour 1110nth<. aftcr conlrol. ~he had i\ ~lf\lke ~ntl ~~pit in 
wa~ replaced by accnocoumoroL Ten tI<lY~ Jaler. \he 
.wqained an anterinr MI. The thwml>otil" occiu,ion in Ihe' 
treated siTe was e(Jutlrmed by ungiogrJph)'. 
Discussion 
Plllg[Cs~ion to tolal {lcdu\ion aftcr SA i, a ~T;!\Jlc pnlce~, in 
the general nonirradialcd pnpuliiTion whkh n,Xur.. ilt "PPW\-
imate!), 4% of patienl~, leading 10 0 Ml in <(}.Y7~.I~ In 
conlraSI. our study sh(ll-l's 0 high inl'itJ,'(K\' (6.()<}·) (If thrill\(-
butk clinit'ol event_ 2 10 15 nwnTh\ ana "TCA and 
hwchYlhcmp)' . 
Coronary dissection after SA is associaled with ~brupt 
closure: howe\w. tYre n di~~cl'1i(ln\ (NIILBI da"Hk;(-
lion), n~ ob.'ief\·cd after BA in OUT patienlS. hal'e lHlt heen 
reliltetlto lhroll1bolk e\'e!tt~. (' The mlnllal h~aling plllec". 
present afTer ui~~ectiutl';, may be itllpaireu after introcurl)' 
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nary radi~tinn.H Whelher unhealed dh~ections, as demon-
strated in p~tlent J, is related to late thrombosis remains to 
b~ elndUated in :l huger plIpnlutinn. Further, the nece~~ity 
of ~Ienting miltl Llh~ecli(ln~ without compromising !lUll' 
ufter wdiothcrupy ~h{)ultl be inve,ligatcd. 
The mean time of subacute thrombosis aner stenling is 
approximately.'i to 6 days.~·' In a recent study, subacute 
thrombosi~ on:urred within Ihe first 24 hours in 86% of 
patient~ treated with a\pirin anti ti<:lmJipine for 14 duy~, 
with no ca_~e of thrombnlic events occurring ufter 15 
daysY Colombo el al reported onty 2 cases (0.6%) of 
thrombosis occurring 2 10 6 monlhs ~fter slenting.1 In 
('onlra,l, in nur .~!Udy, 4 patient\ receiving n .\tent (IU!%) 
cXpCriCllL'cd Ihromlll"j, laic lIfter ntdiatitln. 
Expcri!llent~lIy. reendothclialilation ufter injury tukes 
>4 weeks to be compleled. 'h However, tlte dinical pre-
~cn[alinn ur \Uha<:ulc lhrumhll,i, inrrCtlucntly o..:cnrs 1,lter 
than 15 days after stenting, I~ when Ihe reend{Jlhelializalion 
proce>~ may still be incomplete. Delayed reendotheli-
alizution as a trigger mechalli~m of late ~tent Ihrombosis 
after antineoplastic therapy has been hypothe~iled previ-
(lu~ly.l' Farb etlti rcpullcd ill!;(lmpkt..: cllduthelialil.alitln] 
months after plat.:ement of j1·radioactive sten!.l" Neverthe-
less, the same group showed no differences regarding 
endothelial cell growth between rntliuactive and conlrol 
stenh in another experimental modelY Further ~tutlie" 
should address the timing of sten! recndothelialization 
after brachylherapy to determine ils role on the pathogen-
esis of late thrombosis. 
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Figure 1. Patient 1. A, Preprocedure 
angiography shows a significant lesion in 
Ihe mid-third of left circumne~ anel)'. B, 
Radioactive SOUlce placed in treated sl\e 
C, Postprocedure angiography and lVUS 
images show an optimal result (arrow-
heads). 0, AI 2 months, Ihe pro~lmal part 
of stent appeared occluded. 
Although multiple stents have been related [0 subacute 
thrombosis,leo the signil1cunce of mulliple stenl implanta-
tion (p<lticnt I) un latc thrombotic phenomena ha~ not been 
demon~lrutcd. 
The uw uf intf(l":urllll,lfY tJ·radiatiull i~ u Ul!1l11l1lll 
feature in our patient~. Huwever, the judgment of whether 
radiation is lhe key faclor in the pathogenesis of late 
thrombosis shoultl await Ihe anal~'sis of ongoing triah. 
Cuncomilanlly, the henefit of prolunged antiplatekt lha-
apy with the cOl1lhin~titl!1 (If ;hpirin, dopidugrd, or 
liclopidinc should be considered. 
IJmllallulls 
Ollr patknt~ wcr..: illduJ..:J in \\,cll-l'oHlrotlcd #'raJiuli"n 
sludie~ with similar ba~eline charuc[cri\lics anti inc1u\ion 
criteria (lesion length <15 nUll, tre~tn1ellt of siugle \'e;~el). 
lIuwcwr, 2 dirkr..:nl ~)'-'I..:m' hi d..:IiI'Cf ~·nHtiali(!n WCre' 
used. 
In mJdition, it is nnt po,sible to rule OUt the Il~tural 
hislory of Coronary disease as a cause of late thromb{"I';i~. 
Howel'cr, the incidenl"e of total ucdu,inn in thc general 
nnnirr;ldiatcd populatiull i~ mudl I\lw~r than lhal uh<'rv~d 
in our ~Iudy. In fact, the incidence of tatc thrombutk 
e\'ents would be even higher if, in the interest of romplete-
ne<;s, we waited fllr I-year follow·up in the total patient 
pupulation. 
Finally, wh~lh~r lale thrombosis is a generk complica-
tion of illtr:lcornnary ratliolherap)' or is restriCted to the use 
of iJ-sources l'unnlll b~ extrupolat..:d from OUr fjr1l.ling~. 
Figure 2. Pal'enl 3, A, Poslplocedule COlonary dissection, demonstlaJed bolh on angiography and IVUS, d,d not COillpromi5e How in 
tleated area (al(owhead), B, This d,ssecHon pNslsJed unhealed al6-month conllol (arlOwhead). C, AilS mO<lllls, i"ad,ated segment 
appeared occluded. 
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CHAPTER 12 
Late Stellt Malapposition Occurring after Intracoronary 
Beta-Irradiation Detected by Intravascular Ultrasound. 
Ken Kozuma\ 1vID, Marco A Costal. IVID, Manel Sabate\ MD, Pedro Serrano!, MD, \Villem J. 
van der Giessen', MD, PhD, Jurgen M.R. Ligthart', Veronique L.M.A. Coen', MD, Peter C. 
Levendag', MD, PhD, Patrick W. Sermys', MD, PhD 
'Thoraxcenter, Dijkzigt University Hospital, Rotterdam, The Netherlands. 
2Daniel den Hoed, Cancer Center, Rotterdam, The Netherlands . 
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---4 Vascular Brachytherapy _______________ _ 
Late Stent Malapposition Occurring After 
Intracoronaty Beta-Irradiation Detected by 
Intravascular Ultrasound 
Ken Kozuma, MD, Marco A. Costa, MO, Manel Sabate, MO, Pedro Serrano, MD, 
Willcm 1. van der Giessen, MD, PhD, Jurgen M.R. Ligthmi, 'Veronique L.M.A. eoen, MD, 
'Peter C. Levendag, MD, PhD, Patrick W. Sem,ys, MD, PhD 
ABSTRACT: We report a case of lale stell I mal apposition occurring 6 months after intra-
coronary beta-irradiation detected by three-dimensional infl'avascular ultrasound, in spite of 
good apposition immediately after the procedure. Volumetric quantification revealed -that stellt 
volume remained unchanged, whereas tolal vessel yolull1c increased by 13% after 6 months 
wUhin the stent area. The Increase of the vessel volume took place mainly In the proximal part 
of the stellt, where the malapposiUol1 was located. 
J INVAS CARDlOL 1999;11:651-655 
Key words: angioplasty, brachytherapy, Intra\'ascular ultrasound, vcssel remodcllng 
Experimental studies have shown that endovascular 
radiation reduces neointima formation. I-) In humans, 
three randomized trials have reported a reduction in 
restenosis rate after successful reintervention followed 
by intracoronary brachytherapy for the treatment of in-
stenl res(enosis.~-" Early safety of this new therapy has 
been demonstrated.) 1 Although 2- and 3-year follow-
up of patients treated with gamma-radiation has been 
reported,w,1\ long-term safety of radiation has been 
questioned. I< 
In humans, radiation has been shown to prevent 
vessel shrinkage. 1l inhibit neointimal formation/5 or 
induce vessel enlargement that eventually accommo-
dates an increase in plaque, I~ The importance of vessel 
enlargement in patients receiving stents has not been 
investigated. 
We report a case of laic stellt malapposition occur-
ring 6 months after intraeoronary beta-irradiation 
demonstrated by three-dimensional intravascular 
From the lhoraxcenter, Dijkligt Uni\'ershy Ho>pital *and 1he 
Daniel den Hoed C;mcerCen1er, Rollerdam, The Ne1herlands. 
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ultrasound (lVUS), in spite of good apposition imme-
diately after procedure, 
Case rqwrt. A 60-year-old male wilh Canadian 
Cardiovasclllar Society elm:s III (Ingina pectoris was 
referred to our il/stillltioll/or perclltal/eOIlS trallslllmi-
lIal coronal)' angioplas/y (PTCA), Corol/aI)' allgio-
graphy re~'ealed a severe slenos;s ill the proximal 
segment o/the left anlerior descellding COrollal)' artery' 
(LAD) (Figure IA). Quanlilatil'e corol/aI)' allgio-
graphy (QCA) was pel/ormed o.O:lille (CAAS 11 system, 
Pie Medical, Maaslriehl, The Netherlallds). Lesion 
length measllred 14.9 mill, minimallllll/inal diameler 
(AfLD) 1.20111111, reference vessel diameter 3,10 flllII, 
alld percelltage o.!,diameter slellosis 61%. Although he 
had a previolls myocardial ill/arction, left velltriclilog-
raphy revealed 110 hypokinesia with all estimated ejec-
tiolJ/ractioll 0/54%. 
Strategy, The patient was enrolled ill a study to eval-
lIate sa/ely and efJ1cacy 0/ beta-irradiation/ollowing 
PTCA using the Gliidanllntramsclilar P-32 Radiother-
apy Syslem (Guidmlf COIporatioll Vascular ll1len'ell-
lioll, HOIISIOII, Texas)./J The Medical Ethics Commillee 
a/lite Ulliversity Hospit(/l Dijkzigl approved the flse 0/ 
illtracol'OlIaJ)' radiation, (/nd the patient has gil'en wril-
len ill/armed cOl/senl. The strategy was to pel/orm (/ 
t:UL.uMA, el at. 
Table L IVUS volumetric 3-D reconstruction analysis 
Baseline Follow-up Difference 
Lumen volume (mm') 179.7 
Stem volume (mml ) • 179.7 
EEM volume (mml) 351.8 
Pla4ue volume (mml) 172.1 
Mean lumen area (mm') 9.9 
Mean stent area (mml) 9.9 
Minimum lumen area (mml) 7.8 
Mean EEM area (111m') 19.4 
Minimum EEM area (mml) 18.3 
EEM .. external elastic membr.me 
IB8.1 
IB1.1 
402.6 
214.5 
10.5 
10.1 
B.O 
22.1 
IB.5 
+8.4 
+ 1.4 
+50.8 
+42.4 
+0.6 
+0.2 
+0.2 
+2.7 
+0.2 
direct stellt deploymellt without pre-dilatatioll /ol/oll'ed 
by irradiation 0/ the to/'get segment. 11/e SOllrce Delii'-
('1)' VI/it is a comjJuter-controfle(1, source wire-hal/dUllg 
del'ice Ihat delil'ers localized beta-radiation to a coro-
1Ia1)' artel)' at 0.5 film illlo Ihe \'essel wall.') Tlte radia-
tion dose was randomly assigned to the patienl. The 
Guidallt P32 Source Wire is a 0.018~ guidell'ire lI'ith a 
27-l1Im long bela-emitting source in its tip. The Cellter-
illg Catheter is a multi-lulI/eu, spiral-desigl/ed balloon 
catheter with a rapid-exchange tip, desiglled to opemfe 
I/sillg 4 atmospheres a/pressure (Figure lB). 
Procedure. The left corOl/ol)' artel), was call/lltlat-
ed with a Judkins left 8 French (Fr) guiding calhele/' 
(Cordis COIporalioll, Warrell, New Jersey) usillg the 
stalldard femoral approach. The lesioll lI'as crossed 
with a 0.014: 315-C1ll101lg lIallnibal~ wire (Schneider, 
Biilach, SWilzerialld) which was placed distally ill Ihe 
LAD. Subsequently, a 3.5 x 18 mill Multi-Link'- stellt 
(Guidant CO/poraJion, Sallta Clara, Cali/ol'llia) was 
direclly ill/plallted. A balloon post-dilatatioll o/the tal'-
gel lesioll was pelformed IIsillg (/4.0 x 15 1111/1 Tacker~ 
ballooll (Cordis, Miami, Florida) inflated 10 14 a!mos-
pheres. I1'US images \l'ere t'JeIl obtained /lsillg a 2.9 
Fr mechallical lIitl'aSOlllld catheler operating at 30 
MHz (CVIS, SUllllyvale, Cali/orllia). 11le size 0/ the 
cellierillg balloon was chosell based all mean \'essel 
reference diameter (meml a/proximal alld distal refer-
ence diometel) defined by IVUS. A 3.051/1111 cellterillg 
ballooll lI'as thell placed over the wire at the target 
sileo The radiation sources remained at the [reatmm! 
site ill order to deliver a prescribed dose of 4200 cGy 
al 0.5 mm i1ll0 Ihe i'essel wall (Figllre lB). The delii'-
e/)' III/it based all meall reference vessel diameter a/llo-
II/aticafly calculates tile dwell time. After 
illlracorollOl), irradiation, an ECG-gated IVUS pull-
back at 0.2 IIlIn/step Was pelforllled with the sallie sys-
telll. The slelll was well-apposed wilh a millimalllllllell 
area (MLA) 0[7.8 1111/11 (Figure 2C). No edge teaf' was 
detected by lVUS. QCA revealed a MLD 0/2.79111111, 
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Figure 1. (A) Pre-procedure anJjogmm shows the stenosi.. in the 
pro.\imal segment of the lef! anterior descending arter)'; (D) cen-
wing balloon inflated during irHldialio)Jj (C) post-procedure 
angiogram (arrowhcmf indicates the /ocdlion wilCre stellt lllawJ'-
position atJpemed at follow-up); (D) 6-montli fallaw-up 
angiogram (arrowlie(ul indimtes tlie stem malaPllOsilion si/e). 
located al the proximal portion of the slmt, alld resid-
lial percelltage slellosis of 16% (Figure IC). The 
patient's hospital slay lI'as 1I//(.'wllljitf aI/(/ he was dis-
charged 2 days after the procedure 01/ aspirin (250 
mg/c/ay) alld tic/opidillc (250 IIIg twice a day /01' 15 
days). Six II/olllhs later, Ihe patient retumed to the 
catheterizatioll laboratOf)' for allgiographic alld IVVS 
cOlllrol as part 0/ the protocol. The paliellt had 110 
complaillts alld the stress test was IIcga!il'e. The 
allgiogram (QCA) revealed //0 signs of rest ell os is (Fig-
ure I D) witll (//1 MLD 0/2.3411/111, located olltside the 
stellt, and a diametel' stellosis of33%. Lllmillal diame-
ter at tlte site of lIIalappositio/J was 2.98111111. Six-
mOllth IVUS images, /Ising the sallie system, /'ewaled 
110 neoilllimalformationthrollghout the stellt. However, 
Late Stelll .Malappositioll Occurring After In/mcoral/ar)' Beta-Irradiation 
Area (mm2) 
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Figure 2. (A) Longitwlinal dew of 3·D intnmucuwr II/crosormd (NUS) image recomtrllc/ioll aI baseline; (N) schematic model of 3-D 
'VUS image recollStnielion at Al,eline; (S) longillldinal di'1t! of 3-D reconslnletion NUS image at follow-rIp (mrouhead indicates the 
malapposition site): (B') schematic model of 3-D r"collsfnlelion NUS image at fof/ow-llP; (C) t)[lst-procedure NUS cross-sec/fonal 
imoge ai/he sile wheT<' slem md/npt)[lsition nppeared 01 follOW-lip; (C') schemalic model of NUS '-TOSS sectional image III baseline; (D) 
NUS cross-sectional image 01 fo//ou',up (arrowhemi indirate, a space behind the Henl jIf 2-5 o'clock - stent rna/apposition); (D') 
SchemMic model of /VUS (TOss-scetional image at follow-up; (E) gmphic of extemal elastic membrane (EEM) and S/ellf dUllS at baseline 
(1lppa line: EEl\-! art'd, Iowa line: stem area); (F) gmt/hie ofEEM area and stent area atfollow-ut, (II/,per line: EEM area, lower line: 
Slellt area) (arrowhead indicates the local EEM area i!lcreme from nearly 20 mmllO more than 25 mml). 
a mafappositioll of the proximal el1d qfthe stCllt with-
alit compromising tlte lllmel1 1I'as obsen'ed (Figure 
2D) by IVUS. Contrast injection fWed the cavity 
behilld the stelll, cOlljlrmillg the presence of lIIalappo-
sitiOI/ durillg lVUS imaging. Based 0/1 clillical sta/lls, 
lIofl/rlher illtervelltioll was performed. 
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Intravascular ultrasound measurements. Aff IVUS 
images lI'ere allalyzed off-Iille by 3 im'esligaIOf'S ill a 
"blilld" approach. All ECG-gated image acquisitioll 
and digitizatiol1 lI'orkstatioll (EchoScan, Tom Tec, 
Mllnich, Germany) lI'as IIsed for three-dimensional 
IVUS image recollstrucliOI/. Volumetric qualltification 
KOZUMA, e/ al. 
was peljormed by means of a Microsoft Willdolt's~­
based COII/Ollr defee/if!!! program del'eloped at the T/to-
"".rcelller. N This program constructs Mo longitudillal 
sectiolls fi"om the data sel alld Mentifies the COIIIOIlI'S 0/ 
the Illmen, media alld stellt boul/daries. Nillety-follr pla-
liar cross-sections of the stellted segment were carefitlly 
checked alld edited by 2 cardiologists. The feasibility 
alld illtra- alld illter-ohsen'er variability of lhis system 
haw been previollsly reporled.1w Tile reproducibility of 
measurements of the exlemol elastic membrane (EEM) 
ill stell/cd segme/Jts has beell also demollstrated. n 
n,e results of two-dimensional alld "wee-dimensional 
analysis are sholl'lI ill Table J. Figure 2E, alld Figure 
2F. Tolal,'CSsel \'o/lIl11e increased by 51 '111111 (13%) after 
6 mOllths, parallel to all illcrease ill plaque l'olullle of 42 
I1ml l (20%), HOlI'ewr, the magnitude of the plaque ill 
groll'th lI'as 1I0t sufficient to completely jitfjill the gap le;fi 
betll'eell stellt struts alld vessel wall, The calculated dif-
ference was 7 111m}, No neoil/timaf fOl1l1ation was fOl/lld 
ill the malapposed stell! site, which rel'eated a IlIlIIell 
C5/1 of 8.0 mm l (Figure 2D). 17w illcrease of 'he l'essel 
\'OllIme took place maillly ill the proximal part of the 
stent, where the ma/apposition is located (Figure 2F). 
Stellt \'olllme of the proxima/ enlarged segment (6.9 mm 
ill length) remailled similar (61 flI1II J at baseline l'e''SIiS 
68 1111111 at 6 mOlllhs), whereas total vessel \'olllme 
increased fi'OlII J 40 1111111 to J 79 IIII11J after 6 months. The 
stellllllalappositioll was also demollstrafed 011 the IOllgi-
wdilla/view of tlte three-dimensional recollstruction 
(Figure 2). 
Discussion, This is the first case report which 
demonstrates an unexpected late (at 6 months) stent 
malapposition after intracoronary radiotherapy 
revealed by thrcc-dimensional lVUS, despite the good 
apposition of the stent post-proccdure, Volumctric 
analysis demonstrated a vessel enlargement without a 
concomitant increase or decrease in the stent volume. 
Stent malapposition has been related to an increased 
risk for subacute thrombosis.l~ Thrombotic events late 
aftcr stenting followed by radiation have been reccntly 
reported:1l21 However, the relationship betwecn late 
thrombosis and stent mal apposition late after 
braehytherapy remains to be elucidated in large IVUS 
studies. 
Meerkin et al. demonstrated that EEM area did 
not change during the follow-up period after beta-
radiation.1l However, the analysis of single planar 
cross-sectional images may have underestimated the 
possibility of positive vascular remodeling in their 
study. On the othcr hand, a volumetric tluee-dimensional 
rvus study has demonstrated that radiation promotes 
positive vessel remodeling by showing an increase of 
the EEM volume (40 I11m1) at 6 months after intra-
corollary beta-radiotherapy. '4 In addition, Condado et 
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al. have reported on the occurrencc of coronary 
aneurysm formation, which illustrates an exaggera-
tion of vessel remodeling after high doses of gamma 
brachylherapy.lI In this case, we also obscrved an 
enlargement of tile total vcssel volume (51 mm)). 
Although some previous reports showcd acute 
recoil of the Palmaz-Schatz stent,lI-N tubular stcnts are 
not belicved to recoil or expand chronically.ll-ll Thus, 
the Multi-Link stellt used in this case is not expected to 
change its volume aftcr 6 months,z' Then, considering 
the inability of self-expansion of a rigid tubular stcnt, 
the increase of the total vessel volume may play an 
important role ill the mcchanism ofstent malapposition 
formation late after the treatment, The use of self-
expandable stents in the setting of intracoronary radio-
therapy Illay be an alternative to avoid this problem 
due to their ability to expand chronically.!1 
Besidcs vessel enlargement, we should also consider 
the possibility of tissue or non-ccllular structure (throm-
bus or lipid lakes) occupying the space behind the stcnt 
after the procedure. Such structures may not be detected 
by post-stenting IVUS and may diminish after 6 
months, The "killing" effect of radiation (necrosis or 
accelerating apoptosis) and dissolution, disruption or 
embolization of these non-cellular structl.lres may playa 
role in this phenomenon. These hypotheses shOUld be 
further investigatcd by large popUlation studies. 
In conclusion, this report illustrates an unexpected 
finding following coronary stenting: late stent malap-
position. Whether this finding is related to the combi-
nation of radiation and stent placcmcnt remains to be 
elucidated, Furthcr studies with serial IVUS analyses 
should be performed in order to elucidate the patho-
physiology and clinical impact of this finding. 
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CHAPTER 13 
The Outcome from Balloon-Induced Coronary Artery 
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Outcome from balloon induced coronary artery 
dissection after intracoronary ~ radiation 
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Abstract 
Objectl\'e-To evaluate the healing of baUoon induced coronary artery di,section in individu~ls 
who have received P radiation treatment and 10 propose a new intnll'aseular ullrn,uund (IVUS) 
dissection score to facilitate the comparison of dissection through time. 
DesIgn-Retrospective study. 
Seltlng-lcrtjar~' referrol centre. 
Patlents-31 patients with stable angina pectoris, enrolled in the beta energy rcstenn~is lrinl 
(BERT-L5), were included, After ex'eluding those who underwent stent ;mJlI~nt~ljU!l, the CV;Jlu-
able population was 22 patients. 
Inten'elltiOlls-Ba][ooll angioplasty and intfaCOfonary radiatiun r"Unwed by l.ju~llIitnli\·e c()r"ll~ry 
angiography (QCA) and IVUS. Repent QCA (lnd IVUS were performed llt ~ix munth 1",lIl'W up. 
MaIn outcome mcnsurcs-QCA and IVUS evidence of healing of dissection. Di%ection 
classification for angiography was by the National Heart Lung Blood Institute ~calc. IVUS l'r,1\"ell 
dissection was defined as p~rtial or complete. TIle following IVUS defined clUlmctcristic~ "f di'-
section were described in the alfected coronary segments: length, depth, arc circutllf"rence, pn:5~ 
enee of flnp, and dissection score. Dissection wa5 defined as healed when all realure~ I,f dissccth'n 
had resolved. 'Ine calculated duse of radiation rcceh-cd by the dissected (lrea in those with healed 
versus non-healed dissection was also comparcd. 
Results-Angiography (type A::: 5, U = 7, C = 4) ond IVUS pronn (partial;;;- 12, C('I11-
plete = 4) dissections were seen in 16 patients following intervention. I\t six month li,lIo\\' tip, ~i); 
and eight unhealed disscctions were seen by angiography (/\ = 2, H = ·1) and IV US (p~rtbl = 7, 
complete = I), respectively. TIle mean IVUS dissection score was 5.2 (range 3-8) following the 
procedUre, und 4,6 (range 3-7) at follow up. No correlation was fount! h~tw~en the do,,' 
prescribe(lln the treated area and the presence of unhealed disseclion. No c1wngl' ill ilngi!\~1 S\(]-
IUS was seen despite the presence ofunheuled dissection. 
Concluslon-p radiation appears to alter the normal healing pwces~, l~sultjng in Ilnhc<lkd dis-
section in (:ertaln individuals. In view of the delayed and abnormal healing ubscrved, 1(>1lg tcrm 
follow tip is indicated given the possible late ad..-erse elTects of radiation. Although ill this culwrt 
no increase ill cardiac events following coronar}' di~sectinns was scen, 1;lrgcr l'''I'ULHi''ll~ arc 
needed to confirm this 11hellomcnoll. Stenting of all coronary dissections mny be lI'.1rnJl\led ill 
patients scheduled for brachytherapy after balloon angioplasty. 
(Hfilr/2000;83:3J2-337) 
Despile excellellt acute r~stl!ts, re~tcnosis at six 
month follow tip after coronary aner), balloon 
angiop!asty remains a seriotls problem. I Exccs-
sive neointhnal formation, extracellular matrix 
synthesis, and negative vessel remuddling in 
lesponse to balloon injUry have been docu-
mented as the main mechanisms of 
restenosis." Intracuronary radiation treatment 
has recently emerged as a means of pre..-enting 
and treating restenosis in coronary arteries 
treated by bal/oon angioplast}'. 111(" theoreticnl 
benefit uf radiation in preventing ncointim~1 
proliferation resides in the destruclion of more 
rapidly dividing sm{]oth mu,de cells.' 14 II may 
not be surprising that by inbibiting the abo\'e 
deleterious features of healing after balloon 
angioplasty, ilm1lcoronary radiation m3Y also 
all~r normal he~ling processes. 
Coronary aftery dissection is common after 
balloon .ngioplasty. This is angiographically 
visible in 20--45% of cases following balloun 
angioplast~·11 and present in tip to 85% uf coses 
when intravascular ultrasound (IV US) assess-
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men I i~ u,cd," If furthL'r :lngi"pl~~ty <If th~ 
lesiun is nllt und~rtak.:n, then it i, r~l'(lglli~cd 
tlwt nearly all angiographic diS'ic~ti"n will lwa! 
over a six month lime fram\',"" Whether 
intracoHln~r}' radiation \l'i!! I'r~'\'l'llt tIll' proccs\ 
of natural healing after balloon induc~d dissce-
tion has nut beell \h>cuillent~d tllu, lilC ill 
humans. 'Ih exam inc thi" II'C rctrn'ip~ctird\' 
analysed coronar),' artery di~"ccth'n~ using 
angiography and IVUS, at thc time nf tre~t­
ment and at six nwllth lilllow til', ill l'.ltiL"nts 
trealed \\'ilh intracoronacy rndialhm Ji,ll<,wing 
balloon angiuplasty. \X'e al'i<l aimcd to CIHllpan' 
the prescrihed dose received by the treated area 
in inJil·jdua]s willi nnn-he;1ling Jiss<:l"Iiol1 with 
the dose recei'.-ed by tho~e indil·iduoh with 
healed dissection. 
Methods 
rATIENT SElECTION 
Paticllls eligible fur the ~ltId)' wac Illl"'· 
treated suc.:essfully with balloun rlngiul'l;15ty 
folluwed by intr~corunnr)' irra,li;lti('11 acc"rding 
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to Ihe beta energy restenosis trial (BERT .. !'5). 
The purpose of this !riDI was to evaluate the 
~ufety and elficacy ofl{)\\' dose Jl source irradia-
tion fnlluwinll' balloon anll'ioplasty with Hnd 
without Slelll implantation in patients with sin-
gle "d~ novo" lesions of native comnar)' arter-
ies. The design of Ihis trial was a prospective, 
Illulticentre nnn-randomised feasibility study. 
\Ii'e used a strlJlllium 90 C'Sr) sOUrce with 
yttrium as a pure p emitter, and patients were 
randomised to receil'e 12, 14, or 16 Gray (Gy), 
TIj(~ inclu,ion and exclusion criteria of this trial 
ha\'<~ heen prcl'iously reported," 
RADL\TION DELIVERY srSTEM 
'Ibe Beta-Cath system (Novoste Corp, Nor-
cross, Georgia, USA) wus used to deliver IncHI-
ised ~ radiation to a coronary ana), at the site 
of coronary intcrvell1ion. 'Ibe device consists 
of three components: (I) Ihe Ifansfer delice 
which More~ the radiation source train and 
allows the positioning: I,f Ihese sources within 
Ihe catheta; (2) th~ ddil'~ry catheter, which is 
a 'j F muhitumcn ol'a the wire nlln-centred 
catlwh'f which lIses saline solution to send and 
return the radiation source train; and (3), the 
radiation source train consisting of a series of 
12 independent qlindrical seeds which COII-
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tain the radioisotope "Sr sources and is 
bordered by two gold radiopaque markers 
separated by 30 mm," 
IVUS IMAGE ACQUISITION ANALYSIS SYSTDI 
The segment subject to analysis was examined 
with a mechanical IVUS system (ClearView, 
CardioVascular Imaging System (CVIS), Sun~ 
ny\'ak, Cahfl)rnia, USA) with a sheath based 
IVUS catheter incorporating a 30 MHz sing],: 
element transducer rotating at 1800 rpm. The 
transducer is placed inside a 2.9 F 15 cm long 
sonolucent distal sheath which alternalil'ely 
houses the guide wire (during the catheter 
introduction) or the transducer (during imag-
ing, after the guidewire has been pulled back). 
1b assure the correct identification 3nd analy-
sis of the irradiated segment, certain steps were 
followed. First, an angiogram was performed 
after positioning the deliwry catheter, and tht: 
relation betwt:en anatomical landmarks and the 
two gold markers was noted, Typically, the 
aorto-ostial junction and the side branches 
were used ;!s landmarks. The landmark closest 
to cith~r of the gold markers \\'as used as a 
guide, During the motorised IVUS pullb;!ck, 
all side br3nches were counted lind the guiding 
landmark was identified. The correct selection 
of the marker was confirmed by \isualising the 
position of the IVUS probe during 3 contr;!.st 
injection. Once the acquisition was completed, 
we selected the segment of interest by taking 
the digitised cross-sectional images proximal or 
distal to Ihe guiding landmark up to 30 mm, 
which is Ihe area encompassed by the tll'O gold 
markers of the radiation source, At follow up, 
we selected the same region of interest and 
compared it with that after treatment. 
l'](OCE!lUHlj 
The medical ethics committee of the Erasmus 
Medical Center, Rotterdam approl'ed the 
study and ull patients signed a written in-
funncd ({'ment ("rm, In tlw BEKI~I.5 Ifbl 
balloon angillpln~ty was performed acn,rding 
to ~1~nd.1rd clinical practice. Following ~uc~ 
cessful lIngiuplasty, patients were ranuomiscJ 
to receive 12, 14, or 16 Gy, as calculated at 
2 mm from the centre of the radiation source. 
'Ibe 5 F delil'cry catheter of the Beta-Cath 
F.,g,",'''P 
Di",,,i,<,, [;'~.u RD LlS (~~) .III.n UJ 
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FiK!'" I 1II/O"I1I''''WI0, 1,11,,,-,,,,,,,.1 ''''''1:<' (1,1/ "lid '-,'1/11<:) ,Ii'~"'''J:'' d,."N,·lumm I,,'/rt,','" 11 ,,0/.1 I ,,',hk 
rW1i,mn'(mi<'ll. nit "xlir ;ma;:,· ,I",,,, III, lante k""'1 <11 lOt """'lllfi,II01<' I'P Idll, III,· ""1,,,,,1,',//"",' II"".." h'm [.<liL""-" 
Jl ,11/.1 lo'c/ock. 
system was inserted over the guidewire and 
advanced sllch that the two marker band~ 
encompassed the nllgiopl~~I}' site. TI1C 
guidewire was rcmol'ed (lnd the radiation 
source train containing 12 "~Sr seeds was posi-
tioned between the gold markers using fluoru-
scopic visualisation. 11le seeds remained in 
place for 2.5-3.5 minutes to Jc1iwr the 
assigned dose of radiation. Following irradia-
tion, repeat angiography and IVUS pullback 
were performed. Intracoronary nitrates were 
administered before the treated artery was 
examined with IVUS. Thc 2.9 F JVUS cath-
eter (CVIS, Sunnyvale) was advanced di\la!1O 
the treated site. A ccntinuous motorised 
pullback at II speed of 0.5 mmls was carried 
out, followed by an angiographic control, At six 
month angiographic foHow Up, idcnticalqunn-
titative coronary angiography (QCA) and 
IVUS examination of the treated Hea was per-
formed, 
h,'ln,' 2 r,""",,JFY "'''''''WI('''' '/""'Hlx'-'(II) /'",''' (""""""'"m; (II) ",dl,~'dl1" <"",,,' 
1'/ '1111, ff,) (''''II"rrrIC''1I0",'<1",J (lJ) the f<1n:( I .... "" <11 ,;_, 11I'''IIIr!,II,,,,, "f'. ,,",w IJr, 
f',w",' cf ,,,, ,J~'~ (fllel {J~d <1~""'~ 4 (IIIg,,'Cr<1phic d,'ss,",I!"" '" ,i, 1II"I1I"j.'IJ,~" III' 
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!lEFlN! t r(lN~ 
Dissection W:lS dcfincd both ungh\gl~phic~lIy 
[lnd br IVUS, Angiogrnrhk di,sc'c'tioll \\';1, 
defined using the Notional H~~rt LUllg nnd 
Blood Institute criteria for the classificntion of 
dissectiun," QCA atl~lysis \\'a~ p~rforl1lcd 
hefnre the intervenliull, ~ft~r tr~(I\m~nt, ;lnd ~t 
si:-l: nlOnlh [(I!lUW lIJl u~illg idellliL'al g;llltry 
positions, Coronary :lngiogruphy was pcr-
formed after intraCOfOnary (ldministwtion of 
nitrates, The omine ':Ill(llysis of (I( least two 
orthogonal projectinns II'~~ pnCormcd hy 
means of (hc cardi(lI'awul(lf (lllgiogwphy 
analysis sytcm (Ct\I\S 11, l'k ,\\cdkal i!V, 
t.hastrkht, 'Ibe Netherland~). Calihrntion of 
the system was based on dimcnsions (If the 
c3theters nnt filled with COIltr:I'{ medium. Thh 
me thud uf nnalysis hilS bl'c'n pr~\'itlusly 
validated,~'" 'I11e foJJ(lWing measurements 
were obtained in each pwjet:tinn: mininwl 
luminal diameter (l\ILD), reference dimncter, 
% di~lI1etcr sICIW,i~, nnd k~iun length. I.c~iun 
length was u~cr dcfillL'd nnd not done oy till 
algorilhm u~ing <:tu 1',nUlC :llt;ll_\'~I' ufth,' di,llll~ 
elcr ftHKliul1. TIll' rl'il'rl'lIn' dl,lnlc'll'l II.!' 
oht:dllc'd \1)' :Ill ill!~·f\',>I.lll'd mCllwd. ,\l'lIll' 
gain \\';1', .ldincd B~ ,\IID me;l'lIlcd :lIi~r 
trc:l\!l1,'lH millil" ,\II.!) 1'!~'illter\,~'IlIH'll. 1_:111.' 
l(l~~ 11':1\ dl'lillni ;1' ,\\i.l) :ltl~'1 IIc,llllTCIlt millll' 
,\II.!) tit I'ull"w lIl" I :lIc' I"" 111<"'\ 11:1' ,klill",1 
;]~ I:n.' h,,~ didded I>y an\le ~:III\, 1{c"lell'''I' 
\\"a~ defined ,1\ > 50"" di:ll\wll'r 'Inll"i' at 1',,1_ 
101\' lip :Ill.! I<'l'.!t,-d \1 ithm Ih .. 11,-.\11.'.1 .lle'a 
IVUS di,~<:<.:ti"l1 II:!' ddill,'d "':l l"ll)!lludi-
11:11 1<'.11 l'al:1I1<-1 I" 11,,· \,'",'1 \\,111' III ,-III 
patknl' II ith [VUS dc,tc'ul'd dl"'-'Li"'II,IClI)!lil. 
nr\', :111.1 ,krIll Ilcre )c~-PI,kd. h'l III.-1l1'I"1l ill 
Ih~ study lill di.,,~~ti"Il' \\"~'rc' h'l':ltnl \1 ithill the 
mC:l treated hI' 1:llfi,lti"ll .\\i:1I kll)!th II.!' 
mca~ured ill lIlil)illl~'lrn, {:ir~ulllt'c'r~'IIII,tI ~".\­
ten_inll 1I'.1~ 1l\~:!'"r~'d:1' ,Ill "r~' ill dc·gr,'C". '1l1C' 
Ill>lSllIla! depth pr 11:111 <li'IIII'II"1l 1\:1' ddlll",1 
:1, f(lll(lIl'~: pllrtilll plaque I>~tll~~-Il tC',1I :1Ilt! 
mkcll!ili:1; <':!lllll'kt,· lull Ihid;m'" 1,'.11' ,':-.,-
I~lldillg t!lrough Illc' PI.IlIIiC 1" IhL- adlelHlll:I.' 
1\1l IVUS di"el'lioll 'C,'I,' Ila, (I,'atcd I" 
rank the ~~\'crity or di"'e~ti"l1 1I.lhk I). Thi, 
,e"fe f<ldlit,lt~' l'<'lllp.lrt"'1l "I di"c<.:(i"11 altcr 
Ill\' I'rurnhln' :11,,1:11 1'"11",,, "I' '\"\lIlIill1~ 111:11 
II dl"l'L1illll I, 1'ln~'lIr, tIl,' l'''tl'IIII.1I 1.llIg,' "t 
the di,~~<:tilln >l','rc' 11,1' l 'I. Tllc di",'<:li,," 
was consid~red to be h~[lkd II'hell ;I]) k;ltUI~,., 
/".>1;'''1 
, 
, 
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I 
• I , 
, 
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" 
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" 
" .'.Ioan 
1.2 -
l'i",m! </ QCA a""(ysis ,1 }""IM I"mu """·htuJ,,J 
,/h"'d;"" (p = NS). 
of cliss~ction had dis~ppcarctt. Purti~1 h~;\liug 
W;JS considered 10 have occurred when at least 
one feature of dissection persisted at follow up. 
Absence ofheaHng was defined as no change to 
the dissection on follow up. 
The prescrib~d radiation dose delll'ered to 
2 mm from the source was recorded and com~ 
pared between indilliduals with and without 
healed disse<.:tion, 
s 1',1 I IS-I H·,\1. AN,II.YSIS 
Quantitative data are presented as mean (SO). 
The non-paired two tailed Student's I test was 
used to compare dose levels and h~a!cdlnun~ 
healed dissection. 
Hcsults 
n.\~Et INri (:[1'\1(,\(. t 1'1(1'>1 !I.\ 
f'n'!1l April [<l n~el.'!1lhn [(J<)7, JI I',uil.'nh 
II'nl.' trl.',u.:d ut Ollr iU'litutioJl ,lcc"r~linl! I" tlH,' 
IIERT [,'> IrLl1. Eiglu 1'.ltk!H~, WillI !:'l'~'I"l.'d 
st.:nt illlpl~ntutiun b~.:~u>e of impurt,ull r.:..:,ul 
or angiographic and IVUS pnmm dissection 
afta balloun ;Ingi(\pla~ty, \\'er~ ~.\cl\lded frolll 
the a .. \.:"m~nt. One patknt rdll~ed [VU~ M 
Jollow lIJl; the ~um~ pJtient h:1l1 nu ~I'id~n~<.' 0/ 
di~~cct!on following tr<.!~tment. Therefor..: the 
study population was 22 patients. The baseline 
characteristics of the p~tients are shuwn in 
lable 2. 
(:fJNlCAl, ANOlOGR.~rIllC, A};,D JVUS H1LL(I\\ n' 
AI follow up 1..1 patients (63%) r~mained 
asymptomatic. Six patients presented with 
stable angina pectoris: one with Canadian 
Cardinvaseular Sodety (CCS) dass 1 nngina, 
one with CCS dass 2, nnd fuur with CCS elas~ 
3. ille fHlluw up angiograph}' demonstrated 
restenosis (> 50% diameterstenosis on quanti-
tativ<.! coronary angiography) in fiw patients 
(24%). These included the four palients with 
CCS class 3 angina. One restenOlic patient 
&howcd ancurysmatic f()rmation within the 
irradiated ar<.!a, 'Ine prcscribed dose in rc~ten~ 
oti<.: patients was 12 Gy in one patient, 14 Uy 
in one patient, and 16 Gy in three patients. 
Dissection was seen in 16122 patients (73%) 
after inter\'~ntion using h'lth angiographk and 
lVUS criterb. At six lI10nth (O!lOl\' up dissl!<.!~ 
liun W;lS sel.'ll in six patkms Oil angil'grul'hy 
(38%) and eight patients on NUS (50%) 
(tab!e 3), Disagreement between IVUS and 
angiography was caused by the presenc ... I,f a 
Juuble tUIll~n in one individual (ng I) and a 
nap in another (figs 2 and 3), neither ofwhkh 
was detected by angiugraph}', Angiograpnk 
analysis of healed versus non-healed dissection 
is pfl'scntcd in fig 4. No diffcr~nee wa.~ ~ccn in 
Ihc refnence diameter, ';-;. Jiameter s\cnm,i" 
and M I.D bdon: or :Jfter th~ prot-edufe Of :1t 
follow up for either the healed or the 
non-healed dissection groups (table 3), As 
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expected late loss and late 105s index were 
greater in the healed dissection group, but the 
difference was not significant. Eight patients 
had persisting dissection after IVUS 
cxamination~six had no ~vjdellce of healing 
and two had partial healing (table 4). Three of 
the healed dissections resulted in restenosis. 
The mean IVUS dis~ection score was 5.2 
(range 3-8) after tlu' proccdure and 4.6 (nlllgc 
3-7) at follow Ull. IVUS healed dissection 
received a mean prescribed dose of 14 Gy and 
non-healed dissection received 13.8 Gy (p 
value not significant). 
Discussion 
\,\'e describe coronary 3ftery dis'iection follow-
ing intracoronary radiatiun treatment in a 
group of individuals who had disscction noted 
angiographkal!y 31ld with IVUS, but whu did 
not undergo stent implantation as the lesioll 
appeared stable under standard clinical condi-
tions. These dissections were not associated 
with any significant acute or subacute clinical 
sequelae. What is remarkahle is that after six 
month follow up, six uf the angiogral'hk 
dissections and eight of the IVUS proven dis-
sections persisted. In a similar patient popula-
tion who had undergone cOIll'entional balloon 
angioplasty (n = 183),87 patients (47%) suf-
fered a type A-C dissection after coronary 
angioplasty. Only one dissection persisted at 
six month follow up coronary angiography 
(DEBATE I sub3n3Iy~is, unpublished dota, 
1999). 
Why should these dissections fail 10 heul in a 
predictuble manner as previously described in 
conventional angioplaslY? In an cxperimental 
model, a reduction of cell proliferation in the 
media and ad\·entitia has been observed in the 
early phase after baUoon injury a/ld radiation 
treatment. Furthermore, the expression of « 
smooth muscle actin in the advenlitia is 
reduced after rooiatio/l tr('atmcnt. ~u""c~tinl! fI 
posItive elfect UII vascular remudelling." Con-
sequently it appears that radiation treatment is 
directly implicated In altering the healing proc-
ess after balloon angioplasty, increasing the 
potential for positiVe remllddling, H arterial 
dilatation, and non-healing dissection. 
It remains uncertain as to whether the 
dhsections described represent permanent dis-
ruptions to the vessel wall or merely a retarda-
tion in the healing process. The possible 
inhIbitory healing effect of radiatiun rna}' 
diminish lI'ith lime such that at a critical point 
there may be a funher activation of the resten-
otic process associated with the healing uf the 
dissectiun. 
In an animal model, Farh and col1eugues 
showed a reduction in neointimal formation in 
"P-emitting radioactive Ments three months 
after implantation; endolhclialisation was in-
complete, however, with only one third of the 
entire intimal surface showing endothelialisa-
tion with poor formation of cell junetions.n As 
a result of incomplete or delayed cndothcliali-
sation, late thrombosis may also occur among 
the described dissections. It therefore would be 
of cOlISiderable interest to repeat IVUS assess-
men! of individuals undergoing intracoronary 
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mdiation treatment at a later date (12-18 
months postintervention) su 35 to see if there is 
evidence of persisting dissection or of wuund 
healingfreslenosis, which may present in a 
dd3)'ed fashion.l' 
Although the dissections did not 1c;ld (0 ;In 
increase of cardiac e\'ents in our populati!'Il, 
Pre!sack und colleague.' reccntly dcsc-ril>cd 1I 
higha e~'ent rOle in patients \l'hn ~ujkn:d <:<If-
onM)' dissection, after balloon dilatation only." 
In this study, the dissection type was highl~' 
correlated with the probability of a clinical 
e\'ent. Other authors harc Iwt found [\ 
difference in six month clinical event rate in 
raticnt~ with ~table cnrtIlWr)' di<;~1.'ctinll~.:· 
\'{Ie feci that additional 5ttnt implantation 
may be justintd in patient, \\'ilh di"1.'ctio1\S 
who are about In receive hrachylhcwpy fnttn\\'-
jng balloon angioplasly. 'Illis o)lprllach may h1.' 
warranted e\'en if the dis<;ectinn i, stable. After 
stent implantation in these circumstances, we 
fed that a long term antipl<"ttc!et regitl1~11 (> J 
months) m(lY prove helpful in the pr<:n~ntil'l1 I,f 
late thrombotic nCclll'>inll, gil'cll re~ 
endotltdialislItilll1 ~e('m, tn b~ d~lnr~d ill thi, 
patient cohort. 
TIlece have be('n n{1 re[,olts I'll y rndiatil'lI 
causing intecferen~e with th~ h"a1ing of diswc-
tioll. Compared wilh y radiation n higher d"~,, 
of p energy is required ill the ncar field to 
deliver the prescribed dose tu 2 mm. This 
intrinsic feature of p radiation lIl~y be {-ausing 
the dcleterjou~ effect witttc~~,,\!.· 
TIle IVUS {iisseclion scor" was cr"ated tu 
obtain a means uf wnldllg nnll C(1l11pnring di<;-
section between postproc~dural and follow up 
features. Up to tltis point, ther<: !la<; bL'<:1l nil 
systcm that elllplor~ the \I'~ll dc~crih,'d f~alure, 
of dissection (are, length, d,'pth, and pr<:sence 
of Ilnp) to cr~ate ,lIch n ranking. Ckarly, the 
fate III six month follow Ill' \If IVUS I'fl1\-('1l 
Postproceduwl disSL'ctioll i, tlllt well dc~<:Jib('<1 
nn\! \\.(' 1Il11~t rel\' Oil <'\'ill,'I1«' th~t j_ <'-.:lr.Ktcd 
fWIll angillgrapitk j,,1]I1I\' IIJl dCI\lI. ,\Il I\,US 
r~nking system may be m<:ful w describe the 
fate at follow up of dissection llI:a only in th" 
context of normal h:lllooll ungil1p!a,tr, but ah(1 
after illtra<:oflll1:lry rudil)tltl'j ;IP),. 
Using the prescribed dn~e deli\'<'r<:d 10 the 
\l)tal treated an.'a ther1.' \\"o~ 110 dilkn'lIce 
between the dose pre,crihed a\ld the prL's<:me 
of non-healing dissectiNl. On the one hand this 
relation may be genuine, on the lither it IIlay hc 
argued that this lack of cllrrdatil'!l r<:,lIlt, rflllll 
the use ufthe measur(' ufradi;!tiolJ rL'cl'iI'l,:d by 
the total vessel; thi~ mal' nllt rcnect the 
radiation dose recei,·('d by the 'I'~dtie ar~a Ilf 
dissection," IIr the radiatit'll \Ihkh i. \,lIt<:n-
liall)' tran,luitted dll\\'n the di,ntpt<:d ti,,\le 
plnnes of the dissection. It is pl1\~ihk th'1I sud. 
tiswe planes may permit grenter 1';J~_~ge of 
fIIdiation with dd~teriu\ls ~Ilw.elju~tl~<:s ~uch 
non-healing or aneurysmal change. Eljuaily, it 
is possible that certain tissue chorJeteri<;tics, 
such as heal,)' calcification, mar illlerrupt 
radiation du~iny to the k\'C1 of th~ :ltil·clllili;1. 
Clearly, IVUS provide3 ~U!1erior information to 
angiography in describing tissue characteristics 
and is likely to be nn integral part ill the calcu-
lation of appropriate radiation dose in the 
future," so as to maximise cfficacy and 
minimise thc complications of over~ and 
underdosing. 
Thc design of the radioKtive source delivcry 
Catheter may also be relevant 10 its efficacy. A 
non-centred catheter as used in this study may 
lead to inhomogeneous dosing. Alternative 
Centred devices are available; however, the 
issue is as}''''1 unresoked and will he thc subject 
of further research. '" 
iJ.\\!l'A'no.,<s. 
\V ... dc's<.:ribe the J1h~n')mel1{ln (If non-healing 
coronary artery dissection after balJoon angio-
plastr in II small group of patients. The 
uutcome uf dissection in those with flow limit-
ing dissection has not been defined, as these 
individuals all had stems implanted. 'nlC 
angiographic dissection control group for this 
stud~' is historical and there is no good descrip-
tion in the literature on the lung term outcomc 
oflhose with lVUS pruven dissectlun. 
CONCLUSION 
/1 Radiation alters Ihe normul healing process, 
resulting in unhealed dissection in certain indi-
vidu~ls, In view uf the delayed lind abnorm(l\ 
hl'oling witnessed, long term follow up may be 
prudent. t\lthough no increase in cardiac 
el'ents at six months following coronary dissec-
tion was seen in this cohort, larger populations 
urI.' Il~~dcd to confirm this phenomenon. 
Slenting of all coronary dissections and the use 
uf prolonged courses of antiplate!et agents nlay 
be wlIrranted in patients scheduled for brachy-
Ihewpy following balloon lIngioplllsty. 
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Summary and Conclusions 
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The mechanism of restenosis after percutaneous coronary interventions and its treatment have 
previously been investigated. However, due to its complexity and multifactorial nature, the 
pathological process leading to restenosis is incompletely understood and consequently the 
"magic bullet", if there will be any, has not yet been found. In the first part of this thesis we 
endeavor to improve our understanding of the mechanism of restenosis after plain balloon 
angioplasty and stenting - the current standard practice, In the second part of the manuscript, we 
report on a new technology aimed at preventing the occurrence of restenosis: intra coronary 
radiation therapy. Therefore, specific biological markers (first chapter) and the use of three-
dimensional intravascular ultrasound represented fundamental tools in our investigations. 
The first chapter is an overview of the complex restenosis phenomenon. In the second chapter, 
the relationship between inflammation, i,e. activated neutrophils expressing CD66 antigen, and 
lumen renarrowing after coronary stenting and balloon angioplasty was tested, Our results 
confirmed previous hypothesis of a beneficial role of activated neutrophils in the restenotic 
process after plain balloon angioplasty. The lack of relationship between activated neutrophils 
and lumen renarrowing after stenting suggested that this leukocyte may favorably affect the 
remodeling process. 
The third chapter, corroborates not only those findings from previous intravascular ultrasound 
(IVUS) studies showing that unfavorable remodeling plays a major role in the mechanism of 
restenosis after balloon angioplasty, but also provides a new methodological approach to 
investigate the restenotic process in humans. By the use of a new technology, three-dimensional 
(3D) IVUS, we were able to demonstrate that: I) the pattern of remodeling may vary within 
individual coronary segment, 2) the selection of the crossMsection with the minimal lumen area 
at followMup for serial IVUS analysis may be inaccurate since it does not reflect the location of 
maximal lumen loss (i.e., the maximal restenotic reaction). In chapter 4, we demonstrated, lIsing 
volumetric IVUSM3D quantification of the entire stented segment, that the restenotic process 
after implantation of two new generations tubular stents are exclusively due to neointimal 
formation. In spite of differences in design and stmt thickness, MUL TILlNK( and NIR( stents, 
both recently approved by the FDA, were able to maintain their radial support over six months 
(Le. no stent recoil) and elicited similar amount of neD intimal proliferation. 
In the second part, chapter 5 reports on the clinical application of a new therapy developed to 
reduce restellosis, intravascular radiation. This new technology has recently been applied in 
Europe and USA, and the first clinical studies have demonstrated its safety and feasibility with 
promising results on reduction of restenosis. 
As a new technology emerges, new methodologies must be developed to assess its clinical 
impact. In chapter 6 we proposed a new QCA methodology, in which specific coronary 
segments were defined: target segment, injured segment, irradiated segment and vessel segment. 
Thus, we observed that "relocation" of the minimal lumen diameter is a frequent phenomenon 
foHowing intracoronary radiation using the 90Y Msource and should be considered when 
reporting the result of clinical trials. 
Another fact to consider in the setting of radiation therapy is the need for accurate matching 
between the injured and irradiated zones. In the field of radio-oncology, the so-called 
geographic miss has been implicated in treatment failure. Thus, we investigated (chapter 7), 
using a specific QCA methodology, the incidence and clinical impact of not having completely 
covered the injured coronary segment by the radioactive source. Although we were dealing with 
a "benign" disease, geographical miss, which occurred in 31.9% of the cases, had also a 
negative clinical impact in our series, probably due to the combination of low dose radiation and 
vascular injury, Late lumen loss was much higher in the segments with geographical miss as 
compared to either irradiated or uninjured segments. The need for longer (> 30 mm) radioactive 
sources has become obvious, since one third of the cases of geographical miss would have been 
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avoided by the use of longer sources. 
Considering the promising results of the first clinical trials (chapter 5) and based on the 
observations of the first part of this thesis, one may consider the possibility that intravascular 
radiation prevents both unfavorable vessel remodeling (after balloon angioplas~) and 
neointimal formation (after stenting). Therefore, in chapter 8, we assessed the effect of 3 P beta-
radiation following coronary interventions with and without stents. By the use of IVUS-3D 
volumetric analysis, we demonstrated that radiation indeed reduces both unfavorable vascular 
remodeling in non-stented vessel and neointimal formation within stented segments. The results 
also suggested that plaque may grow outside the stent struts which was accommodated by vessel 
enlargement. 
The fact that segments adjacent to the irradiated "zone" will invariably receive lower dose of 
radiation raises an important issue: "Does low-dose radiation induce lumen reduction andlor 
plaque growth in uninjured coronary segments?" Using IVUS-3D volumetric quantification 
(chapter 9), we observed that lumen loss and plaque proliferation were similar between low-
dose irradiated and non-irradiated (non-injured) coronary segments. These results provide an 
encouragitlg answer to the above query. These findings together with those from chapter 6 
highlight the need for precise matching of the injured and irradiated segments for clinical 
efficacy of intracoronary radiation. 
Both catheter-based systems (high dose-rate) and radioactive stents (low dose-rate) have been 
used to deliver beta radiation in the clinical setting. Given the different dose rates and total dose 
delivered by each system, one may expect different arterial response subsequent to each 
treatment. Thus, we investigated (chapter 10), by the use ofIVUS-3D volumetric analysis, the 
vascular response to either radioactive stent (0.75-1.5 !lei and 6-12 ~tCi) implantation or 
"conventional" stenting followed by catheter-based irradiation. Patients treated with 
conventional stents \vithout radiation were also included in this study. The first observation that 
emerges from our analysis was that low-activity radioactive stents had a similar effect, in terms 
of neointimal formation, remodeling and "edge-effect", to that of conventional stenting without 
radiation. Secondly, we observed that both conventional stenting followed by irradiation and 
higher activity radioactive stents inhibits neointimal hyperplasia. The somewhat intriguing 
findings were the increase in total vessel and plaque volumes behind the stent when catheter-
based irradiation was applied. This phenomenon, preliminarily described in chapter 7, was not 
observed after implantation of either conventional (without radiation) or radioactive stents. 
Finally, lumen loss at stent edges was comparable between groups. 
After understanding the mechanisms and clinical applications of these new technology, a word 
of caution is provided in the final chapters (l1-13) of this thesis, where potentially deleterious 
effects ofintracoronary radiation were critically analyzed. In chapter 11, an alarming high 
(6.6%) incidence of sudden coronary occlusion late after intravascular radiation therapy was 
reported. Delayed endothelialization, late stent maiapposition and persisting dissection may be 
implicated in this phenomenon. From this "unpleasant" experience, we learned that prolonged 
antiplatelet therapy is highly recommended after intracoronary radiation therapy. 
Chapter 12 reports on the occurrence of stent malapposition detected by lVUS at 6-month 
follow-up, in spite of good apposition after the procedure. By volumetric IVUS-3D 
quantifIcation we noticed that vessel significantly enlarged in the segment of stent 
malapposition. As described in the chapters 7 and 10, vessel enlargement (remodeling) is one of 
the major consequences of intracoronary radiation and may be observed even in the presence of 
coronary stents. The combination of rigid tubular stents, vessel enlargement and diminished 
tissue proliferation after radiation were the most plausible explanation for this uncommon 
finding. Considering that both stent mal apposition and delayed reendothelialization may be 
implicated with late thrombosis and its potentially catastrophic consequences, implantation of 
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coronary stents in the setting of catheter~based radiation therapy may be discouraged. 
The fact that residual dissections may not be resolved until 6 months after treatment in about 
50% of the cases is another unique lVUS finding related to the use of brachytherapy (chapter 
13). It is nevertheless important to note that the presence of unhealed dissection was not related 
with any untoward clinical consequences. 
In conclusion, intracorona'Y radiotherapy is a robust and promising technique to prevent 
restenosis. Taking advantages of the accumulated knowledge in the first series of clinical trials, 
in which difficulties in dealing with the "unknown" became apparent, the second wave of 
clinical trials has the potential to establish the place of this new therapy. Whether tIlis exciting 
technology is a panacea has not been defined yet, but it is not likely considering the adverse 
side~effects presented in this thesis. However, il1tracoronary radiation h,as certainly opened an 
avenue for the application of "new energies" in the field of in terventiona I cardiology, 
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Samenvatting en Conclusies 
Het mechanisme van restenose nu percutane corona ire interventies and de behandeling hiervan 
is het onderwerp geweest van eerdere onderzoeken. De complexiteit en het Illulticausale van dit 
proces van restenose maakt dat het nog niet volledig begrepen wordt. Daarom is een eenduidige 
oplossil1g van dit probleem oak nog steeds niet gevondell. Het eerste deel van dit proefschrift 
behancleld het probleem van restenose na ballaH angioplasliek en stent implantatie- de huidige 
standaard behandeling. In het tweecle deel word! een nieuwe behandelingsmethode am restenose 
te voorkomell beschreven: intracoronaire irradiatie. Specifieke biologische factoren ( eerste 
hoofdstuk) en het gebruik van drie-dimensionele (3-D) intravasculaire echografie zijn de 
belangrijkste onderzoekstechnieken in dit proefschrift. 
Deell 
Hoofdstuk 1 geeft een overzicht van het cOlllplexe fenomeen restenose. 
In hoofdstuk 2 wordt de relatie tussen de ontstekingsreactie, zoals geaktiveerde neutrofiele 
granulocyten die CD66 antigeen op hun oppervlak tonen, en de restenose na stenting en ballan 
angioplastiek onderzocht Onze resultaten bevestigen de eerder geopperde positieve raJ van 
geaktiveerde neutrofieJen in het restenose proces na ballon angioplastiek. De afwezigheid van 
een positief effect van geaktiveerde neutrofielen op restenose na stenting zou op een rol van 
deze cellen in het proces van remodelering kunnen wijzen. 
Hoofdstuk 3 bevestigt Iliet aileen het proces van negatieve remodelering na ballon 
allgioplastiek, maar beschrijft bovendien de door ons geprefereerde methode van bestudering 
van restenose.Door gebruik te maken van deze nieuwe techniek: 3-D intravasculair 
ultrageluidsonderzoek waren we in 'staat om aan te tonen dat: 1. De uiting van remodelering 
verschilt tussen coronaire segment en, 2. het coronaire segment dat het grootste verschil in lumen 
diameter tOOIl! bij vervolgonderzoek kan varieren. 
In hoofdstuk 4 tonen we met 3-D echografische volume-metingen aan dat het restenose proces 
na implantatie van twee nieuwe stents bemst op neoilltime vorming. Dlldanks verschillen in 
ontwerp en draaddikte bleken Multi-Link- en NlR-stents, beide goedgekeurd door de FDA, 
allebei evenveel steun aan de vaatwand te verlenen over een periode van 6 maanden en 
aal1leiding te geven tot een vergelijkbare hoeveelheid neointimale hyperplasie. 
Deel2 
Hoofdstuk 5 beschrijft de klinische toepassing van cen nieuwe therapie om restenose te 
voorkomenlbehandelen: intravasculaire radiotherapie. Deze therapie werd recent voor het eerst 
toegepast in Europa and de USA, en deze eerste klinischc studies toonden de toepasbaarheid, 
veiligheid en voorlopige effectiviteit bij de vermindering van restenose aan. 
Wanneer nieuwe technieken het licht zien, hebben we vaak nieuwe methoden nodig am de 
effectiviteit te met en. In hoafdstuk 6 introduceren we een aangepaste methode voor 
quantitatieve coronair angiografie (QCA), waarbij specifieke coronaire segmenten worden 
gedefinieerd: het te behandelen segment, het door de (ballon)behandeling geraakte segment, het 
bestraalde segment en het behandelde bloedvat. Op deze manier konden we aantonen dat de 
plaats met de kleinste diameter (MiD) en dus de belangrijkste vernauwing vaak van plaats 
verschuift na intracoronaire bestraling met de Y-90 bron en dat dit fenomeen in aanmerking 
moet worden genomen bij de beschrijving van resultaten van klinisch onderzoek. 
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Uit het vorige voigt dat bij intrwasculaire radiotherapie de bestraalde zone de behandelde 
zone llauwkeurig en volledig client te omvatten. In geval dit niet gebeurd ant staat er een situatie 
waarbij het doelgebied voar bestrating zogenaamd efiectief geografisch wordt gemist, eell 
bekellde oorzaak van therapiefalen in de bestralingsbehalldeling van tumoren. Daarom 
onderzochten we in hoofdstuk 7 met behulp van deze aangepaste QCA methode het voorkomen 
restenose in die gevallell waarin de radioactieve bron het behandelde coronaire segment uiet 
voldoende had omva!. Het bleek dat in die gevallen de opteedende weefseleeactie indeedaad 
meer uitgesproken was en in veel gevallell (32%) aanleiding gaf tot klinische gevolgen. Late 
vermindering van de vatdiameter bleek significant vaker op te treden in de segmentell met 
geogeaphisch gemiste bestraling, vergeleken met effectief bestraalde of onbeschadigde 
segment en. Het gebruik van Jangere radioactieve bronnen zou een oplossing kunnen vormen 
voor dit fenollleen. 
Restenose wordt voornamelijk veroorzaakt door vaatkrimp (na ballonangioplastiek) en 
neointimaIe hyperplasie (l1a stent plaatsing). Om het effect van radiotherapie te evalueren 
onderzochten we in hoofdstuk 8 het effect van P-32 beta radiatie op coronaire interventies met 
en zander sterlts. Door middeI van 3-D IVUS analyse konden we aantonell dat bestraling zowel 
negatieve remodelering na balionangiopIastiek als neointimale hyperplasie na stenting 
verlllindert. De resultaten suggereren ook dat de groei van de atherosclerotische plaque buiten 
de stent toeneemt, maar dat dit gecompenseerd wordt door vergroting van de totale 
vaatdiameter. 
Het feit dat vaatsegmenten aansluitend aan de bestraalde zone zander uitzondering een iagere 
bestralingsdosis krijgt, werpt een belangrijke vraag op: "Stimuleert lage-doseeing eadiatie 
lUlllenafname en/of plaquegroei in onbeschadigde segmenten van de coronair arterie?" Met 
behulp van 3D-volumeteische ultrageluidsanalyse konden we in hoofdstuk 9 aantonen dat 
lumenafname en plaquegroei in vergelijkbare mate optraden in met lage dosis bestraalde en niet-
bestraalde, niet bij PTCA beschadigde delen van de vaten. Deze bevindingel1 tezamen met die 
van hoofdstuk 6 benadmkken de noodzaak van precieze lokalisatie van de bestralingbron over 
het gehele beschadigde gebied 0111 effectiefte zijn. 
ZoweI Iijnbronsystemen (hoge dosisafgifte per tijdseenheid), als radioactieve stents (Iage dosis 
per tijdseenheid) worden toegepast tijdens klinisch onderzoek. Gegeven deze verschillen in 
stralingskwaliteit zou er een potentieel verschil in vaatwandreactie te verwachten zijn. Daarom 
vergeleken we in hoofdstuk 10 met 3-D volumetrische echoanalyse de vaatwandreaktie na een 
radioaktieve stent (0.75-1.5 ~Ci en 6-12 [rCi) met die na een niet-radioactieve stent gevolgd 
door bestraling met een lijnbron. Als deede groep bestudeerden we patienten behandeld met een 
conventionele stent zonder bestraling. De eerste conclusie van ons ollderzaek was dat 
radioactieve stents met de laagste aktiviteit zich niet anders gedroegen wat betreft neointimale 
groei, remodelering en "edge-effect", dan niet-radioaktieve stents.Ten tweede bleken 
conventionele stents die nabestraling ontvingen, en de hogere aktiviteit radioactieve stents beide 
neointimagroei te remmell. Tot allze verrassing namen we hierbij eell toename van vaatvolume 
alsook plaquevolume waar, echter uitsluitend bij de groep met cOllventionele stents met 
nabestraling. Dus dit fenomeen van positieve remodelering dat als voorlopige resultaten 
gepresenteerd wordt in hoofdstuk 7) treffen we niet aan na radioaktieve stellts, of conventionele 
stents zonder nabestraling. 
Na het onderzoek naar de klinische toepasbaarheid en het werkingsmechanisme van deze 
nieuwe techniek, waarschuwen we in de hoofdstukken 11 tot 13 voor enkele potentieel nadelige 
bijwerkingen van intracoronaire bestraling. In hoofdstuk II rapporteren we als eersten een 
alarmerend frequent (6.6%) optreden van plotse late kransvatafsluiting na eerdere 
endovasculaire bestraling. Vertraagde endothee1celbekleding, late stent-malappositie, ell 
persisterende dissectie kunnen alledrie verantwoordelijk zijn geweest voor dit fenomeen. De les 
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van deze onaangename ontdekking was dat langdurige anti-thrombotische behandeling ten 
zeerste aanbevolen dient te worden na endovasculaire bestraling. 
Hoofdstuk 12 beschrijft het vaststellen van stent "malappositie" (het overbJijven van een 
ruimte tussen de stentdraad en de vaatwand) door lVUS na 6 maanden, ondanks een goede 
lIappositie ll (overal goed kontakt tussen stent en vaatwand) direct aan het eind van de 
implantatie. Met 3-D volumetrische intravasculaire echo konden we aantonen dat ter plaatse van 
de malappositie het bloedvat juist verwijd was. Zoals eerder beschreven in de hoofdstukken 7 en 
10, is vaatvergroting (remodelering) een van de belangrijkste konsequenties van endovasculaire 
bestraling en treedt zeIfs op in aanwezigheid van stents. Het samengaan van eell rigide 
cyIindrische stent, vaatvergroting en het verminderen van weefseIgroei na radiatie vormt de 
meest plausibele verklarillg voor deze bevinding. Overwegende dat zowel stent malappositie als 
vertraagde endotheelbedekking beide verantwoordelijk kunnen zijn voor late thrombotische 
afsluiting, en de meestal kwalijke gevolgen daarvan, dringt zieh de gedaehte op om 
terughoudend te zijn in het gebruik van stents in geval dat ook bestraling wordt toegepast. 
Het feit dat vaatwand dissecties (scheuren) 6 maanden na de behandeling met radiatie nag in 
50% van de gevallen niet genezen zijn, is een volgende echografische bevinding bij het gebruik 
van brachytherapie en beschreven in hoofdstuk 13. Het is in deze contekst echter weI 
belangrijk op te merken dat het persisteren van zoln dissectie niet geassocieerd was met eell latc 
komplicatie. 
Ais eindconclusie van dit proefschrift mag gelden dat intracoronaire radiotherapie een 
krachtige en veelbelovende methode is om restenose te remmen. Gebruikmakend van de 
ervaring opgedaan tijdens de eerste kIinische onderzoeken, kan verder klinisch onderzoek de 
plaats van deze therapie nader bepalen. Of deze interessante technologie als panacea kan worden 
toegepast, is nog niet uitgemaakt, maar gezien de bijwerkingen zoals geschetst in dit proefschrift 
niet waarschijnlijk. Intracoronaire radiotherapie vormt tenslotte wei duidelijk een llieuwe 
energiebron voor interventiecardiologen in hun strijd tegen restenose. 
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